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Abstract 
This thesis aims to improve our understanding of zygotic gene regulation during early 
vertebrate development using Xenopus tropicalis as a model system. The aim of the first part 
of the work was to differentiate between maternal polyadenylation and zygotic transcription 
as mechanisms of gene activation in the early embryo. This work used non-polyA+ selective 
gene expression analysis to systematically discriminate de novo zygotic transcription from 
polyadenylation of maternal transcripts. It concludes that immediate post-fertilisation 
transcripts are activated by polyadenylation and shortly before mid-blastula transition (MBT) 
transcription becomes the dominant mechanism of activation. The motivation then was to 
explore the gene regulatory network downstream of early activated transcription factors. A 
Morpholino screen of early, transiently activated transcription factors was carried out and 
Mix1 was selected for its early, penetrant phenotype. The aims of the following work were 
to identify the targets of Mix1, and to evaluate the use of knockdown time-series RNA-seq as 
a means of determining transcription factor targets. To identify downstream targets of Mix1, 
the transcriptomes of knockdown and control embryos were compared over a time course. 
This work concludes that the time-series RNA-seq approach can be used to identify candidate 
Mix1 targets, but that these may include morpholino-specific off-target effects. The final aim 
was to control for off-target morpholino effects and to validate candidate Mix1 targets. To 
do so, two additional knockdown time-series were generated using two different translation-
blocking morpholinos targeting Mix1 and Mixer. In addition, mix1-expressing animal cap 
explants were transcriptionally profiled to validate candidate Mix1 targets. This work 
concludes that nine Mix1 validated activatory targets are found, most of which are 
transcription factors which are enriched for functions in neural development indicating a 
novel role for Mix1, as well as functions in antero-posterior and dorsal-ventral patterning, 
supporting previous publications linking Mix1 to dorso-anterior development. 
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Chapter 1: Introduction 
 
1.1 Aims of this thesis 
 
This PhD project focuses on the early regulation of gene expression. First I investigate the 
regulation of maternal transcript polyadenylation and zygotic gene activation in the embryo 
of Xenopus tropicalis. The aim was to distinguish between polyadenylation and transcription 
as mechanisms of gene activation in order to understand when maternal transcripts are 
activated and when zygotic transcription becomes the dominant mechanism.  
 
Next I investigate the early gene regulatory networks that regulate development, by 
investigating transcription factor targets. I carried out a morpholino screen for knockdown 
phenotypes in order to identify developmentally important transcription factors for further 
investigation. From this screen I selected Mix1 due to the early and penetrant phenotype 
found in knockdown embryos. 
 
In the final chapters of the thesis I investigate the transcriptional targets of the homeobox 
transcription factor Mix1, which is amongst the earliest genes to be transcribed in the X. 
tropicalis embryo. I compared data from different morpholino knockdown RNA-seq time-
series to control for off-target effects. In order to validate candidate Mix1 targets, mix1-
expressing animal caps were sequenced to identify targets. The developmental functions of 
these targets were used to understand the likely functions of Mix1 in development.  
 
The key aims of the thesis are: 
 To distinguish between the early mechanisms of gene activation; polyadenylation 
and transcription. 
 To identify targets of the zygotic transcription factor Mix1 
 To investigate the likely functions of Mix1 through analysis of identified targets. 
 
The computational analysis in this project was carried out by Nick Owens (See Materials and 
Methods for details).  
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The following introduction is subdivided into (i) the regulation of transcript polyadenylation 
in the oocyte and early embryo, (ii) the regulation of zygotic genome activation and mid-
blastula transition (MBT), (iii) the methods used for investigating transcription factor targets 
and gene regulatory networks, (iv) examples of gene regulatory networks which regulate 
embryonic patterning, (v) the transcription factor Mix1 and related proteins and (vi) 
morpholino oligonucleotides as a tool for knocking down gene function.  
1.2 Regulating the polyA tail length of gene transcripts in the early embryo 
1.2.1 Specific transcript deadenylation in the oocyte and post-fertilisation embryo 
The shrinkage of the polyA tail (deadenylation) depends on some non-coding regulatory 
elements frequently located towards the 3’ of the transcript. These are AU -rich elements 
(AREs) with the sequence motif AUUUA and the U(G/A)-rich embryo deadenylation element 
(EDEN) (Ueno and Sagata 2002). Deadenylation is slower in the oocyte than in the early 
embryo. The degradation of deadenylated transcripts does not occur until MBT, so 
deadenylation does not destabilise transcripts (Voeltz and Steitz 1998).  
In the oocyte and early embryo, EDEN-BP (embryo deadenylation element binding protein) 
binds to the EDEN and directs deadenylation of specific transcripts at the 3’ end. EDEN -BP 
changes from a phosphorylated state in the maturing oocyte to a dephosphorylated state 
after fertilisation. This shift in phosphorylation state is calcium dependent and is 
accompanied by an increase in the rate of EDEN-dependent deadenylation (Detivaud et al. 
2003). The deadenylation and translational arrest of mos and eg2 mRNAs is driven by an 
EDEN in the 3’UTR. This effect is enhanced by an ARE located  distally from the EDEN, also 
within the 3’ UTR (Ueno and Sagata 2002). Eg2 is among the first deadenylated mRNAs and 
has cis-regulatory motifs that instruct its rapid deadenylation. The deadenylation of eg2 is 
sufficient for its degradation at the blastula stage and forced polyadenylation was sufficient 
to block transcript degradation (Audic, Omilli, and Osborne 1997). A large scale study 
revealed that 158 maternal mRNAs were targets of deadenylation mediated by EDEN and 
these genes were enriched for factors regulating oocyte maturation in X. tropicalis 
(Graindorge et al. 2008).  
1.2.2 Regulation of polyadenylation in the oocyte and early embryo 
During oocyte maturation, transcripts which regulate early oogenesis are deadenylated as 
they are no longer required. For example, mRNAs encoding cytoskeletal actin, ribosomal 
proteins and translation elongation factor 1a are deadenylated which reduces their 
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translational efficiency (Varnum and Wormington 1990). Also during meiotic maturation, 
mRNAs encoding factors that function in the establishment of mitosis are polyadenylated, 
these include c-Mos kinase and mitotic cyclins (Radford, Meijer, and de Moor 2008). 
Two elements regulate polyadenylation; these are the hexanucleotide AAUAAA sequence 
and the cytoplasmic polyadenylation element (CPE). The CPE must be bound by CPE-binding 
protein (CPEB) for polyadenylation to occur (Hake, Mendez, and Richter 1998). The 
hexanucleotide sequence is bound by the cleavage and polyadenylation specificity factor 
(CPSF) and functions as part of the polyadenylation machinery (Dickson et al. 1999). The 
distance between these two elements affects the timing of polyadenylation. Bringing these 
two elements closer together causes precocious completion of transcript polyadenylation 
(Simon, Tassan, and Richter 1992). Pre-fertilisation polyadenylation is specific to the 
transcripts which contain a CPE. This protects them from the default deadenylation pathway 
(Legagneux, Omilli, and Osborne 1995).  
Several maternal mRNAs with a role in meiosis II and mitosis such as cyclins a, b1 and b2, and 
c-mos are amongst those polyadenylated during oocyte maturation. The polyadenylation of 
such transcripts is necessary for the progression through meiosis II and for the establishment 
of mitosis (Weeks, Walder, and Dagle 1991; Barkoff, Ballantyne, and Wickens 1998; Groisman 
et al. 2000). 
Maskin is a factor which can block translation of CPE-containing mRNAs in the oocyte by 
associating with CPEB and the translation initiation factor eIF4E (Fig. 1.1) (Cao and Richter 
2002). This blocks the association between eIF4E and eIF4G which is necessary for the 
formation of the translational machinery. During oocyte maturation, progesterone induces 
the phosphorylation of CPEB by Aurora kinase A, which promotes the association of CPSF 
with the hexanucleotide element. Once CPSF is bound to the mRNA, polyA polymerase (PAP) 
associates with the 3’ end of the mRNA and activates polyadenylation. Once the polyA tail is 
elongated, several PABP molecules bind to it causing Maskin to the dissociate from eIF4E 
which permits formation of the translation complex on the mRNA (Fig. 1.1) (Cao and Richter 
2002). 
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Figure 1.1. Maskin mediates inhibition of translation in the immature oocyte. Following a 
progesterone signal during oocyte maturation, phosphorylation of CPEB by Aurora kinase 
A mediates elongation of the polyA tail. PABP associates with the polyA tail and associates 
with eIF4G which in turn associates with eIF4E, displacing it from Maskin. The 40S 
ribosomal subunit is then bound by eIF3 which associates with eIF4G. Figure adapted from 
(Cao and Richter 2002).  
In the Xenopus embryo, maternally-deposited mRNAs are polyadenylated from fertilisation 
through to the blastula stage (Sagata, Shiokawa, and Yamana 1980). A class of mRNAs which 
includes cl2 and c-raf was identified, these transcripts are present in a deadenylated state in 
the oocyte and become polyadenylated after fertilisation (Paris et al. 1988). The same as in 
the oocyte, two cis elements in the 3’UTR of maternal mRNAs; the CPE and hexanucleotide, 
instruct polyadenylation in the embryo, leading to translation. The cl2 and c-raf mRNAs also 
have a masking element which prevents their polyadenylation in the oocyte (Simon and 
Richter 1994). 
In the mouse oocyte, the necessity for the CPE and hexanucleotide elements in the regulation 
of cytoplasmic polyadenylation has been demonstrated for several mRNAs including C-mos 
and CyclinB1. The CPEB proteins are highly homologous in Xenopus and mouse and both 
undergo phosphorylation during oocyte maturation, and in mouse this may also mediate 
polyA tail elongation (Richter 1999). In contrast to Xenopus, polyA tail elongation and 
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translation do not appear to be coupled in the mouse oocyte. Instead, an unknown mRNA 
binding protein associates with the CPE during oocyte maturation and this is removed to 
unmask sequences and allow translation to occur in the presence of a short polyA tail (Stutz 
et al. 1998). In the post-fertilisation mouse embryo, polyadenylation of maternal transcripts 
occurs, as is found in Xenopus embryos. This indicates that maternal factors may be 
important for early development in mouse, even though zygotic transcription is established 
at the 1-cell stage and maternal transcripts are deadenylated at the 2-cell stage (Richter 
1999).  
Bicoid, Toll and Torso are essential to axis formation in Drosophila embryos and are present 
as maternal transcripts which undergo polyadenylation as a means of translational activation, 
as is found in Xenopus (Salles et al. 1994). The in vivo function of the CPE and hexanucleotide 
elements have not been demonstrated in Drosophila. However Orb, an orthologue of CPEB, 
along with an elongated polyA tail, are essential for Oskar translation during oocyte 
maturation in Drosophila (Castagnetti and Ephrussi 2003). This suggests that the CPE and 
hexanucleotide-mediated pathway of polyadenylation that is found in Xenopus is also active 
in Drosophila. Xenopus cyclinB1 transcripts were used to demonstrate the ability of 
Drosophila to regulate polyadenylation through the CPE and hexanucleotide element (Coll et 
al. 2010). Other mechanisms of regulation of polyadenylation exist, Toll mRNA contains a CPE 
hexanucleotide element which is not required for its polyadenylation. Instead, the 
polyadenylation of Toll was found to be regulated by a region of 183 nucleotides in the 3’UTR 
known as the polyadenylation region (PR) (Coll et al. 2010).  
The mechanism of cytoplasmic polyadenylation in zebrafish appears to be much the same as 
in Xenopus, requiring a CPE and hexanucleotide sequence. However, the CPE sequences in 
cyclinB1 mRNA have diverged, resulting in higher efficiency of polyadenylation and 
translation in Xenopus than in zebrafish, most likely due to differing requirements for levels 
of CyclinB1 protein (Zhang and Sheets 2009). The specific transcripts that were detected as 
being regulated by cytoplasmic polyadenylation in the early zebrafish and  Xenopus embryo 
were compared. Of the early polyadenylated genes in zebrafish which had an orthologue in 
X. tropicalis, 20% were also polyadenylated shortly after fertilisation in X. tropicalis embryos 
indicating some level of conservation in the targets for maternal polyadenylation (Collart et 
al. 2014; Aanes et al. 2011). 
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1.2.3 Polyadenylation affects translation efficiency 
In the oocyte and early embryo, polyadenylation is used to control translation of specific 
transcripts (Paris and Philippe 1990). The process of polyadenylation directly induces 
translation by stimulating methylation of the ribose cap. This methylation event is permissive 
for translation of maternal transcripts polyadenylated during oocyte maturation (Kuge and 
Richter 1995). The methylated 5’ cap can then be bound by a protein complex which 
regulates the association of the small ribosomal subunit to the mRNA. A long polyA tail 
stimulates translation by the formation of a closed loop between the 5’ and 3’ end of the 
transcript attracting major components of the translation machinery (Piccioni, Zappavigna, 
and Verrotti 2005). The polyadenylation of the maternal mRNA c-mos is sufficient to trigger 
its translational activation, which is required for meiotic maturation. 
Transcriptome-wide sequencing was used to monitor polyA tail length in pre-MBT and 
gastrula stage Xenopus and zebrafish embryos. Before MBT longer polyA tails correlate with 
higher translational efficiencies. At the gastrula stage, this correlation is lost and the polyA 
tail appears to protect against transcript degradation (Subtelny et al. 2014).  
1.2.4 Transcript degradation at MBT 
The introduction of the degradation pathway at MBT means that polyadenylation then 
stabilises transcripts and removal of the polyA tail causes rapid degradation of transcripts 
(Duval et al. 1990). To address whether deadenylated transcripts can persist in the embryo 
until degradation is established at the MBT, Audic et al. injected β-globin mRNAs comprising 
just the 3’ UTR and ORF into X. laevis embryos in polyA+ and polyA- forms. After MBT, only 
the polyA+ transcripts were resistant to degradation and deadenylation was necessary to 
promote their degradation (Audic, Omilli, and Osborne 1997). The zygotically transcribed 
miR-427 directs deadenylation of maternal transcripts after MBT to regulate transcript 
clearance. This is mediated through a miR-427 binding sequence found in the 3’UTRs of 
mRNAs such as cyclin a1 and b2 (Lund et al. 2009). 
Degradation of maternal transcripts is regulated by maternal factors in Xenopus. The post-
MBT degradation pathway is blocked in embryos without de novo protein synthesis. However, 
blocking transcription does not inhibit the degradation of aurka (aurora kinase A) mRNA. 
Together these results indicate that the translation of maternal factors is necessary for the 
degradation pathway to function (Bouvet et al. 1991; Duval et al. 1990).  
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Possible reasons for the absence of degradation in pre-MBT embryos are: (i) A limiting factor 
of the degradation machinery is not translated before MBT, (ii) RNA binding proteins protect 
transcripts from degradation before MBT, or (iii) A component of the de-capping pathway is 
synthesised at MBT (Audic, Omilli, and Osborne 1997). De-capping of mRNAs is necessary for 
their degradation in yeast where the enzyme Dcp1 is required for de-capping activity 
(Beelman et al. 1996).   
1.2.5 Large scale studies into transcript polyadenylation during embryogenesis 
Large-scale studies have uncovered a detailed picture of the genes that are regulated post-
transcriptionally in early development. Graindorge et al. used microarray technology to 
identify 500 genes that undergo changes in polyA tail length during oocyte maturation and 
early embryogenesis in X. tropicalis (Graindorge et al. 2006). They found that during oocyte 
maturation 142 mRNAs were polyadenylated and 294 were deadenylated. After fertilisation 
114 mRNAs were polyadenylated and 122 were deadenylated. Interestingly, in around 75% 
of the transcripts polyadenylated during oocyte maturation no CPE was found, which would 
render these transcripts permissive to the default deadenylation pathway (Graindorge et al. 
2006). RNA-seq was used to reveal maternal polyadenylation of 551 genes in the early wave 
of gene activation which occurs over the first two hours of development (Collart et al. 2014). 
To investigate the dynamic changes in polyA tail length and transcript abundance, X. 
tropicalis embryos were profiled at several developmental stages for polyA+ and total RNA 
(Paranjpe et al. 2013). Over 9000 transcripts were found to undergo changes to their polyA 
tail length (Paranjpe et al. 2013).  
 
1.3 The Mid-blastula transition and zygotic genome activation 
1.3.1 The Mid-blastula transition 
The mid-blastula transition (MBT) is characterised by the switch of maternal to zygotic 
control of development. At MBT maternal gene products are degraded and zygotic 
transcriptional regulation is established (Newport and Kirschner 1982a). In Xenopus, rapid 
cell cycles lacking gap phases become asynchronous and more highly regulated to include 
gap phases and cell cycle checkpoints. In addition, cell motility is established at this stage 
(Newport and Kirschner 1982b; Shimuta et al. 2002). 
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Figure 1.2. The early stages of Xenopus development. The mid-blastula transition (MBT) 
occurs after the first twelve rapid cleavages in Xenopus. The developmental stages in the 
blastula and gastrula stages occur at irregular intervals. Xenopus stage images reproduced 
from Nieuwkoop and Faber (Nieuwkoop and Faber 1994) with permission Garland 
Science/Taylor & Francis, LLC. 
 
The MBT occurs independently of transcription and the number of cell cycles completed 
(Newport and Kirschner 1982a). The onset of MBT was proposed to be regulated by the 
down-titration of an unknown factor as its cytoplasmic concentration decreases in 
proportion to cellular DNA levels over successive cell divisions, known as the 
nucleocytoplasmic ratio. Transcription can be induced prematurely in X. laevis embryos by 
injecting enough RNA to recapitulate the level of DNA that is found at MBT (Newport and 
Kirschner 1982b). As well as transcriptional activation, the nucleocytoplasmic ratio regulates 
the lengthening of the cell cycles at MBT and the establishment of cellular motility (Clute and 
Masui 1995; Newport and Kirschner 1982b). It has been proposed that the cell cycle 
checkpoint is regulated by developmental timing rather than nucleocytoplasmic ratio (Clute 
and Masui 1995).  
The induction of transcription at MBT is thought to be triggered by the depletion of a DNA-
binding repressive factor (Newport and Kirschner 1982b). A gradual increase in genomic DNA 
that causes the levels of free histones to deplete leading up to MBT was reported in Xenopus. 
As the DNA concentration increases, the transcriptional machinery is able to outcompete 
histones for DNA occupancy (Hair et al. 1998). The histone proteins H3 and H4 form 
tetramers and have been shown to regulate the activation of transcription as well as the 
elongation of cell cycles which occurs at MBT (Amodeo et al. 2015). Depletion of H3 induces 
early transcription and increased cell cycle length, whereas addition of H3/H4 decreases cell 
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cycle length. The high histone to chromatin ratio in the early cell cycles creates a densely 
occupied chromatin which is inaccessible to transcription factors and transcriptional 
machinery. As the ratio decreases over successive cell cycles, histones are titrated and the 
chromatin becomes more accessible (Amodeo et al. 2015). However, pre-MBT gene 
transcription occurs which indicates that some genomic regions are accessible earlier than 
MBT (Collart et al. 2014). Histone modifications at specific regions may facilitate transcription 
factor binding before MBT.  
The increasing nuclear concentration of DNA leads to down-titration of four DNA replication 
factors RecQ4, Treslin, Drf1, and Cut5 (Collart et al. 2013). They are implicated in regulating 
the increased initiation of origin firing at MBT, which controls the rate of DNA synthesis. 
When all four factors are overexpressed, the post MBT cell cycles do not lengthen and rapid 
cell divisions continue beyond the twelfth cycle leading to an increased cell number. 
Furthermore, the checkpoint protein Chk1 is prematurely activated by phosphorylation, 
extensive MBT transcription is delayed and embryos fail to gastrulate normally (Collart et al. 
2013). This is a convincing explanation for the regulation of the number of rapid cell cycles 
occurring, but it is unclear how transcription could be controlled by these DNA replication 
factors.  
1.3.2 Epigenetic regulation of zygotic genome activation 
Epigenetic marks come in the form of chemical modifications of the DNA and histones, such 
as methylation of cytosine within DNA and the addition of methyl and acetyl groups to amino 
acids of histone proteins. Such modifications are usually found at promoter, enhancer and 
coding regions and act to alter chromatin packaging to control its availability for gene 
expression events (Bogdanovic, van Heeringen, and Veenstra 2012). The ability of a cell to 
specify genes as active or inactive enables the emergence of distinct cell lineages each with 
their own repertoire of expression events (Bogdanovic, van Heeringen, and Veenstra 2012). 
By altering the epigenetics within individual cells, organisms can adapt to changes by 
regulating gene expression at the chromatin level (Bruce et al. 2003).  
In the pre-MBT embryo, genes with developmental and homeostatic roles are regulated at 
the level of chromatin modification. They can be given permissive H3K4me3 and/or 
repressive H3K27me3 or H3K9me3 histone marks, specifying different states of gene 
expression from the MBT and onwards (Lindeman et al. 2011). The H3K27me3 histone 
modification alters the chromatin to a closed and repressive state through recruitment of 
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PRC1 to the histone tail which in turn recruits SWI/SNF chromatin remodelling factors (Cao 
et al. 2002).  
ChIP-seq revealed enrichment of the permissive H3K4me3 histone modification at the 5’ end 
of genes which is associated with their transcription in X. tropicalis. Similarly, the H3K27me3 
signal is associated at the 5’ end of genes, but corresponds with restricted gene expression. 
ChIP-seq also revealed enrichment of RNA polymerase II (RNAPII) primarily at the 
transcriptional start site (TSS) and to a lesser extent along the length of the reading frame 
(Akkers et al. 2009). The H3K36me3 modification is commonly associated with transcriptional 
activity and can often be found downstream of the H3K4me3 promoter mark, across the 
reading frame of active genes (Mikkelsen et al. 2007).   
In X. tropicalis, no histone modifications were found in the pre-MBT embryo where a 
repressive chromatin state is maintained (Akkers et al. 2009; Bogdanovic et al. 2011). 
H3K4me3 marks were present from the MBT on many genes and the introduction of this 
signal generally preceded or coincided with gene expression. The majority of H3K27me3 
modifications were detected from the mid-gastrula stage and were frequently accompanied 
by a reduction in gene expression (Akkers et al. 2009).  
In the Xenopus embryo, Beta-catenin is maternally deposited and is activated downstream 
of asymmetric Wnt signals (Schroeder et al. 1999). Beta-catenin specifies the dorsal-ventral 
axis by the 4th cleavage even though its first downstream targets nodal5 and nodal6 are not 
expressed until the 8th cleavage (Blythe et al. 2010). The implication is that chromatin 
modifications induced by Beta-catenin in the early embryo regulate later transcriptional 
events. Beta-catenin is necessary for the establishment of H3K4me3 histone marks at the 
promoter regions of its targets sia1 and nodal3, establishing a poised transcriptional state 
(Blythe et al. 2010). Importantly, the interaction between Beta-catenin and the 
methyltransferase Prmt2 is necessary and sufficient for dorsal specification (Blythe et al. 
2010).   
Regions co-enriched for H3K4me3 and H3K27me3 modifications appeared to correlate with 
low levels of gene expression and RNAPII association in X. tropicalis (Akkers et al. 2009).  ChIP-
seq of embryos dissected into animal-vegetal and dorsal-ventral halves revealed that the 
H3K27me3 modification is associated with spatially restricted genes along the animal-vegetal 
or dorso-ventral axes. Different histone marks are present within different cell populations 
in the embryo to allow localised gene activation (Akkers et al. 2009). For example, at the vegt 
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locus, H3K27me3 was present in the animal pole segment, which is consistent with the 
localised expression of vegt in the vegetal pole (Akkers et al. 2009).  This contrasts with the 
finding in mouse ESCs and zebrafish embryos that bivalent H3K4me3 and H3K27me3 
modifications at a single locus are associated with genes poised for transcriptional activation 
(Lindeman et al. 2011; Bernstein et al. 2006).  
The maternally encoded DNA-methyltransferase Dnmt1 regulates the timing of zygotic gene 
activation. A methylated DNA state is found in the sperm and oocyte but is not maintained 
after fertilisation and diminishes up to the MBT, reaching a state of hypomethylation 
(Stancheva et al. 2002). Dnmt1 is required for specific methylation of promoter regions of 
MBT-transcribed genes in order to prevent premature expression. Depletion of Dnmt1 was 
associated with loss of promoter methylation and precocious expression of brachyury, gft3a, 
and myc. The same was not true for genes expressed after the MBT, suggesting a role for 
Dnmt1 in temporally regulating the earliest zygotic transcription events. As the histone to 
DNA ratio decreases leading up to MBT, DNA methylation is reduced and transcription is 
rapidly de-repressed (Stancheva et al. 2002).  
When Dnmt1 was depleted by morpholino knockdown, the premature induction of MBT 
expressed genes was observed 2 cell cycles early even though methylation at promoter 
sequences was not reduced compared to controls at stage 8. Rescue using mutant human 
mRNA demonstrates that the methyltransferase activity of Dnmt1 is not required for 
repression of pre-MBT transcription (Dunican et al. 2008). Dnmt1 seems to function as a 
transcriptional repressor by binding non-specifically to un-methylated gene promoter 
regions. Dnmt1 has a dual function to both directly negatively repress gene induction through 
promoter binding, and to methylate chromatin to generate a general state of transcriptional 
repression. Both functions are necessary for gene induction, genes such as sp1 and oct91 are 
sensitive to Dnmt1 repression through direct promoter binding, whereas brachyury is 
sensitive to Dnmt1-mediated methylation of its promoter (Dunican et al. 2008). 
1.3.3 The regulation of zygotic genome activation by transcription factors 
Different “waves” of zygotic transcription were identified in zebrafish, the first wave emerges 
from 4.0 hpf and is regulated by maternal factors and zygotically-regulated transcription 
occurs in subsequent waves. In zebrafish, three transcription factors were identified as 
master regulators of the initial wave of zygotic transcription, these were Nanog, SoxB1 and 
Pou5f1 (Oct4) (Lee et al. 2013). Depletion of all three factors using morpholinos reduced 
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expression of zygotic genes activated in the first wave by 77%, and expression of maternal 
and zygotic genes in the first wave by 50% leading to a greater effect  in the reduction of 
subsequent transcription. The three transcription factors induce transcription of miR-430, 
leading to maternal transcript degradation once zygotic transcription is established (Lee et 
al. 2013). 
In the mouse embryo Oct4, Sall4 and Nanog are responsible for the activation of widespread 
zygotic transcription from the 2-cell stage. Over 2000 mRNAs and 120 miRNAs were 
downregulated in Oct4, Sall4 or Nanog single knockdown embryos.  (Tan, Au, Leong, et al. 
2013). ChIP-seq data revealed that mouse ESCs have enriched binding of Sox2, Oct4 and 
Nanog (Lee et al. 2013). There are similarities in the transcription factors that regulate mouse 
and zebrafish transcriptional activation, as Pou5f1 and Oct4 are orthologous proteins, 
however no striking similarities to Xenopus have been identified.  
 
In Drosophila development, the transcription factor Zelda activates early zygotic 
transcription and maternal transcript depletion. Zelda null embryos underwent extensive 
down-regulation of zygotic expression. Affected genes were enriched for the CAGGTAG 
TAGteam motif close to the TSS. Zelda is sufficient to induce expression through the TAGteam 
motif (Liang et al. 2008). No Zelda orthologue or similarly functioning factor has been 
identified in Xenopus (Skirkanich et al. 2011). 
In Xenopus, no transcription factors have yet been identified which act as master regulators 
of zygotic transcription. Ventx factors are ventrally expressed and have been found to be 
functionally and structurally similar to mammalian Nanog. Similarly to mammalian Nanog, 
Xenopus Ventx factors interact with Pou5f1 factors such Oct91. Ventx overexpression 
represses differentiation to committed cell fates in all germ layers, indicating a function for 
Ventx factors in promoting pluripotency. The pluripotency factor Oct91 was repressed when 
Ventx was knocked down. Morpholino knockdown of Ventx generated a dorsalised 
phenotype, which was rescued using mouse Nanog mRNA (Scerbo et al. 2012). 
The timing of the onset of zygotic transcription varies between species. In zebrafish and 
Xenopus embryos, transcription is first detected at the 64-cell stage and in Drosophila the 
earliest transcription is detected at the 1024-cell stage (Wang and Davis 2014). Low level 
transcription is detected from the 1-cell stage in mouse embryos, followed by the onset of 
major transcription during the 2-cell stage (Abe et al. 2015; Wang and Davis 2014). There is 
a correlation between the timing of onset of zygotic transcription and the length of 
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embryonic cell cycles. In mammals, early cleavages are slow and allow sufficient time for 
transcription to proceed between cell divisions, whereas animals with faster early cleavage 
times, such as Xenopus, zebrafish and Drosophila cannot commence transcription until later 
(Wang and Davis 2014). Maternally deposited proteins and the post-transcriptional 
regulation of maternal transcripts occurs in Xenopus, zebrafish and Drosophila to sustain the 
early embryo before zygotic transcription is activated (Wang and Davis 2014). 
 
1.4 Studying gene regulatory networks 
1.4.1 Experimental methods for identifying transcription factor targets 
Gene targets can be investigated using loss-of-function strategies e.g. morpholino 
knockdown and transgenic lines. The control and knockdown samples can be compared in 
order to examine which genes are differentially expressed in response to depletion of a 
particular transcription factor. Microarray and RNA-seq are commonly used to identify 
expression changes in knockdowns (Plouhinec et al. 2014; Kwon et al. 2014). A weakness of 
knockdown studies is that transcription factors may have redundant functions to activate the 
same downstream genes, which can mask the identification of transcription factor targets.  
In S. cerevisiae, an issue with knockdown studies for identifying transcription factor targets 
is that some transcription factors may not be expressed under certain growth conditions. An 
alternative strategy was employed in yeast: generating transcription factor overexpression 
strains and analysing downstream gene expression by microarray to identify transcription 
factor targets (Chua et al. 2006). The functional classes of identified targets were used to 
characterise transcription factor functions (Chua et al. 2006).  
In Xenopus, animal cap explants are commonly used as a gain-of-function assay to measure 
gene induction in response to injection of a particular transcription factor or signalling 
molecule mRNA. The animal cap cells of the Xenopus embryo retain pluripotency and can be 
treated or injected with molecular signals to manipulate the caps to express different genes 
and to differentiate into different tissues (Ariizumi et al. 2009). This technique combined with 
RNA-seq and RT-PCR has been successfully used to identify gene interactions downstream of 
the transcriptional regulator Cited2 (Yoon et al. 2011).  
A caveat of overexpression analysis is that when transcription factor protein levels are 
elevated above normal levels, a transcription factor may indiscriminately target gene 
expression leading to false identification of targets. To overcome this problem, comparative 
Chapter 1 – Introduction 35 
analysis of transcription factors targets identified by gain-of-function and loss-of-function 
analysis of transgenic lines can be applied to provide stringent identification of targets 
(Horton et al. 2003), much like my approach of using morpholino knockdown and animal-cap 
sequencing experiments to complement one another. 
1.4.2 Determining direct transcription factor targets 
There are several techniques which enable us to detect direct TF targets. One of them, 
commonly used in Xenopus is the animal cap assay performed with a translational repressor, 
and more recently ChIP experiments have been used to determine direct transcription factor 
targets. Xenopus animal cap explants and whole embryos can be treated with translation 
inhibitor cycloheximide to demonstrate direct transcription factor-target interactions 
(Yokotal et al. 1995). However cycloheximide treatment has been shown to induce gene 
expression, therefore results from experiments using cycloheximide must be validated by 
other means (Hu and Hoffman 1993). Alternatively, the physical binding of a transcription 
factor to genomic regions can be demonstrated by electrophoretic mobility shift assay 
(EMSA). This technique tests binding of an isolated transcription factor to specific DNA 
sequences by assaying the gel size shift of protein-DNA complexes compared to unbound 
DNA (Garner and Revzin 1981). However, this technique is now outdated and large scale 
approaches are more commonly used to assay transcription factor binding. 
To demonstrate potential global direct transcription factor-target interactions, the genomic 
binding regions of a particular transcription factor can be determined using Chromatin 
immunoprecipitation (ChIP) (Robertson et al. 2007).  Proteins and DNA are cross-linked and 
the chromatin complexes are immunoprecipitated using an antibody specific to a 
transcription factor. Microarray (ChIP-chip) or RNA-seq (ChIP-seq) can then be used to 
determine genomic binding locations or ‘peaks’ (Robertson et al. 2007). Candidate target 
genes are determined by proximity to peaks, and can be validated individually by qPCR, or at 
a larger scale by comparative transcriptomics (Ramagopalan et al. 2010; Robertson et al. 
2007). Typical ChIP experiments may yield several thousand peaks, implicating at least many 
hundreds of candidate target genes (Robertson et al. 2007; Sakabe et al. 2012). This approach 
is complicated by the discovery of functional enhancers hundreds of kb from the relevant 
gene promoter (Hallikas et al. 2006). For this reason, binding proximity of a transcription 
factor to a transcriptional start site is not a reliable way of identifying transcription factor 
targets and ChIP should be used in combination with other techniques. 
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Different ChIP-seq studies have applied various parameters for the identification of 
transcription factor targets based on binding proximity to the transcriptional start site (TSS). 
A comparative analysis of the methods used in 68 ChIP-seq studies revealed that for 
determination of transcription factor targets, all peaks in proximity of a gene should be taken 
into account and each peak should be scored based on intensity and proximity to the TSS. 
This means long range interactions cannot be reliably detected using this method (Sikora-
Wohlfeld et al. 2013).  
These approaches mentioned, when used in combination can be a particularly powerful 
strategy for identifying transcription factor targets. The targets of transcription factors can 
be identified through morpholino injection, followed by animal cap dissection, culture and 
RNA-seq to identify differentially expressed genes. ChIP-seq can then be used to determine 
transcription binding regions, and this data can then be combined with the RNA-seq data by 
comparing targets identified in each assay to determine direct transcription factor targets 
(Kwon et al. 2014). A caveat of using tagged-ChIP is that overexpressing a transcription factor 
may lead to mis-regulated binding to regions not usually regulated by that transcription 
factor. 
1.4.3 Computational methods of investigating transcription factor targets 
Sequence analysis can be used to predict transcription factor binding sites. Bioinformatics 
was used to predict genomic binding sites for E2F family transcription factors based on the 
proximity of binding motifs to transcriptional start sites. This method was used to identify 
numerous known and novel putative targets likely to have a role in cell-cycle processes. One 
novel target was confirmed through ChIP-PCR to confirm transcription factor binding in 
mouse, human and hamster (Kel et al. 2001).   
TargetOrtho is a bioinformatics tool which carries out a genome-wide search for established 
transcription factor binding motifs in related species in order to predict transcription factor 
targets. Novel predicted transcription factor binding sites were validated using a reporter 
assay, demonstrating the effectiveness of this technique in C. elegans (Glenwinkel et al. 
2014). Prediction of transcription factor targets through sequence analysis may be prone to 
errors because transcription factors may not bind to all consensus sequences and binding to 
sequences may be context dependent. Furthermore, there may be a high frequency of 
predications for degenerate motifs. 
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1.4.4 Methods for constructing gene regulatory networks 
Combined knockdown analysis of several genes has been used to study GRNs. Embryos 
individually depleted of three known regulators of endoderm; Mixer, Nodal and Sox17 were 
analysed by microarray for expression of genes enriched in the vegetal region. Unique and 
shared targets were identified between Mixer, Nodal and Sox17, providing an understanding 
of part of the complex regulatory network governing endoderm induction and mesendoderm 
repression (Sinner et al. 2006).  
Data can be taken from multiple gene perturbation analysis studies to map together gene 
interactions of numerous transcription factors and signalling molecules. A network for 
endomesoderm development in sea urchin embryos has been developed, which collates 
information on gene perturbation analysis, gene localisation and directness of gene 
interactions defined using computational and experimental methods. This reveals feedback 
loops, and localised mechanisms of activation and repression that function to specify 
endoderm and mesoderm (Davidson et al. 2002). Loose and Patient carried out a meta-
analysis to collate previous work into visual GRNs of Xenopus mesendoderm development. 
Gene interaction networks were constructed based on gene expression changes influenced 
by altered upstream gene expression and proof of transcription factor binding within 
regulatory regions, or the demonstration of direct interaction. The GRNs display spatial and 
temporal organisation of signalling events as well as distinguishing between maternal and 
zygotic signals (Loose and Patient 2004). 
The cell cycle gene regulatory network in S. cerevisiae was studied by identifying direct 
targets of nine known cell cycle transcriptional activators using ChIP-chip (Simon et al. 2001). 
Transcription factors were found to regulate other transcription factors functioning in 
successive stages of the cell cycle, resulting in a circuit of gene regulation. The transcription 
factors were each found to have stage-specific functions to form a highly regulated network 
controlling all processes involved in the cell cycle (Simon et al. 2001). As a follow up to this 
study, transgenic stains were individually constructed for 106 transcription factors to contain 
a myc epitope tag. ChIP-chip was then used to identify likely transcription factor targets. This 
revealed nearly 4000 gene interactions which were mapped to construct highly 
interconnected gene regulatory networks for different processes e.g. metabolism and 
developmental processes. Furthermore, different regulatory motifs within the network were 
identified e.g. positive feedback loops, giving an insight into the regulatory mechanisms 
within the network (Lee et al. 2002).  
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A major advantage of computational methods for building gene regulatory networks is that 
large datasets can be combined which use different conditions and therefore availability of 
co-factors to build a richer picture of gene regulation. Gene interactions identified by Lee et 
al. through ChIP-microarray analysis described above (Lee et al. 2002), were compared to a 
library of gene expression data collected from hundreds of transcriptomes (Gao, Foat, and 
Bussemaker 2004). Gene interactions that were correlated in both data sets were assigned a 
“coupling strength” based on the significance of the measured interactions. Gene ontology 
analysis revealed functional enrichment amongst the significant gene interactions. This 
revealed that approximately half of targets identified through ChIP analysis were not 
validated through expression data. The unconfirmed ChIP interactions may be false positives, 
but may also reflect complex regulatory scenarios e.g. the presence of inhibitory factors, 
chromatin inaccessibility and the lack of co-factors (Gao, Foat, and Bussemaker 2004). This 
approach of combining large-scale datasets is more sensitive for determining direct 
transcription factor targets than simply combining loss-of-function data with ChIP data from 
a single study. 
In an attempt to understand the networks which regulate human disease, ENCODE ChIP-seq 
data was compared to functional modules derived from microarray meta-analysis to improve 
the identification of transcription factor targets (Karczewski et al. 2014). Functional modules 
are sets of genes which are co-regulated in different experimental conditions. Transcription 
factor targets identified by ChIP-seq analysis were compared to the functional modules. If 
many genes share a functional module, they are more likely to be genuine transcription 
factor targets. The functional modules associated with transcription factors were subjected 
to gene ontology (GO) analysis and many were associated with known functions of the 
associated transcription factor. Different functional modules were connected when 
regulated by the same transcription factors, revealing network interactions. These module 
connections based on transcription factor regulation were used to generate disease 
networks. The transcription factors associated with particular diseases clustered into 
different sub-networks. This method was used to identify thousands of significant 
transcription factor targets, and associations with 253 diseases (Karczewski et al. 2014).  
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1.5 Patterning the early Xenopus embryo 
1.5.1 The establishment of embryonic axes 
The early embryo depends on maternally deposited proteins and mRNA to direct the early 
specification of dorso-ventral and animal-vegetal axes. After zygotic genome activation, a 
complex gene regulatory network that regulates embryonic development is established 
(Heasman 2006).  
The sperm entry point defines the position of the dorso-ventral axis, Wnt11 accumulates 
dorsally through differential polyadenylation and translation of wnt11 mRNA (Schroeder et 
al. 1999). Wnt11 then signals through Beta-catenin to activate tcf3 which then drives 
transcription of nodal5 and nodal6 to influence dorsal fates (Yang et al. 2002). The Spemann 
organiser forms at the gastrula stage on the dorsal side of the embryo and is expressed in the 
mesoderm and endoderm from the upper blastopore lip to the blastocoel (Sudou et al. 2012).  
1.5.2 Formation of the Spemann organiser 
At the blastula stage two distinct signalling centres form downstream of the maternal Beta-
catenin signal; the Nieuwkoop centre and blastula Chordin and Noggin expressing centre 
(BCNE centre), which express genes that establish formation of the Spemann organiser at the 
gastrula stage (Kuroda, Wessely, and De Robertis 2004). The BCNE centre is established in 
the dorsal animal region of the embryo and expresses chordin, noggin, siamois (sia1) and 
nodal3. BCNE cells give rise to anterior neural plate and contribute to brain and retina 
formation. The Nieuwkoop centre is located in the dorsal vegetal region of the embryo and 
expresses nodal signalling molecules and Cerberus (Kuroda, Wessely, and De Robertis 2004).  
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Figure 1.3. Signalling centres at the blastula and gastrula stages. At the blastula stage, the 
BCNE and Nieuwkoop centres form in the dorsal region and each expresses secreted factors. 
At the gastrula stage the Spemann organiser forms in the dorsal mesoderm and endoderm 
and expresses secreted BMP antagonists (Chordin, Noggin and Follistatin), secreted Wnt 
antagonists (Frzb1, sFRP2, Crescent and Dickkopf-1), and Cerberus which antagonises BMP, 
Wnt and TGFβ signals. ADMP is also expressed in the Spemann organiser, despite being a 
BMP protein which is activated at low levels of BMP. A ventral centre expresses BMP 
growth factors and several BMP regulating factors (Cv2, Bambi, Sizzled, Xlr and Tsg). Figure 
adapted from (Kuroda, Wessely, and De Robertis 2004; De Robertis 2006). 
Genes expressed in the two early signalling centres cooperatively induce anterior CNS. At the 
8-cell stage Cerberus was knocked down in the dorsal vegetal cells and Chordin was knocked 
down in the dorsal animal cells. When either morpholino was injected alone this caused a 
partial loss of anterior CNS formation. When both were knocked down, anterior CNS 
formation was completely blocked, demonstrating a cooperative effect of genes from the 
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BCNE and Nieuwkoop centres in driving neural differentiation (Kuroda, Wessely, and De 
Robertis 2004). This cooperation between BCNE and Nieuwkoop centres demonstrates a 
partial overlap in function between the presumptive ectoderm and mesendoderm germ 
layers and also shows that neural induction starts as early as the blastula stage (Kuroda, 
Wessely, and De Robertis 2004). 
The Nieuwkoop centre is located in the dorsal vegetal cells and is induced by the vegetal VegT 
signal and the dorsal Beta-catenin signal (Agius et al. 2000). Cerberus, a known antagonist of 
nodal signalling molecules, can block dorsal and ventral mesoderm formation. Dose response 
experiments using Cer-S; the carboxy-terminal region of Cerberus which specifically inhibits 
Nodal signalling, revealed that a gradient of Nodal activity is established from the Nieuwkoop 
centre. This graded expression of the Nodal related proteins from the Nieuwkoop centre 
drives the specification of dorsal mesoderm. Nodal signalling is sufficient to induce 
expression of several genes expressed in the Spemann organiser; follistatin, frzb1, dkk1, 
cerberus, goosecoid (gsc), chordin and noggin (Agius et al. 2000). 
At gastrulation, signals from the BCNE and Nieuwkoop centres specify  the formation of the 
Spemann organiser in the dorsal mesoderm which expresses genes essential for anterior 
development (Lane and Sheets 2000; Kuroda, Wessely, and De Robertis 2004). The 
assignment of the embryonic axis changes between gastrula and neurula stages so that the 
embryonic dorsal pole becomes the definitive anterior pole. It is proposed that some of the 
genes expressed in the Spemann organiser region e.g. gsc, cer1 and sia1 are markers for 
anterior development (Lane and Sheets 2000). Gsc is expressed in the Spemann organiser 
and induces head formation. Ectopic expression of gsc in the ventral side of X. laevis embryos 
is sufficient to induce a secondary dorsal axis complete with head structures and notochord 
(Cho et al. 1991). 
Ectopic expression of cerberus in the ventral vegetal region of the 32-cell stage embryo was 
sufficient to induce a secondary head structure as well as secondary liver and heart tissue 
(Bouwmeester et al. 1996). Cerberus is secreted from the endoderm and binds to and 
antagonises Nodal1, BMP4 and Wnt8a to allow a permissive state for head specification 
(Piccolo et al. 1999). The head inducing ability of Cerberus through antagonism of BMP, Wnt 
and Nodal signalling molecules was demonstrated. Defective head formation was observed 
when the Cerberus antagonistic targets BMP4, Nodal1 and Wnt8a were specifically 
expressed in the anterior dorsal endoderm under a Cerberus-like promoter. A Cerberus 
morpholino further potentiated this decrease in anterior neural development however this 
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morpholino was later shown to be ineffective in targeting all Cerberus alleles in X. laevis. Had 
a more effective morpholino been used, complete loss of head formation would be expected. 
Although the morpholino was not fully effective, a reduction in forebrain markers and an 
increase in krox20, a posterior neural marker was observed, further confirming the pro-
anterior neural function of Cerberus (Silva et al. 2003).  
1.5.3 BMPs antagonise neural development 
BMP4 and BMP7 signals drive ectoderm maintenance through repression of neural inducing 
signals. The specification of ectoderm into neural tissue is thought to be the default 
mechanism, and BMP signals are required to allow epidermis to form on the ventral side 
(Hawley et al. 1995). Dominant negative BMP4 and BMP7 injected into the ventral marginal 
zone drive ectopic expression of neural markers and formation of a secondary axis. 
Expression of dominant negative BMP4 and BMP7 in animal caps up-regulate neural marker 
expression (Hawley et al. 1995). BMP4 overexpression leads to an increase in ventral 
mesoderm formation and can induce postero-ventral mesoderm in animal caps (Dale et al. 
1992; Jones et al. 1992). 
BMP antagonists emanate from the Spemann organiser to regulate the dorso-ventral axis, 
and the formation of neural tissue. Follistatin is a soluble BMP antagonist which is expressed 
in the Spemann organiser and notochord which are both neural inducing tissues. Follistatin 
induces neural formation and blocks mesoderm (Hemmati-Brivanlou, Kelly, and Melton 
1994). Noggin is secreted from the Spemann organiser and antagonises BMP4, BMP2 and 
BMP7 by strongly binding to them and preventing them from binding to BMP receptors 
(Zimmerman, De Jesus-Escobar, and Harland 1996). Chordin binds with high affinity to BMP4 
and inhibits its receptor-binding potential, as a result of this BMP antagonism. Chordin can 
dorsalise mesoderm and neuralise ectoderm when expressed in ventral marginal zone 
explants (Piccolo et al. 1996). 
The three BMP antagonists Chordin, Follistatin and Noggin were knocked down using 
morpholinos to give a more severe phenotype than is produced in single or double 
knockdowns of these genes. This suggests that these three genes have a shared and 
cooperative function. In triple knockdown embryos ventral tissue formation was increased 
and dorsal and neural development were blocked. This was caused by a loss of BMP 
antagonism leading to widespread neural repression. The phenotype can be partially rescued 
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by injection of noggin mRNA or morpholinos targeting BMP4 and BMP7, where the neural 
plate formation is restored (Khokha et al. 2005).  
Simultaneous knockdown of BMP2, BMP4 and BMP7 blocked tail and trunk development, 
and generated dorsalised embryos. When formation of the Spemann organiser was also 
blocked in these embryos using UV or knockdown of Beta-catenin, head and neural 
development were unaffected. This indicates that the ectoderm forms neural tissue by 
default, and the antagonism between BMP and the Spemann organiser signals regulates the 
formation of epidermis in regions where BMP signals dominate (Reversade et al. 2005). 
1.5.4 Mesendoderm specification 
VegT protein and mRNA are maternally deposited and are responsible for establishing 
endodermal signals in the animal hemisphere by first inducing the TGFB signalling molecules 
nodal1, nodal2, nodal4 and gdf3 (Xanthos et al. 2001). This leads to activation of the pro-
endodermal transcription factors mixer, sox17, gata4, gata5 and gata6 (Xanthos et al. 2001). 
VegT also induces the ventral mesodermal gene wnt8a and the mesodermal genes brachyury, 
mix1 and eomes (Stennard, Carnac, and Gurdon 1996). Mixer antagonises mesodermal fates 
by repression of the mesoderm inducing growth factors nodal1, nodal5, fgf3 and fgf8 (Kofron, 
Wylie, and Heasman 2004).  
Nodal5 and nodal6 are activated cell-autonomously by maternal Beta-catenin and VegT and 
induce mesendoderm and the expression of nodal1 and nodal2 (Takahashi et al. 2000). 
Nodal1 and Nodal2 control the convergent extension movements of axial and paraxial 
mesoderm and mesoderm migration during gastrulation (Luxardi et al. 2010).  
FGF signalling is essential to the patterning of the posterior and lateral mesoderm (trunk and 
tail mesoderm). Blocking FGF signalling through injection of a dominant negative FGF 
receptor disrupts lateral mesoderm differentiation (Amaya, Musci, and Kirschner 1991). 
Downstream of Activin signals, FGF induces mesodermal gene expression, including 
brachyury and xpo1 in the equatorial zone of the blastula stage embryo (Amaya et al. 1993; 
Cornell, Musci, and Kimelman 1995). FGF is required for the maintenance but not the 
activation of several organiser genes such as chordin, noggin and gsc (Fletcher and Harland 
2008). FGF has been shown to be essential for the initiation and maintenance of brachyury 
expression and the resultant formation of paraxial mesoderm (Fletcher and Harland 2008).  
A complex set of signals define the dorso-ventral axis. Wnt8a and gsc are induced in the 
mesoderm cell autonomously, but wnt8a is primarily expressed in the ventral mesoderm and 
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endoderm, whereas gsc is localised within the dorsal mesoderm (Lemaire and Gurdon 1994). 
Wnt8a has a strong ventralising influence on mesoderm and inhibits dorsal mesoderm 
development. When ectopically expressed, wnt8a can block organiser induction and 
ventralise prospective notochord cells to form muscle, and can re-specify ectoderm cells to 
ventral mesoderm (Christian and Moon 1993). As mentioned, Gsc has a strong dorsalising 
influence and when expressed ventrally, induces a secondary dorsal axis with head and axial 
structures (Cho et al. 1991). 
1.6 The homeobox transcription factor Mix1 
Mix1 is a homeobox transcription factor found in X. tropicalis which is a member of the Mix 
family of homeobox genes. The Mix family genes have duplicated and diverged in fish and 
frog. In X. tropicalis, four Mix family genes are found; mix1, mixer, bix1.1 and bix1.2, whereas 
six Mix family genes are found in X. laevis and four are found in zebrafish. In mammalian 
species and chicken no duplication events have occurred and just one Mix1 family gene exists 
in each (Pereira et al. 2012).   
1.6.1 The activation of mix1 
 
The homeobox transcription factor Mix1 is activated in untreated and cycloheximide-treated 
embryos indicating that a maternal factor initiates its expression (Yasuo and Lemaire 1999). 
At NF stages 9 and 10, mix1 was induced in vegt-expressing animal caps. To test whether 
mix1 induction is cell contact dependent, embryos were injected with vegt mRNA, animal 
caps were dissected at stage 8, dissociated and cultured to stages 9 and 10. Mix1 was induced 
in stage 9 dissociated caps but not in stage 10 dissociated caps indicating that early induction 
of mix1 is not dependent on cell communication (Yasuo and Lemaire 1999). Mix1 was also 
expressed in animal caps expressing the TGFβ family growth factors nodal1, nodal2 or gdf3 
(Yasuo and Lemaire 1999). These results suggest that early maternal signals such as VegT 
activate mix1, and later mix1 transcription is dependent on TGF beta signalling molecules 
such as Nodal1, Nodal2 and Gdf3 to signal within the endoderm (Yasuo and Lemaire 1999). 
This fits with the activation times of these genes in X. tropicalis, as nodal1, nodal2 and gdf3 
are activated at approximately the same time as Mix1, so would make implausible initial 
activators, and vegt is present as a maternal transcript throughout the early cleavage stages 
(Collart et al. 2014).  
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Several studies have shown that TGFβ family growth factors are sufficient for Mix1 induction. 
Animal caps expressing bmp4 (Mead et al. 1996), gdf1 (vg1) and activin (inhba) can induce 
mix1 expression (Cornell, Musci, and Kimelman 1995). Mix1 expression was down-regulated 
in embryos expressing a dominant negative type II activin receptor (Yasuo and Lemaire 1999). 
In vitro, activin has been shown to affect the expression of mix1, but activin is first expressed 
several hours after mix1 is activated (Collart et al. 2014), therefore maternally deposited 
Activin protein might regulate mix1 expression. Gdf1 is more plausible as an initial activator 
of mix1 as gdf1 transcripts are present from fertilisation until gastrulation (Collart et al. 2014). 
BMP4 is unlikely to be the initial activator of mix1 as it is activated at the same time as Mix1 
and is expressed in the ventral marginal zone, whereas mix1 is expressed in the dorsal and 
ventral marginal zone (Knochel, Schuler-Metz, and Knochel 2000; Lemaire et al. 1998).  
 
1.6.2 The localisation of mix1 
The homeobox transcription factor mix1 is first expressed in the vegetal hemisphere of the 
X. laevis embryo (Rosa 1989). During early gastrulation its expression intensifies throughout 
the marginal zone, this region includes prospective endoderm and mesoderm (Rosa 1989). 
Mix1 transcripts are present throughout the vegetal hemisphere and are most abundant in 
the marginal zone at stage 10 (Lemaire et al. 1998). From stage 10.5 mix1 becomes gradually 
more enriched in the ventral marginal zone and is last detected at stage 12.5 (Colas et al. 
2008).  
1.6.3 Mix1 protein structure 
The structure of Mix1 protein is conserved over different species, consisting of an N-terminal 
proline-rich domain, followed by the conserved DNA-binding homeodomain and a C-terminal 
polar/acidic domain. The proline-rich domain does not have any conserved motifs, but may 
function as a helix breaking domain, a protein association domain or a transcriptional 
repression or activation domain. The polar/acidic region is conserved and could potentially 
form an amphipathic helix which could function as an activation domain (Sahr et al. 2002). A 
yeast two-hybrid screen was carried out using mouse Mixl1 protein to reveal that the 
homeodomain and the C-terminal domain, but not the N-terminal domain are necessary for 
reporter gene induction, indicating an essential role for the polar/acidic domain. Mouse 
Mixl1 binds to the motif TAATTGAATTA, but not single TAAT motifs, indicating that it 
homodimerises for DNA-binding to the palindromic TAAT sequences (Sahr et al. 2002). 
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Figure 1.4. Mix1 protein domains. Mix1 protein has an N-terminal proline-rich domain, a 
homeodomain and C-terminal polar/acidic domain (Sahr et al. 2002). 
1.6.4 Mix1 in endoderm development 
Mix1 has a general role to promote endoderm formation and inhibit mesoderm 
differentiation. Overexpression of mix1 in the dorsal marginal zone induced a2m 
(endodermin), an endoderm and dorsal mesoderm marker, but did not perturb expression of 
cer1, an anterior mesendoderm marker. Mix1 may promote endoderm formation in the 
dorsal region (Lemaire et al. 1998). 
Vegetal expression of dominant negative enRMix1 caused a reduction in gut development 
indicating a requirement for Mix1 in endoderm formation (Lemaire et al. 1998). In support 
of this, the endoderm marker sox17a was repressed in whole embryos expressing enRMix1 
(Latinkic and Smith 1999). Animal caps injected with mix1 mRNA expressed very low levels 
of the endoderm marker a2m but no other endoderm markers were induced (Lemaire et al. 
1998; Henry and Melton 1998). The expression of a2m in animal caps was synergistically 
increased by co-expression of sia1 and mix1. Animal caps expressing sia1 and mix1 induced 
expression of the posterior and anterior endoderm markers, respectively, fabp2 and pdx1. 
Low level induction of the anterior mesendoderm marker gene cer1 was detected in sia1 and 
mix1-expressing animal caps. This indicates Mix1 activates endoderm weakly alone, and 
works in combination with Sia1 and potentially other factors in endoderm induction (Lemaire 
et al. 1998). Sia1 and Mix1 are able to form stable heterodimers and this association may be 
key to the synergistic induction of endoderm gene expression (Mead et al. 1996). 
Mix1 and Gsc are also able to heterodimerise (Wilson et al. 1993). Mix1 induces Gsc in 
cycloheximide-treated animal caps (Latinkic and Smith 1999). Mix1-expressing animal caps 
induce low level expression of the endoderm marker sox17a, this effect is greatly enhanced 
by coinjection of gsc mRNA (Latinkic and Smith 1999). Gsc is expressed in the Spemann 
organiser region and patterns dorsal mesoderm (Steinbeisser et al. 1995).  
The transcription factors Mix1, Sia1 and Gsc have a synergistic effect on the rate of cell 
motility in the head mesoderm, part of the dorsal mesendoderm, in the direction of the 
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animal pole during gastrulation (Luu et al. 2008). It is possible that this is linked to the 
heterodimerisation of Mix1 with Sia1 or Gsc. 
1.6.5 Mix1 in anterior development 
Mix1 binds to gene regulatory regions in cooperation with other transcription factors to 
activate downstream gene expression. Mix1, Lim1 and Sia1 synergistically activate cer1 
through binding to the 3xTAAT promoter element (Yamamoto et al. 2003). Mix1 can 
independently and directly activate gsc in vitro by binding to both the proximal and distal 
elements of its promoter (Latinkic and Smith 1999). An in vivo study revealed that this region 
of the gsc promoter is bound cooperatively by Mix1, Lim1, Otx2, Sia1 and VegT at the early 
gastrula stage (Sudou et al. 2012). These five transcription factors also cooperatively bind to 
the promoter of cer1 at this stage in the U1 region which contains a T-box recognition 
sequence and 5xTAAT elements. These transcription factors all have expression domains that 
overlap with the Spemann organiser and mediate the expression of their targets cer1 and gsc 
in this region (Sudou et al. 2012) which in turn promote head development (Bouwmeester et 
al. 1996; Cho et al. 1991). The cooperative binding was in X. laevis but the cis-regulatory 
elements in the gsc and cer promoters are conserved in X. tropicalis (Sudou et al. 2012).  
When dominant negative enRMix1 was expressed in the dorsal-vegetal region, head 
development was severely disrupted, leading to many embryos developing with cyclopia or 
no head. Embryos also displayed enlarged axial structures (notochord and somites). This 
effect was rescued by injection of mix1 mRNA. A2m and cer1 were down-regulated in 
enRMix1 expressing embryos and chordin was unaffected, indicating that anterior 
endomesoderm but not dorsal mesoderm is dependent on mix1 expression (Lemaire et al. 
1998).  
Mix1 loss-of-function by injection of either dominant negative enR-Mix1 or antisense mix1 
mRNA in X. laevis disrupted head formation and led to heart and gut defects implicating Mix1 
in regulation of dorso-anterior endoderm and mesoderm development (Latinkic and Smith 
1999). Over half of embryos developed without a heart, however this apparent induction of 
mesoderm tissue by Mix1 may be indirect as dorso-anterior endoderm contributes to heart 
development (Latinkic and Smith 1999; Nascone and Mercola 1995). Mix1 may repress 
posterior development as overexpression of mix1 in the ventral-equatorial region generated 
embryos with tail defects (Lemaire et al. 1998). 
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1.6.6 Mix1 in mesoderm development 
Several studies have implicated Mix1 in the repression of mesoderm development. Mix1 
mRNA was injected dorsally, laterally or ventrally and repressed expression of the 
mesodermal activator brachyury within the targeted region. Brachyury overexpression 
caused localised down-regulation of mix1 (Lemaire et al. 1998; Conlon et al. 1996). Mix1 and 
brachyury have overlapping expression domains at stage 10, and by stage 10.5 a negative 
feedback loop is established and their expression domains within the marginal zone 
segregate. Lemaire et al. hypothesise that the exclusion of mix1 from the brachyury domain 
in the marginal zone is required to generate a permissive state for mesoderm to form 
(Lemaire et al. 1998). Mix1 was shown to block brachyury induction in FGF expressing animal 
caps, however this may not be a direct effect as Mix1 is known to repress FGF expression 
(Latinkic et al. 1997; Colas et al. 2008). 
Previous work suggests that brachyury may be an indirect target of Mix1 (Latinkic and Smith 
1999). Two possible indirect mechanisms of brachyury repression by Mix1 exist; through 
repression of fgf8 and fgf4 which both activate brachyury (Fletcher, Baker, and Harland 2006; 
Isaacs, Pownall, and Slack 1994), and through activation of gsc which directly represses 
brachyury (Latinkic and Smith 1999).  
Mix1 was fused to a viral transcription activation domain to make VP16Mix.1, a dominant 
positive Mix1 that would induce all Mix1 targets, both repressive and activatory. VP16Mix.1 
blocked mesoderm development indicating that Mix1 functions as an activator to repress 
mesoderm (Lemaire et al. 1998). A luciferase reporter assay and the induction of gsc in 
animal caps further demonstrate the ability of Mix1 to activate gene expression (Latinkic and 
Smith 1999). 
Mix1 overexpression can block mesoderm differentiation. Ventral overexpression of mix1 
down-regulated the ventral mesoderm markers, xpo and ventx1.2, whereas dorsal mix1 
overexpression down-regulated the dorsal mesoderm marker chordin. Mix1 overexpression 
in the marginal zone can block dorsal and ventral mesoderm tissue formation. The 
phenotypic effects of mix1 overexpression were severe, beginning with blastopore closure 
failure, leading to defective notochord and muscle formation and in some cases a complete 
loss of these tissues, furthermore embryos were highly truncated along the anterior-
posterior axis (Lemaire et al. 1998). A dominant positive Mix1 construct was used to generate 
similar phenotypic effects characterised by a reduction in axial structures, leading to the 
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conclusion that Mix1 blocks mesoderm induction through transcriptional activation. Lemaire 
et al. oppose the proposition by Mead et al. that Mix1 represses dorsal mesoderm because 
they demonstrated that Mix1 can also repress ventral mesoderm (Lemaire et al. 1998; Mead 
et al. 1996). 
When implanted at the early gastrula stage, mix1-expressing cells can integrate normally into 
somites, indicating that Mix1 repression of mesoderm observed by Lemaire et al. is non-cell 
autonomous. This indicates that once FGF signalling has been established, Mix1 may be 
permissive to mesoderm development (Colas et al. 2008). 
Mix1 is thought to repress fgf3, fgf4 and fgf8 expression. The expression domains of the 
mesodermal genes fgf4, fgf8 and of the mesodermal FGF targets brachyury and myod were 
enlarged at stage 10 in response to morpholino knockdown of Mix1 and of both X. laevis 
homeologs Mix1 and Mix2 (Colas et al. 2008). The same result was found using dominant 
negative Mix.1, although the targets were induced to a lesser extent. Morpholino knockdown 
of Mix1 or both Mix1 and Mix2 lead to repression of the pronephros mesoderm markers lim-
1 and pax-8, but this effect was rescued by inhibition of the FGF receptor. This indicates that 
elevated expression of fgf can repress pronephros induction. Mix1 overexpression in the 
marginal zone repressed the mesodermal marker genes brachyury, myod, fgf3, fgf4 and fgf8 
at the mid-gastrula stage (Colas et al. 2008).  
1.6.7 Mix1 in blood development 
Several studies have linked Mix1 to blood development, blood forms in the ventral 
mesoderm (Kumano and Smith 2000). Overexpression of mix1 at low doses caused a 
reduction in the number of α-globin expressing cells, and at high doses blocked their 
production entirely (Lemaire et al. 1998). Mead et al. report the opposite scenario, in which 
injection of mix1 mRNA leads to the expression of globin throughout the dorsal-ventral 
marginal zone and in animal caps (Mead et al. 1996). Injection of the same dose of mRNA at 
the 2-cell stage was later reported to ventralise the embryo and induce elevated expression 
of the blood marker scl (Mead, Kelley, et al. 1998). These conflicting effects on globin 
expression may stem from different dosing and localisation of mix1 expression in different 
overexpression experiments. Lemaire et al. injected 100pg or 400pg mix1 mRNA ventrally at 
the 4 cell stage, whereas Mead et al. injected 1ng at the 1 cell stage (Mead et al. 1996; 
Lemaire et al. 1998). When injected at 1ng, Mix1 may repress downstream FGF signals, which 
confine primary blood islands to the ventral region and can repress globin expression 
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(Kumano and Smith 2000; Colas et al. 2008). Loss of FGF signals can therefore lead to 
delocalised blood island formation in the dorsal region, which would explain why mix1-
induced dorsal marginal cells expressed globin (Mead et al. 1996).  
It is interesting that ventral overexpression of mix1 leads to loss of blood formation, as one 
would expect elevated globin expression in the ventral region if FGF signals were suppressed 
(Lemaire et al. 1998; Kumano and Smith 2000). Lemaire et al. suggest that Mix1 acts to block 
terminal differentiation of ventral mesoderm cells (Lemaire et al. 1998). Mouse ESCs 
expressing Mixl1 develop embryoid bodies which do not express hematopoietic progenitor 
markers but have elevated endoderm gene expression (Lim et al. 2009). Mix1 may block 
mesoderm in favour of endoderm expression. 
The opposite result was derived using doxycycline-inducible Mixl1-expressing mouse ESCs, 
which formed embryoid bodies expressing mesoderm markers, including elevated 
hematopoietic progenitor expression (Willey et al. 2006). MIXL1 is expressed in human T and 
B progenitor cells in the bone marrow and is expressed in various leukemic cell lines. 
Expression of human MIXL1 in X. laevis animal caps induced α-globin which demonstrates a 
role for human MIXL1 in hematopoiesis (Guo et al. 2002). Clearly the role of Mix1 in blood 
formation is complex and not fully understood. Mix1 may repress blood formation in a dose 
dependent manner and interact with nearby genes to establish the localisation of blood 
islands.  
1.7 Other Mix family genes present in X. tropicalis 
1.7.1 Mixer induction and localisation 
Mixer is a homeodomain transcription factor in the Mix family (Pereira et al. 2012). Mix1 and 
Mixer are able to form heterodimers, which reduces the ability of Mixer to induce endoderm 
(Mead, Zhou, et al. 1998).   
 
Maternal VegT activates endodermal genes such as gata4, gata5, gata6, sox17a, a2m and all 
of the Mix family genes including mixer. Nodal signals downstream from VegT activate mixer 
and gata5 (Xanthos et al. 2001). The nodal-related genes cyc and sqt are necessary for 
appreciable levels of Mixer induction in zebrafish embryos and for endoderm and mesoderm 
formation (Alexander and Stainier 1999).  
 
Chapter 1 – Introduction 51 
Mixer is thought to be induced by zygotic factors, as cycloheximide treated embryos do not 
express mixer (Yasuo and Lemaire 1999). Mixer is activated shortly before the MBT so a 
zygotic activator must function rapidly to activate it (Collart et al. 2014). Mixer was expressed 
in animal caps expressing nodal1, nodal2 or gdf3 (Yasuo and Lemaire 1999). However, nodal1 
and nodal2 are activated after mixer, and gdf3 is activated 30 minutes before mixer (Collart 
et al. 2014).  It may be plausible that mixer activation is not dependent on Nodal1, Nodal2 
for its activation, but these genes may maintain its expression, and Gdf3 may be a zygotic 
activator of mixer (Yasuo and Lemaire 1999). In conflict with the finding that mixer is 
zygotically activated, Mixer was found to act downstream of a maternal transcription factor. 
In animal caps, mixer is activated downstream of the maternally deposited growth factor 
gdf1 (vg1), and the induction of endoderm genes downstream of Gdf1 was blocked in animal 
caps expressing dominant negative Mixer (Henry and Melton 1998; Collart et al. 2014). 
Mixer was expressed at stage 10 in animal caps injected with vegt, furthermore this induction 
was cell-contact dependent. Vegt is expressed as both a maternal and zygotic transcript in 
the early embryo. A zygotic factor is thought to be responsible for mixer induction and this 
could be zygotic Vegt (Collart et al. 2014; Yasuo and Lemaire 1999).  
1.7.2 Mixer in endoderm and mesoderm specification 
Dominant negative Mixer-enR injected embryos displayed gastrulation defects, anterior 
truncation, abnormal head and gut formation as well as loss of endodermal markers. Mixer-
enR was used to show that mixer is essential for endoderm induction and for the expression 
of sox17a and sox17b (Henry and Melton 1998). Mixer is activated shortly after sox17a and 
sox17b in X. tropicalis therefore Mixer is unlikely to be the initial activator of the sox17 genes, 
but may be necessary to maintain their expression (Collart et al. 2014). Morpholino 
knockdown of Mixer in X. laevis delayed gastrulation and caused anterior and gut defects at 
the tailbud stage. Vegetal cells showed increased mesoderm differentiation. Knockdown 
embryos showed reduced expression of endodermal genes gata5/6, cer1, a2m and sox17 
and increased expression of mesodermal genes e.g. brachyury, eomes, bix1, bix4 and fgf8 
and the TGF beta genes nodal1 and nodal5. This shows that Mixer can drive endoderm and 
block mesoderm development (Kofron, Wylie, and Heasman 2004).  
The carboxyl terminus and homeodomain of Mixer are both necessary to induce endoderm, 
and a mutant Mixer protein comprised of just these two regions can drive endoderm 
specification in animal caps. X. laevis embryos injected with mutant mixer mRNA were 
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ventralised with underdeveloped heads and tails (Doherty et al. 2006). Embryos 
overexpressing mix1, mixer or mix4 were ventralised and with increased blood formation. 
Overexpression of mixer in the whole embryo induced ectopic endodermin expression and 
caused severe axial abnormalities (Mead, Zhou, et al. 1998).  
 
Microarray analysis of separate Mixer, Nodal and Sox17 depleted embryos revealed common 
and unique downstream targets. Mixer was found to have 66 unique targets, and 31 shared 
with Sox17 and 35 shared with Nodal (Sinner et al. 2006). This contrasts with previous work 
which implicates Sox17 as the major transducer of Mixer signalling (Alexander and Stainier 
1999). The majority of Mixer targets were repressed and localised in the equatorial region, 
suggesting that Mixer may repress mesoderm gene expression (Sinner et al. 2006). Mixer- 
and sox17b-expressing animal caps were analysed by microarray to reveal 71 targets, 10 of 
which were targets of both genes indicating separate and shared functions in endoderm 
specification (Dickinson, Leonard, and Baker 2006). 
 
1.7.3 Bix1.1 and Bix1.2 
 
The majority of work on bix1 has been carried out in X. laevis, this work has shown that bix1 
is activated by Brachyury and Vegt, and promotes endoderm and ventral mesoderm 
development (Tada et al. 1998). When bix1 is expressed in animal caps at low concentrations, 
ventral mesoderm markers wnt8 and ventx1.2 were upregulated, and at higher 
concentrations of bix1 expression, the endoderm markers sox17a, a2m and fabp2 were 
induced in animal caps. At all doses of bix1 expression in animal caps, the anterior 
mesendoderm markers gsc and cer1 were induced (Tada et al. 1998). This indicates that 
Bix1.1 and Bix1.2 may have a similar function to Mix1 in inducing endoderm and anterior 
development.  
 
1.8 Mix family genes in other vertebrates 
 
1.8.1 Mix genes in zebrafish 
 
The zebrafish gene mixl1, previously known as bon, is a Mix-related gene (Pereira et al. 2012). 
Zebrafish mixl1 is expressed in the mesoderm and endoderm and, downstream of nodal 
signals, induces sox17 expression and endoderm development (Kikuchi et al. 2000). Mixl1 
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knockout embryos have a smaller forebrain than wild types and the expression domain of 
the neural plate marker otx2 is reduced, implicating Mixl1 in neural patterning. 
Differentiation is disrupted in the anterior axial mesoderm, demonstrated by reduced gsc 
expression in knockout embryos at 90% epiboly (Trinh, Meyer, and Stainier 2003). Sebox 
(previously known as Mezzo) is another zebrafish Mix family gene which is activated by 
activin and nodal signals in the prospective mesendoderm. Sebox has a role in endoderm 
specification and activates the endodermal genes sox17 and sox32/cas and the mesodermal 
gene ntl (brachyury). Reduced endodermal markers were expressed in morpholino injected 
embryos, and endoderm and heart defects were observed. Mixl1 and Sebox may work 
cooperatively to pattern mesoderm as sebox mRNA can partially rescue the Mixl1 mutant 
heart defect phenotype (Poulain and Lepage 2002). 
1.8.2 Mixl1 in mouse 
 
Mixl1 is the only Mix family gene present in mouse and is orthologous to Xenopus mix1 (Hart 
et al. 2002). Mixl1 is expressed in the primitive streak in early gastrula stage mouse embryos, 
and later is localised to each end of the primitive streak in tissues fated to become mesoderm 
and endoderm (Wolfe and Downs 2014). Mixl1 knockout embryos exhibit a shortened axis, 
abnormal neural folds and heart and gut defects. Mixl1 is thought to regulate cell movements 
that occur at gastrulation which allow spatial patterning of mesoderm and endoderm. Mixl1 
null embryonic stem cells were ineffective at inducing endoderm tissues in chimeras 
indicating an essential role in endoderm differentiation. (Hart et al. 2002). Mixl1 homozygous 
knockout mice were found to have reduced recruitment of cells from the primitive streak to 
the prospective endoderm and increased recruitment of primitive streak cells to mesoderm 
when compared to heterozygous mice. Furthermore, the endoderm cells remained 
stationary in the knockdown whilst the mesoderm cells retained their motility, suggesting 
that Mixl1 functions to drive cell movement in the prospective endoderm, leading to 
recruitment of cells from the primitive streak into endoderm (Tam et al. 2007). 
Mixl1-expressing mouse stem cells expressed elevated levels of the endodermal genes foxa2, 
sox17, cer1 and e-cadherin, and the anterior primitive streak marker gene gsc, further 
implicating Mix1 in endoderm and anterior specification. The finding that Mixl1 binds to and 
activate the promoters of gsc, sox17 and e-cadherin supports the notion that Mix1 promotes 
endoderm formation (Lim et al. 2009). Mouse Mixl1 mRNA was injected into X. laevis animal 
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caps to induce the endodermal markers endodermin, gata5 and pdx1. Similarly to Mixer in X. 
laevis, Mixl1 promotes endoderm specification in mouse (Mohn et al. 2003).  
1.8.3 CMIX the chicken Mix1 orthologue 
The Mix1 orthologue found in chicken is CMIX. The CMIX homeodomain has 71% sequence 
similarity to that of X. laevis mix1 and is expressed in the posterior marginal zone in the early 
embryo. It later expands to occupy the antero-posterior axis of the primitive streak in 
ectoderm and mesoderm cells. Its expression pattern is similar to that of brachyury in the 
early and primitive streak stages (Peale, Sugden, and Bothwell 1998).  
1.9 Morpholino oligonucleotides 
Morpholino oligonucleotides (MOs) are commercially available antisense oligonucleotides of 
approximately 25 bases which bind to mRNA by base pairing. MOs are resistant to nucleases 
because they consist of a morpholine ring rather than the ribose ring normally found in 
nucleic acids (Summerton and Weller 1997). Translation blocking MOs inhibit translation by 
binding to targeted regions upstream of the start codon, and splice blocking MOs bind to a 
region overlapping a splice junction which blocks the association of the translational or 
splicing machinery with the mRNA. Blocking translation or splicing prevents mature protein 
being processed and therefore gene function is blocked (Eisen and Smith 2008). MOs disperse 
quickly throughout the stage 1 Xenopus embryo and are a convenient tool for inducing loss 
of gene function without having to produce a transgenic line (Nutt et al. 2001). 
 
MOs have non-ionic backbones, rather than the negative backbones naturally occurring in 
nucleic acids which often interact with proteins. This means that MOs are unlikely to cause 
toxic and off-target effects other than those caused by non-specific RNA binding. MOs are 
also highly stable meaning no degradation products are present which could be toxic to cells 
(Summerton 2007). MOs have a high affinity for RNA which means they can associate even in 
the presence of secondary structures and can diffuse between the nucleus and cytoplasm to 
block both splicing and translation (Summerton 2007). The optimum temperature for 
morpholino activ ity is 37°C, which is higher than the incubation temperature for Xenopus 
embryos which is approximately 25°C for X. tropicalis and 22°C for X. laevis. Target sequences 
with a higher A-U content are thought to be more amenable to specific interactions at low 
temperatures (Summerton 2007).  
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MOs can cause off-target effects by mis-targeting mRNA sequences and causing depletion of 
the incorrect protein (Eisen and Smith 2008). It can be difficult to differentiate between 
effects caused by gene knockdown of an intended gene and off-target effects. For this reason, 
validation steps are very important in order to be confident of any results. The most reliable 
way to validate a MO is by rescue as this proves that knockdown is caused by depletion of 
the intended protein. This is done by injecting both a MO and MO-resistant mRNA into the 
embryo to see if phenotypic or downstream gene expression effects can be reversed 
(Fletcher and Harland 2008). Partial rescue is an acceptable validation, whereby a certain 
percentage of embryos are restored to the normal phenotype, or the phenotype is less 
severe in rescue embryos than in knockdown embryos. Rescue is often difficult as replicating 
the dose, timing and amount of mRNA can be problematic (Eisen and Smith 2008). Antibodies 
can be used to demonstrate depletion of protein as a result of MO knockdown. 
A useful control is a 5-base mismatch MO because it is designed to resemble the original MO 
without blocking translation or splicing of the target gene. A standard control MO is available 
from Gene Tools and targets the human β-globin pre-mRNA and can be used as an injected 
control (Eisen and Smith 2008). Both of these controls are limited as the specific sequence of 
a MO is likely to cause any off-target effects. 
There are cases where MO experiments seem to indicate a particular gene function, backed 
up by rescue, for example in zebrafish, Prox1b was found to be essential for lymphatic 
development, and the MO phenotype was rescued by mRNA injection (Del Giacco, Pistocchi, 
and Ghilardi 2010). A later study using two MOs targeting Proxb1 and a Prox1b zebrafish 
mutant were found to have no lymphatic defects, contradicting the previous finding that this 
gene is essential for normal lymphatic development (Tao et al. 2011). The lymphatic defect 
was possibly an off-target effect of the Prox1b MO used in the earlier study. Alternatively, 
the first result could be genuine, and compensatory mechanisms may be acting in mutant 
embryos.  
A study in zebrafish set out to recapitulate knockdown phenotypes found in MO-injected 
embryos by generating mutants using zinc finger nucleases (ZFNs), transcription activator-
like effector nucleases (TALENs) and the clustered, regularly interspaced, short palindromic 
repeats (CRISPR)-Cas9 system (Kok et al. 2015). All three approaches are used to generate a 
targeted gene disruption to generate mutant lines. 24 mutant lines were generated and the 
phenotypes were compared to those reported for the MO knockdown of these genes, and 
only three phenotypes were consistent in both (Kok et al. 2015). A wider comparison of 
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mutant and morphant phenotypes was carried out by comparing mutants reported in the 
Sanger Zebrafish Mutation Project (ZMP), where 24 cases were found in which a MO 
knockdown generated an overt phenotype (Kok et al. 2015). Only five of these 24 genes had 
consistent defects induced by both loss-of-function strategies. These two comparisons reveal 
that over 80% of MO phenotypes were not recapitulated in mutant lines (Kok et al. 2015).   
 
Interestingly, five of the genes for which the phenotype was not recapitulated in mutant 
embryos had been validated through phenotypic rescue in MO knockdown studies (Kok et al. 
2015). New evidence suggests that compensatory gene regulatory networks can be activated 
in knockout lines, which essentially rescue the effect of gene deletion (Rossi et al. 2015). 
Therefore, MOs may be a more useful tool for loss-of-function analysis in certain cases. 
Caution should be taken when using MOs to infer gene functions. A useful control would be 
the comparison of morphant and mutant phenotypes as a confirmation of their specific effect 
(Schulte-Merker and Smith 1995). 
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Chapter 2- Materials and Methods 
2.1 Xenopus techniques 
2.1.1 Xenopus tropicalis embryo generation 
Animal procedures were performed under license, as required by Animals (Scientific 
Procedures) Act 1986 (UK). Xenopus tropicalis embryos were generated through in vitro 
fertilisation (IVF). Female frogs were primed by subcutaneous injection of 10 units of hCG 
(Human chorionic gonadotropin Sigma CG10) in 100ul sterile water into the dorsal lymph sac 
20 hours prior to IVF. The following day the female frogs were boosted by injection of 100 
units of hCG in 100ul sterile water to induce ovulation. Approximately 4 hours later the frogs 
were held over a petri dish containing a drop of 1XMMR and gently squeezed on the lower 
abdomen to collect eggs. To prepare testes for IVF, male frogs were killed according to 
schedule 1 guidelines by immersion in 0.2% Ethyl 3-aminobenzoate methanesulfonate 
(MS222, Sigma E10521) for 15 minutes followed by decapitation. The testes were dissected 
and crushed with a pestle in an Eppendorf tube containing Leibovitz's L-15 Medium (Sigma 
L5520) + 10% fetal bovine serum (FBS, Sigma 12003C). The testes solution was m ixed with 
the eggs and after 4 minutes the dish was flooded with 0.05X MMR; a low salt solution for 
egg activation. Approximately 10 minutes later the embryos may show signs of fertilisation 
such as cortical rotation and contraction of the pigmented region. The embryos were de-
jellied in 2.2% cysteine in 0.05X MMR for 3-5 minutes before being washed in 0.05X MMR. 
Embryos were then incubated in 0.05X MMR + gentamicin (Sigma G1914) at 25-28°C. All 
solutions were pH7.8. 
 
2.1.2 Xenopus Laevis embryo generation 
Female X. laevis were primed 3-7 days prior to use by injection of 50 units of hCG. The day 
before use they were boosted by injection of a further 500 units of hCG. Female frogs were 
kept in tanks of 1xMMR to lay eggs directly into a high salt buffer to preserve egg quality. To 
prepare testes for IVF, male frogs were killed according to schedule 1 guidelines by 
immersion in 0.2% Ethyl 3-aminobenzoate methanesulfonate (MS222, Sigma E10521) for 30 
minutes followed by decapitation. Testes were then dissected and could be stored at 4°C for 
up to one week in 70% L-15. To fertilise eggs in vitro, all 1X MMR was removed from a petri 
dish containing eggs, and a small piece (approximately 1/6) of testis was dissected and 
homogenised in an Eppendorf tube of 1XMMR. The sperm media was mixed in with the eggs, 
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incubated at room temperature for 6 minutes and the plate was then flooded with 0.1X MMR 
to lower the salt concentration of the buffer. This allows the eggs to activate and induces 
cortical rotation in those which are fertilised and takes around 15 minutes. Embryos were 
then de-jellied in 1% cysteine in distilled water for approximately 5 minutes, when the jelly 
coat has visibly gone. Embryos were then washed twice on 0.1X MMR and injected in small 
plates containing 2.5% ficoll in 0.1XMMR embryos were then incubated at 14°C overnight.  
2.1.3 Morpholino Microinjection 
Glass capillaries (WPI 1B100F-4) were pulled using a micropipette puller (Sutter p97) to make 
needles for microinjection. For X. tropicalis needles the heat was determined by a heat ramp 
and the settings were; pull 180, velocity 80, time 60. For X. laevis needles the heat was 
determined by a heat ramp and the settings were; pull 55, velocity 55, time 10. 
Embryos were injected in plates containing filter sterilised 2.5% ficoll in 0.05X MMR. 
Morpholino oligonucleotides can be injected directly into embryos to knock down gene 
expression by specifically targeting mRNAs to block splicing or translation. Morpholinos were 
supplied by gene tools and stock solutions diluted in distilled water at 15ng/nl. For injection 
10ul of each morpholino stock was diluted to 10ng/nl in 5ul 10% Dextran Alexa Fluor 488 
10,000MW dye (Life Technologies D-22910) or 5ul 10% Dextran Texas Red 10,000MW (Life 
Technologies D-1863). 1nl was injected for a 10ng dose into each embryo. Embryos were 
injected at the 1 cell or 2 cell stage, following injection they were kept in 2.5% ficoll for 1 
hour. The non-cleaving embryos were removed and using a fluorescence microscope (Leica 
M165FC and Leica UV Lamp) any non-injected embryos were removed.  
See table 2.1 for antisense morpholino sequences. 
2.1.4 In vivo morpholino assay 
To test translation blocking MO2 in vivo, embryos were injected with 50pg mixer-HA mRNA, 
and then split into four plates. Three plates were injected with different doses of MO2 at 5ng, 
10ng and 15ng doses. Embryos were then incubated at 25°C and 40 embryos from each 
injected condition, and WT embryos were harvested at 7.0 hpf and protein was immediately 
extracted as described above. Immunoprecipitation and western blot were carried out as 
described below.  
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2.1.5 Time course knockdown experiment 
Embryos were injected as described above at the one cell stage with either a morpholino or 
control morpholino and some were left as un-injected WT controls. The first 6 cleavages were 
observed and rapid or slow cleaving embryos were removed to improve synchronicity of cell 
cycles within each clutch. The timing of the cleavages was also recorded in order to predict 
the timing of MBT for a particular clutch. Embryos were then cultured in 1/20X Marc’s 
Modified Ringers (MMR) + gentamycin (100ug/ml) at 25°C. for each time point in each time-
series, 5 embryos were harvested for each condition and were homogenised by pipetting up 
and down in 200ul Trizol (Life Technologies). Samples were then snap frozen in liquid 
nitrogen.  
 
2.1.6 RNA extraction from Xenopus tissue 
The trizol homogenate samples were thawed and 80ul of chloroform was added. Samples 
were vortexed thoroughly and centrifuged at 13000RPM at 4°C for 20 minutes to allow 
separation of the phases. The top layer was collected, an equal volume of isopropanol and 
samples were left to precipitate at -20°C for at least 30 minutes. Tubes were then centrifuged 
at 13000RPM at 4°C for 30 minutes, washed in 70% ethanol and centrifuged for a further 5 
minutes at 13000RPM at 4°C. Samples were then re-suspended in 40ul nuclease-free water 
(Ambion AM0038). Samples to be used for qPCR were DNase treated with 1ul DNase I 
(Ambion AM2222) for each 1ug DNA present in each sample and incubated at 37°C for 20 
minutes. An equal volume of LiCl (Sigma L7026) was added to each sample and precipitated 
for at least 1 hour at -20°C. Samples were then centrifuged at 13000RPM at 4°C for 30 
minutes, washed in 70% ethanol and centrifuged for a further 5 minutes at 13000RPM at 4°C. 
Samples were air dried for 5 minutes then re-suspended in 40ul nuclease-free water. 1ul of 
RNA from each sample was quantified using a NanoDrop (Thermo scientific ND1000 
Spectrophotometer). Samples to be used in RNA-seq library preparation were sent for QC 
(see below for details).   
 
2.1.7 Animal Cap Explants 
Animal cap experiments were carried out in X. laevis as the larger embryos and slower 
divisions are more practical for dissecting animal caps. Embryos were injected with 250pg 
mix1 mRNA into the top of the animal pole at the 1-cell stage. Injected and WT embryos were 
placed at 14°C overnight in 0.1X MMR. At stage 8.5, the embryos were placed on an agarose 
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dish in 0.7X MMR and forceps were used to remove the vitelline envelope. The animal cap 
was then dissected using forceps and placed in an agarose plate with 0.7X MMR. Animal caps 
and whole embryos were then incubated at 22°C. After two hours, animal caps were 
harvested at stage 9. 30 animal caps were pooled and homogenised in trizol for each sample, 
by pipetting up and down, and snap frozen in liquid nitrogen. RNA was extracted and qPCR 
was carried out as described below to assay for transcriptional induction in animal caps. Gsc 
primers were used to assay for induction by mix1 mRNA, vegt was used as a negative control. 
Illumina TruSeq libraries were then prepared and sequenced as described below. 
 
2.1.8 Over-expression experiments 
To test the effects of over-expressing a gene, mix1 mRNA was injected into the 1 cell embryo. 
Concentrations of 25ng/ul or 50ng/ul were prepared with 5% Dextran Texas Red 10,000MW 
(Life Technologies D-1863). 1nl was injected to give a dose of 25pg or 50pg, respectively. The 
mRNA was injected into the vegetal pole where endogenous mix1 is expressed. 
 
2.1.9 Whole Mount in situ Hybridisation 
Embryos were fixed in MEMFA overnight at 4°C in glass vials, the following day they were 
gradually dehydrated by washing for 5 minutes in 75% MEMFA/25% methanol, then 50% 
MEMFA/50% methanol, then 25% MEMFA/75% methanol and finally 100% methanol for 3 
washes. Fixed embryos can then be stored at -20°C long term. 
For in situ hybridisation, fixed embryos were first rehydrated in methanol gradually with 5 
minute washes in 100% methanol, 75% methanol, 50% methanol, 25% methanol/75% PBST, 
and finally 3 washes in PBST. Embryos were permeabilised for 5 minutes in 10ug/ml 
proteinase K (Sigma) in PBST and washed twice for 5 minutes in 0.1M triethanolamine (TEA 
Sigma 90279). 12.5ul of acetic anhydride (Sigma 320102) was added to 5ml TEA and added 
to embryos for two washes. Embryos were then re-fixed in 4% paraformaldehyde (Santa Cruz 
sc-281692) for 20 minutes, and then washed 5 times in PBST for 5 minutes. Embryos were 
then submerged in hybridisation buffer and incubated at 60°C for 3 hours to pre-hybridise 
embryos. Embryos were then separated into baskets which were indiv idually placed in glass 
vials and 500ul DIG labelled antisense RNA probe was added at 1ug/ml and incubated 
overnight at 60°C.  
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The following day embryos were given a 5 minute wash in hybridisation buffer at 60°C and 
3x 30minute washes in 2XSSC at 60°C. Probes were stored at -20°C for re-use. They were then 
incubated for 30 minutes at 37°C in 20ug/ml RNase A (Sigma) and 10ug/ml RNase T1 (Sigma). 
This was followed by a 10 minute incubation at room temperature in 2XSSC and 2x 30 minute 
incubations in 0.2XSSC at 60°C. Embryos were then given 2x 15 minute washes in MAB before 
blocking for an hour in MAB +2% BMB Blocking reagent (Roche 11096176001). Anti-
digoxigenin AP antibody (Roche 11093274910) was then applied in MAB +2%BMB at 1:3000 
concentration and incubated for 4 hours at room temperature. Embryos were then given 2x 
5 minute MAB washes at room temperature and an overnight MAB wash shaking gently at 
4°C. 
The following day embryos were washed at room temperature 3x in MAB for 15 minutes, 
then 2x in alkaline phosphate buffer for 5 minutes. Embryos were the removed from baskets 
and placed in a 24 well plate and submerged in BM purple (Roche 11442074001) and 
wrapped in aluminium foil to protect from light and kept a room temperature. The duration 
of incubation of BM purple depends on the probe so embryos were checked hourly for 
sufficient staining. If necessary, the plate could be left overnight at 4°C to allow the reaction 
to develop slowly. To stop the reaction, embryos were washed twice in MAB. Embryos were 
then fixed in Bouin’s solution (VWR 7000.1000) for 1 hour at room temperature. Embryos 
were washed for 5 minutes in 70% ethanol, then 100% methanol. Bleaching solution was 
applied (formula) to remove pigment from the embryos by placing on a light box for 2 hours. 
Embryos were then washed in 100% methanol, and rehydrated with 5 minute washes in 75% 
methanol/25% PBST, 50% methanol/50% PBST, 25% methanol/75% PBST and 2 washes in 
PBST.  
Embryos were placed on a thick agarose petri dish in PBS for imaging on the microscope 
(Leica M165FC). 
2.1.10 β-Galactosidase Staining 
To detect the morpholino injection site, NLS-β-Galactosidase mRNA was co-injected with 
Mix1 MO into 1 cell of the stage 2 embryo to give unilateral depletion. The reaction for β -
Galactosidase was carried out using Salmon gal (Apollo scientific) to give a red nuclear stain. 
To prepare Salmon gal 1ml was set up as follows- 20ul 50X Ferricyanide, 20ul 50X 
Ferrocyanide, 2ul 1M MgCl2, 10ul 100X Salmon gal, 948ul PBS. To stain X. tropicalis embryos, 
they were first fixed in MEMFA for 20 minutes, washed twice in PBS and then submerged in 
Chapter 2 – Materials and Methods 62 
the Salmon gal stain for 40 minutes. Finally, embryos were washed twice in PBS and fixed 
overnight in MEMFA. 
 
2.2 Sequencing Techniques 
 
2.2.1 Illumina RNA-seq library preparation 
 
For Illumina library preparation, the TruSeq RNA Sample Prep Kit v2 (Illumina kit RS-122-
2001) was used to generate polyA+ RNA libraries.  
For library preparation 400ng-1.5ug of mRNA was suspended in 50ul nuclease-free water for 
each sample. For the animal cap sequencing libraries 400ng of mRNA was used, for the 
knockdown time-series sequencing libraries 1.5ug of mRNA was used, for the RiboZero and 
accompanying PolyA+ time-series 1ug of mRNA was used. Starting amounts were decided to 
allow sufficient mRNA for library repeats in the case of failure during preparation.  
1. Purify and fragment mRNA 
50ul of RNA Purification Beads were mixed into each mRNA sample and heated in a 
thermocycler (MJ Research PTC-225) at 65°C for 5 minutes, then incubated at room 
temperature for 5 minutes to allow the mRNA and beads to bind. 
The plate was then placed on a magnetic stand for 5 minutes at room temperature, 
the supernatant was removed and beads were resuspended in 100ul bead washing 
buffer by pipetting up and down. The plates were incubated for 5 minutes at room 
temperature and then on the magnetic stand for 5 minutes before removing the 
supernatant.  
The beads were then suspended in 50ul elution buffer and placed in a thermocycler 
at 80°C for 2 minutes. 50ul of Bead Binding Buffer was mixed into each well and 
incubated for 5 minutes at room temperature. The plate was then placed on a 
magnetic stand for 5 minutes and the supernatant was removed. The beads were 
washed once more in 200ul bead washing buffer. Finally, the beads were suspended 
in 19.5ul Elute, Prime, Fragment Mix and the plate was incubated in a thermocycler 
at 94°C for 8 minutes.  
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2. Synthesise first strand cDNA 
The plate was placed on the magnetic stand for 5 minutes and 17ul of supernatant 
was placed into a new plate. 50ul of Superscript II polymerase was added to the tube 
of First Strand Master Mix and mixed. 8ul of the First Strand Master Mix was added 
to each well of the plate. The plate was then incubated in a thermocycler with the 
following program: 
25°C 10 minutes 
42°C 50 minutes 
70°C 15 minutes 
4°C hold 
3. Synthesise second strand cDNA 
25ul of Second Strand Master Mix was then added to each well and incubated in a 
thermocycler at 16°C for 1 hour.  
90ul of well-mixed AMPure XP beads were mixed into each well and incubated at 
room temperature for 15 minutes. The plate was incubated at room  temperature for 
5 minutes. 135ul of supernatant was then removed from each well. Remaining on 
the magnetic stand, 200ul of 80% ethanol was placed in each well without disturbing 
the beads, and then removed. The ethanol washing process was repeated once. The 
plate was left at room temperature to dry for 15 minutes. 
The beads were then suspended in 62.5ul of Resuspension Buffer, incubated at room 
temperature for 2 minutes and placed on the magnetic stand for 5 minutes. 60ul of 
supernatant was removed from each well and placed into a new plate.  
4. Perform End Repair 
40ul of End Repair Mix was mixed into each well and the plate was incubated in a 
thermocycler at 30°C for 30 minutes.  
160ul of AMPure XP Beads were mixed into each well, incubated at room 
temperature for 15 minutes and placed on the magnetic stand for 5 minutes. 127.5ul 
of supernatant was removed twice. 200ul of 80% ethanol was placed in each well 
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without disturbing the beads, and then removed. The ethanol washing process was 
repeated once. The plate was left at room temperature to dry for 15 minutes.  
The dried bead pellet was suspended in 20ul Resuspension Buffer and the plate was 
incubated at room temperature for 2 minutes and placed on the magnetic stand for 
5 minutes. 17.5ul of supernatant was then removed from each well and placed into 
a new plate. 
5. Adenylate 3’ Ends 
12.5ul of A-Tailing Mix was mixed into each well and the plate was incubated in a 
thermocycler at 37°C for 30 minutes. 
6. Ligate Adapters 
A different adapter was added to each well for every row of 8 samples. For each 
adapter a mix was made containing 3ul Resuspension Buffer, 3ul Ligation Mix and 
3ul RNA Adapter Index. Then 7.5ul of the mix was pipetted into each well of the plate 
and the whole volume was mixed. The plate was incubated in a thermocycler at 30°C 
for 10 minutes. 5ul of Stop Ligation Buffer was then added to each well and the entire 
volume mixed. 
42ul of AMPure XP Beads were mixed into each well, incubated at room temperature 
for 15 minutes and placed on the magnetic stand for 5 minutes. 79.5ul of supernatant 
was removed from each well. 200ul of 80% ethanol was placed in each well without 
disturbing the beads, and then removed. The ethanol washing process was repeated 
once. The plate was left at room temperature to dry for 15 minutes.  
The bead pellets were then suspended in 52.5ul Resuspension Buffer and the plate 
was incubated at room temperature for 2 minutes and placed on the magnetic stand 
for 5 minutes. 50ul of supernatant was then removed from each well and placed into 
a new plate. 
50ul of AMPure XP Beads were mixed into each well, incubated at room temperature 
for 15 minutes and placed on the magnetic stand for 5 minutes. 79.5ul of supernatant 
was removed from each well. 200ul of 80% ethanol was placed in each well without 
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disturbing the beads, and then removed. The ethanol washing process was repeated 
once. The plate was left at room temperature to dry for 15 minutes.  
The bead pellets were suspended in 22.5ul Resuspension Buffer and the plate was 
incubated at room temperature for 2 minutes and placed on the magnetic stand for 
5 minutes. 20ul of supernatant was then removed from each well and placed into a 
new plate. 
7. Enrich DNA Fragments 
A PCR reaction was set up to amplify the fragments. 5ul of PCR Primer Cocktail and 
25ul of PCR Master Mix were mixed into each well. The plate was then incubated in 
a thermocycler with the following program: 
98°C 30 minutes  
98°C 10 seconds 15 cycles 
60°C 30 seconds 
72°C 30 seconds 
72°C 5 minutes  
10°C hold  
 
50ul of AMPure XP Beads were mixed into each well, incubated at room temperature 
for 15 minutes and placed on the magnetic stand for 5 minutes. 95ul of supernatant 
was removed from each well. 200ul of 80% ethanol was placed in each well without 
disturbing the beads, and then removed. The ethanol washing process was repeated 
once. The plate was left at room temperature to dry for 15 minutes.  
The bead pellets were then suspended in 32.5ul Resuspension Buffer and the plate 
was incubated at room temperature for 2 minutes and placed on the magnetic stand 
for 5 minutes. 30ul of supernatant was then removed from each well and placed into 
tubes for sequencing. 
The RNA-seq library preparation was carried out over two days, the stopping point was 
usually after end repair or adapter ligation, and plates were left overnight at -20°C. Libraries 
were sequenced on the Illumina Hi-Seq 2000. 
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2.2.2 RiboZero and accompanying PolyA+ library preparation 
To generate comparable RiboZero and PolyA+ RNA-seq libraries, 1ug was taken from each 
time-series sample, and was split to process 500ng as RiboZero and 500ng as PolyA+ libraries. 
The first steps were separate to purify polyA+ and ribosomal-depleted RNA, and then the 
samples were processed simultaneously for the remainder of the library preparation using 
the ScriptSeq™ v2 RNA-Seq Library Preparation Kit (Epicentre kit SSV21106). 
1. PolyA+ mRNA purification 
For polyA+ mRNA purification, the Illumina TruSeq RNA Sample Prep Kit v2 (Illumina kit RS -
122-2001) was used to for the first few steps according to the following protocol: 
50ul of RNA Purification Beads were mixed into each mRNA sample and heated in a 
thermocycler (MJ Research PTC-225) at 65°C for 5 minutes, then incubated at room 
temperature for 5 minutes to allow the mRNA and beads to bind. 
The plate was placed on a magnetic stand for 5 minutes at room temperature, the 
supernatant was removed and beads were resuspended in 100ul bead washing buffer by 
pipetting up and down. The plates were incubated for 5 minutes at room temperature and 
then on the magnetic stand for 5 minutes before removing the supernatant.  
The beads were suspended in 11ul elution buffer and placed in a thermocycler at 80°C for 2 
minutes. The plate was then placed on a magnetic stand for 5 minutes and 10ul of 
supernatant was collected from each well. 
2. Ribosomal RNA depletion 
For ribosomal RNA depletion for RiboZero library preparations the RiboZero ScriptSeq 
complete gold low input kit was used (Epicentre kit SCL24EP).  
90ul of magnetic beads were prepared for each sample by placing beads in a 1.5ml 
microcentrifuge tube, placing the tube on a magnetic stand for one minute, removing 
supernatant and re-suspending beads in RNase-free water. Beads were then vortexed briefly 
and washed twice more in RNase-free water using the magnetic stand. Finally, the RNase-
free water was removed and beads were suspended in 35ul Magnetic Bead Resuspension 
Solution per sample. 35ul of magnetic beads was placed into a new 1.5ml microcentrifuge 
tube in preparation for the RNA samples. 
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RNA samples were then treated by adding 2ul RiboZero rRNA Removal Solution to each RNA 
sample of 500ng, along with 2ul of RiboZero Reaction buffer and RNase-free water up to a 
total volume of 20ul. Samples were mixed by pipetting and incubated at 68°C for 10 m inutes 
and room temperature for 5 minutes. 
RNA samples were placed in the 1.5ml microcentrifuge tubes containing 35ul of washed 
magnetic beads and mixed thoroughly by pipetting and immediate vortexing. This was then 
repeated for each sample to ensure thorough mixing. Samples were incubated at room 
temperature for 5 minutes. Samples were then vortexed for 5 seconds and incubated at 50°C 
for 5 minutes. Tubes were placed on a magnetic stand for at least 1 minute, 50ul of 
supernatant was removed from each tube and placed into a new 1.5ml microcentrifuge tube.  
The ribosomal RNA depleted samples were then purified using AMPure XP beads. 100ul of 
mixed AMPure XP beads were added to each sample by pipetting, tubes were incubated at 
room temperature for 15 minutes and placed on the magnetic stand for 5 minutes. The 
supernatant was removed from each tube. 200ul of 80% ethanol was placed in each tube 
without disturbing the beads, and then removed. The ethanol washing process was repeated 
once. The tubes were left at room temperature to dry for 15 minutes.  The dried bead pellets 
were suspended in 11ul RNase-free water and tubes were incubated at room temperature 
for 2 minutes and placed on the magnetic stand for 5 minutes. The supernatant was removed 
from each tube and placed into a new 1.5ml microcentrifuge tube.  
3. ScriptSeq library preparation 
The maximum volume of 9ul was taken from RiboZero and polyA+ RNA samples for use in 
the ScriptSeq library preparation. 
To fragment RNA and anneal the cDNA synthesis primer 2ul cDNA Synthesis Primer and 1ul 
RNA Fragmentation Solution were added to each 9ul RNA sample in a 0.2ml PCR tube. Tubes 
were incubated at 85°C for 5 minutes and then placed on ice.  
To synthesise cDNA, for each sample 3ul cDNA Synthesis PreMix, 0.5ul 100mM DTT and 0.5ul 
StarScript Reverse Transcriptase were mixed by pipetting. The 4ul of cDNA Synthesis Master 
Mix was then added to each RNA sample on ice and mixed by pipetting. Samples were 
incubated at 25°C for 5 minutes and 42°C for 20 minutes. Once reactions had cooled to 37°C, 
the thermocycler was paused and 1ul of Finishing Solution was mixed into each sample by 
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pipetting. Samples were incubated for a further 10 minutes at 37°C on the thermocycler. 
Reactions were then incubated at 95°C for 3 minutes. During the incubation the Terminal 
Tagging Master Mix was prepared by mixing 7.5ul of Terminal Tagging Premix with 0.5ul DNA 
Polymerase and placing on ice. Reactions on the thermocycler were then cooled to 37°C, 8ul 
of the Terminal Tagging Master Mix was added individually to each reaction and mixed by 
pipetting. Samples were then incubated at 25°C for 15 minutes, 95°C for 3 minutes and then 
placed on ice.  
To purify the cDNA, samples were placed in a 96 well plate and 45ul of mixed AMPure beads 
were added to each sample by pipetting. The plate was incubated at room temperature for 
15 minutes and placed on the magnetic stand for 5 minutes. The supernatant was removed 
from each well. 200ul of 80% ethanol was placed in each well without disturbing the beads, 
and then removed. The ethanol washing process was repeated once. The plate was left at 
room temperature to dry for 15 minutes.  The dried bead pellets were suspended in 24.5ul 
RNase-free water and the plate was incubated at room temperature for 2 minutes and placed 
on the magnetic stand for 5 minutes. 22.5ul of supernatant was then removed from each 
well and placed into a new 0.2ml PCR tube. 
To amplify the library and index samples, each 22.5ul sample of cDNA was mixed with 25ul 
FailSafe PCR PreMix E, 1ul Forward PCR Primer, 1ul ScriptSeq Index PCR Primer an 0.5ul 
FailSafe PCR Enzyme.  
Samples were then placed on a thermocycler with the following program: 
 
95°C 1 minutes  
95°C 30 seconds 15 cycles 
55°C 30 seconds 
68°C 3 minutes 
68°C 7 minutes  
 
To purify the RNA-seq libraries, samples were placed in a 96 well plate and 50ul of mixed 
AMPure XP beads were added to each sample by pipetting. The plate was incubated at room 
temperature for 15 minutes and placed on the magnetic stand for 5 minutes. The 
supernatant was removed from each well. 200ul of 80% ethanol was placed in each well 
without disturbing the beads, and then removed. The ethanol washing process was repeated 
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once. The plate was left at room temperature to dry for 15 minutes.  The dried bead pellets 
were suspended in 20ul RNase-free water and the plate was incubated at room temperature 
for 2 minutes and placed on the magnetic stand for 5 minutes. The clear supernatant was 
then removed from each well and placed into a new 1.5ml microcentrifuge tube. 
2.2.3 Quality control of RNA and libraries 
For quality control of RNA samples prior to library preparation, samples were analysed for 
quality using the Agilent 2100 bioanalyzer (G2943CA). For quality control of libraries prior to 
sequencing, libraries were quantified using with the Qubit 2.0 flourometer (Q32851) with the 
Invitrogen high sensitivity assay kit (5067-4626) and analysed for quality using the Agilent 
2100 bioanalyzer (G2943CA). All QC and sequencing of libraries was carried out by Leena 
Bhaw-Rosun, Abdul Sesay and Debbie Jackson. Following successful quality control, libraries 
were sequenced on the Illumina HiSeq 2000. 
 
2.3 Molecular biology techniques 
 
2.3.1 Synthesis of cDNA 
 
RNA was extracted as described above and the Transcriptor First Strand cDNA synthesis Kit 
(Roche 04897030001) was used for reverse transcription. 1ug total RNA was diluted to 11.4ul 
in nuclease-free water and mixed gently with 2ul Random Hexamer primer. Samples were 
heated at 65°C for 10 minutes to denature RNA, then immediately placed on ice.  
 
The following reaction master mix was set up for all samples- 
4ul Buffer 
0.5ul RNase Inhibitor 
2ul Deoxynucleotide Mix 
1ul DTT 
1.1ul Reverse Transcriptase 
 
8.6ul was added to each tube and mixed gently. A control sample containing all components 
apart from the reverse transcriptase enzyme was also set up. All samples were then placed 
on a thermocycler with the following settings- 
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2.3.2 Quantitative PCR 
QPCR reactions were set up on ice using the KAPA SYBR FAST qPCR Master Mix 2x (Kapa 
Biosystems KK4602). KAPA SYBR Master mix was kept out of direct light when possible, and 
allowed to reach room temperature before use. For each primer pair to be used, a master 
mix was prepared for all reactions as follows- 
 
5ul KAPA Master Mix 2x 
3.6ul Nuclease-free water 
0.2ul 10uM Forward Primer 
0.2ul 10uM Reverse Primer 
 
The master mix was pipetted manually into wells of a 384 well clear qPCR plate, then 1ul of 
the appropriate cDNA was added to each well. CDNA was usually diluted 1:2 or 1:3 depending 
on concentration. 3 technical replicates were run for each cDNA sample and values were 
averaged during analysis. For each primer set, a standard curve of increasingly diluted cDNA 
was run. A 1:2 dilution series was generated using a cDNA sample to give a series of 6 samples. 
1ul triplicates of each dilution were included on the PCR plate. Plates were sealed, 
centrifuged at 1000RPM for 1 minute and placed in the Light Cycler 480 II (Roche). The 
thermocycler conditions were as follows- 
 
Temperature Time 
25°C 10 minutes 
55°C 30 minutes 
85°C 5 minutes 
4°C hold 
Program Temperature Time  
Pre incubation 95°C 3 minutes  
Amplification 95°C 
60°C 
72°C 
3 seconds 
20 seconds 
1 second 
40 cycles 
Melting curve 95°C 3 seconds  
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To quantify the amplified products, the LightCycler 480 software calculated concentrations 
based on the cp values and the standard curves run alongside samples. Using Excel 
(Microsoft), the concentrations were normalised against a control gene by averaging 
replicate samples, and dividing the average of the housekeeping gene odc1, by the average 
of each cDNA sample. The Student’s t-test was applied to the concentration values using 
Excel to compare control and experimental samples.   
See tables 2.2 and 2.3 for list of qPCR primers. 
 
2.3.3 PCR and Agarose Gel Electrophoresis 
PCR reactions were set up using Phusion High Fidelity PCR Master Mix with HF Buffer (NEB 
M0531S). The 20ul reaction was set up on ice: 
1ul 10uM Forward Primer 
1ul 10uM Reverse Primer 
1ul template cDNA 
10ul 2x Phusion Master Mix 
7ul Nuclease-free water 
 
When running several reactions, a master mix was made and aliquoted, before adding 1ul 
cDNA to each PCR tube. 
 
 
 
 
 
 
 
 
60°C 
72°C 
95°C 
20 seconds 
1 second 
 
continuous 
Program 40°C 30 seconds  
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Samples were placed in a thermocycler (MJ Research PTC-225) with the following settings- 
Step Temperature Time 
Initial Denaturation 98°C 30 seconds 
25 Cycles  98°C 
55-65°C 
72°C 
10 seconds 
30 seconds 
1 minute – repeat x24 
cycles 
Final Extension 72°C 10 minutes 
Hold 4°C hold 
 
The annealing temperature is usually 55-65°C and depends on the specific annealing 
properties of each primer pair. New primers were tested with a gradient from 55-65°C across 
the thermocycler plate to test for optimal conditions.  
 
A 1.5% agarose gel was prepared by dissolving 1.5g agarose in 100ml 1X TAE and heating in 
a microwave for 2 minutes. After cooling, 1ul SybrSafe (Life Technologies S33102) was added 
and agarose was poured into a mould with comb for wells and left for at least 30 minutes to 
set. PCR products were mixed with 5X DNA loading buffer blue (Bioline BIO-37045) to a final 
concentration of 1X, and 20ul was loaded onto the gel. Hyperladder 1kb (Bioline BIO-33053) 
or Hyperladder 100bp (Bioline BIO-33056) was loaded alongside samples as a marker. The 
gels were run at 100V for the appropriate time to give good separation of bands. Gels were 
then viewed on the gel dock (BioRad ChemiDoc XRS+ 170-8265) using the Quantity One 
software.  
2.3.4 RT-PCR to test activity of Mix1 splice blocking morpholino 
Primers targeted to exon 1 and 3 were forward (TGGACTCATTCAGCCAACAA) and reverse 
(ACTGGCATCTGCTCAGGTCT) to give a PCR product of 827bp in control cDNA and 1332bp in 
Mix1 morpholino injected cDNA due to inclusion of the first intron. Primers targeted to exon 
2 and exon 3 were forward: (AGCCCGGTACAGAACATCAG) and reverse: 
(GCAGAACATTGCCAAACTCA) to give a PCR product of 947bp in both conditions. 
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2.3.5 In vitro transcription of mRNA 
The mMESSAGE mMACHINE® SP6 Transcription Kit (Life technologies AM1340) was used to 
generate capped mRNA.  
 
The following reaction was set up- 
10ul NTP/CAP 
2ul 10X Reaction Buffer 
1ug linear template DNA 
2ul Enzyme Mix 
Up to 20ul Nuclease-free Water 
  
Reactions were mixed gently and incubated at 37°C for 2-4 hours. Then 1ul TURBO DNase 
was added, mixed and incubated at 37°C for 15 minutes. 30ul Nuclease-free Water and 30ul 
LiCl were added to precipitate RNA for 1 hour at -20°C. Samples were then centrifuged at 
13000RPM for 30 minutes, washed in 500ul 70% ethanol, and centrifuged at 13000RPM for 
10 minutes. Samples were then resuspended in 40ul Nuclease-free water. 1ul of RNA from 
each sample was quantified using a NanoDrop. 2ul was run on a 1.5% agarose gel to check 
for a distinct band which indicates good quality RNA.  
 
2.3.6 Molecular Cloning 
CDNA clones were generated using Zero Blunt® TOPO® PCR Cloning Kit (Life technologies 
K2800-02) or pENTR™/D-TOPO® Cloning Kit (Life Technologies K2400-20). Both kits are useful 
for efficient cloning, the Zero Blunt TOPO kit is used generate clones used for transcription 
of antisense RNA probes for in situ hybridisation. The pENTR™/D-TOPO kit is designed for 
directional cloning, and can be used for flipping the vector insert into destination vectors 
using the gateway system.  
To clone into the pENTR™/D-TOPO vector, forward primers had an additional 5’CACC 
overhang sequence which is used to insert the PCR fragment into the vector in the correct 
orientation. To clone into the Zero Blunt TOPO kit, primers do not require any additional 
sequence and blunt PCR products can be cloned. Phusion High Fidelity PCR Master Mix with 
HF Buffer (NEB M0531S) was used to generate blunt ended PCR fragments. The PCR product 
was isolated by visualising the PCR band on the ChemiDoc and cutting out the band. DNA was 
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extracted from the gel using the QIAquick Gel Extraction Kit (Qiagen 28706) according to 
manufacturer’s guidelines. 
 The following TOPO cloning reaction was set up and incubated at room temperature for 30 
minutes- 
0.5-2ul PCR product 
1ul salt solution 
0.5ul TOPO vector 
Up to 6ul sterile water 
 
2.3.7 Gateway Cloning 
The Gateway cloning system utilises the attL sites in TOPO entry vectors for efficient 
recombination of insert sequence into a destination vector containing attR sites. The 
pENTR™/D-TOPO vectors produced were used for insert recombination into Gateway pCS2+ 
vectors. This was useful for generating tagged constructs, a C-terminal HA tagged pCS2+ 
clone was used for making HA tagged constructs. pENTR™/D-TOPO vector inserts contained 
a coding sequence with the stop codon removed to allow expression of C-terminal tags. The 
Gateway® LR Clonase® II Enzyme mix (Life Technologies 11791-020) was used to catalyse the 
reaction which was set up as follows- 
1ul entry vector 50ng/ul 
1ul destination vector 150ng/ul 
6ul TE buffer pH8 
2ul LR Clonase Enzyme Mix 
Reactions were vortexed briefly and incubated for 1 hour minutes at 25°C then 1ul of 
Proteinase K was added to stop the reaction and 2ul was transformed into bacterial cells. See 
tables 2.4 and 2.5 for cloning primer sequences. 
2.3.8 Bacterial Transformation and plasmid DNA isolation 
2ul of each cloning reaction was gently mixed with 25ul of One Shot® Chemically Competent 
E. coli (Life Technologies) and incubated on ice for 15 minutes. The cells were then heat 
shocked at 42°C for 30 seconds, placed on ice, and mixed with 250ul SOC (Invitrogen 15544-
034). Transformations were shaken at 37°C for 1 hour, then 100-250ul was plated onto a LB 
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agar plate containing 50ug/ml kanamycin. The following day, colonies were picked from each 
plate using a sterile cocktail stick which was placed into a pop-cap tube containing 3-5ml of 
Lysogeny broth (LB) containing 100ug/ml kanamycin or ampicillin. Tubes were shaken at 37°C 
overnight and the following day, were centrifuged at 4000RPM for 5 minutes. The plasmid 
DNA was isolated using the QIAprep Spin Miniprep Kit (Qiagen 27106) according to 
manufacturer’s guidelines and quantified using a NanoDrop. Each clone was then sequence 
verified using an overnight sequencing service (Source Bioscience).  
To obtain a large amount of plasmid DNA a midi-prep was sometimes carried out. This was 
done by taking 100ul from a 3ml pop-cap tube of LB inoculate which had been shaken 
overnight at 37°C. The inoculate was then transferred into a 250ul flask containing 50ul LB 
with 100ug/ml kanamycin or ampicillin and shaken overnight at 37°C. Plasmid DNA was 
isolated using a HiSpeed Plasmid Midi Kit (Qiagen 12643) according to manufacturer’s 
guidelines and quantified using a NanoDrop.  
2.3.9 Vector Linearisation 
Plasmid DNA was linearised using restriction enzymes (NEB). I searched for restriction sites 
within the insert sequence using the NEBcutter web tool (nc2.neb.com/NEBcutter2/). The 
restriction enzymes used are outlined in the table of clones (tables 2.4 and 2.5). Restriction 
digest reactions were set up and incubated for a minimum of 2 hours at 37°C as follows- 
20ug DNA 
5ul 10X NEBuffer 
3ul Restriction enzyme 
Up to 50ul sterile water 
 
Linearised DNA was then purified by adding 200ul TE buffer ph8, 200ul phenol (Life tech) and 
200ul chloroform, vortexing thoroughly, and centrifuging at 13000RPM for 1 minute. The 
upper phase was transferred to an RNase-free tube with 30ul ammonium acetate 
(AppliChem A4716,0250), 3ul MgCl2 and 800ul 100% ethanol. Tubes were placed at -80°C for 
at least 30 minutes to precipitate DNA. Samples were then centrifuged at 13000RPM for 15 
minutes, washed in 500ul 70% ethanol, and centrifuged at 13000RPM for 5 minutes. Samples 
were air dried for 5 minutes then resuspended in 40ul nuclease-free water. 1ul of RNA from 
each sample was quantified using a NanoDrop. 1ul was run on a 1.5% agarose gel to check 
for linearisation. 
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2.3.10 Antisense RNA probe synthesis 
Digoxigenin-labelled antisense RNA probes were synthesised using DIG-RNA Labeling Mix 
(Roche 11277073910) and T7 Polymerase (Thermo EP0111) or SP6 Polymerase (Thermo 
EP0131).  
 
The reaction was set up as follows- 
10ul 5X Transcription buffer 
2ul DIG-RNA labelling Mix 
0.5ul RNase Inhibitor, Murine (NEB MO315S) 
2ug linearised template DNA 
4ul T7/SP6 RNA polymerase 
Up to 50ul Nuclease-free water 
 
The reaction was incubated at 37°C for 2-5 hours, then DNase treated with 1ul DNase I 
(Ambion AM2222) at 37°C for 20 minutes.  
RNA was purified by adding 30ul LiCl (Sigma L7026) and precipitating overnight at -20°C. 
Samples were then centrifuged at 13000RPM at 4°C for 30 minutes, washed in 70% ethanol 
and centrifuged for 5 minutes at 13000RPM at 4°C. Samples were air dried for 5 minutes then 
resuspended in 40ul nuclease-free water. 1ul of RNA from each sample was quantified using 
a NanoDrop. 2ul was run on a 1.5% agarose gel to check for a distinct band which indicates 
good quality RNA. 
 
2.3.11 NanoString transcript quantification 
 
Probes to target genes were produced and designed by NanoString. For the time-course 
experiment, 5 embryos were harvested every 15 minutes and RNA was extracted from each 
sample and diluted to 50ul. Samples were processed by NanoString using the nCounter 
fluorescence-based probe digital counting system. 
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2.4 Western blot techniques 
2.4.1 Extraction of protein from embryos 
Embryos were homogenised by pipetting up and down in PhosphoSafe lysis buffer (Millipore 
71296) supplemented with 1 Complete Mini protease inhibitor tablet (Roche 11836153001) 
per 10ml buffer. Typically for a western blot 40x embryos were homogenised in 250ul buffer 
and incubated on ice for 10 minutes. 250ul FREON (TCTFE, 1,1,2-trichloro-trifluoroethane) 
was then added to each tube and vortexed thoroughly. Samples were then centrifuged at 4°C 
at 13000RPM for 15 minutes. Supernatant was then transferred to a new Eppendorf tube 
and was either used immediately for western blot or immunoprecipitation or snap frozen in 
liquid nitrogen and stored at -80°C.  
2.4.2 Immunoprecipitation of proteins 
Immunoprecipitation (IP) buffer was supplemented with 1 Complete Mini protease tablet 
per 10ml. Approximately 40 embryos were homogenised in a 2ml tube with 250ul ice cold IP 
buffer by pipetting up and down. Samples were incubated on ice for 5 minutes, then FREON 
was added and tubes were vortexed thoroughly. Samples were then centrifuged at 4°C at 
13000RPM for 5 minutes. Supernatant was then transferred to a new tube. An input sample 
of 30ul was taken for western blot and stored at 4°C. 1ug of antibody was added to each tube 
of protein extract and kept overnight at 4°C on a rotator. For all HA tag immunoprecipitation, 
HA antibody produced in rabbit was used (Abcam AB9110). 
The following day Dynabeads Protein A (Life Technologies 10001D) were washed 3 times in 
1ml IP buffer for 15 minutes on a rotator at 4°C and using a magnetic stand to bind beads. 
10ul of Dynabeads was added to each protein sample to bind to the antibody. Samples were 
incubated overnight at 4°C on a rotator.  
The following day samples were washed 5 times in 1ml IP buffer for at least 15 minutes on a 
rotator at 4°C and using a magnetic stand to bind beads. Samples were eluted in 40ul 1X Licor 
protein sample loading buffer (Licor 928-4004). Samples were denatured by heating to 95°C 
for 5 minutes and were then immediately loaded onto a western blot gel. 
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2.4.3 Western Blot 
12% western gels were prepared: 
Casting gel- 
Distilled water- 8.3ml 
30% Protogel (National diagnostics EC-890) polyacrylamide 10ml 
1.5M Tris pH 8.8 6.3ml 
10% SDS 250ul 
10% ammonium persulphate 250ul 
TEMED 10ul 
 
Stacking gel- 
Distilled water- 6.8ml 
30% Protogel (National diagnostics EC-890) polyacrylamide 1.7ml 
1.5M Tris pH 8.8 1.25ml 
10% SDS 100ul 
10% ammonium persulphate 100ul 
TEMED 10ul 
 
Gels were made by pouring the casting gel mix into a mould consisting of 2 glass plates in a 
plastic holder. A space of 1cm was left at the top, and water poured gently over gels to 
remove bubbles. When gels had set the stacking gel was poured on top and the comb 
inserted to make the wells. Once set, gels could be stored at 4°C for up to two weeks. 
Gels were submerged in 1X SDS running buffer in a BioRad tank (Mini-PROTEAN Tetra Cell). 
Proteins were diluted in 1X Licor protein sample loading buffer (Licor 928-4004) and 
denatured for 5 minutes at 95°C. 20ul of each protein sample was loaded into a well of the 
gel, alongside any input controls and 5ul of Novex Sharp Pre-stained Protein Standard ladder 
(Life technologies LC5800). Gels were run at 100V initially for running through the stacking 
gel at the top, then the voltage was increased to 140V for the remaining time. Gels were run 
until the protein stain had visibly run off the bottom of the gel. 
Gels were then transferred to a membrane. The Immobilon-FL (Millipore IPFL00010) 
membrane was immersed in Methanol and the top right corner snipped to orient the 
membrane in later steps. Two sheets of filter paper and sponges were soaked in ice cold 
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transfer buffer. The gel and membrane were placed between two sheets of filter paper and 
two sponges, inside a plastic holder. Bubbles were removed from between the layers by 
rolling a falcon tube over the filter paper. The holder was then placed inside a BioRad tank 
filled with ice cold transfer buffer with the gel closest to the negative pole and the membrane 
towards the positive pole. The blot was transferred at 200mA for 1 hour.  
Membranes were then removed and placed in a tray with 10ml blocking buffer (5ml Odyssey 
Blocking Buffer (PBS) 927-40000 in 5ml PBS) for 1 hour at room temperature on a shaker. The 
Monoclonal Anti-HA antibody produced in mouse (Sigma H3663) was diluted to 1:1000 in 
TBST. The blocking buffer was removed from the membrane and replaced with antibody, 
which was then incubated overnight at 4°C with gentle shaking.  
The following day membranes were given 5x 15 minute washes in TBST at room temperature 
on a shaker. Licor secondary antibodies are light sensitive and were added at a concentration 
of 1:15000 (Licor IRDye 800CW secondary antibody, goat anti-mouse IgG 926-32210), then 
incubated for 1 hour in the dark at room temperature. Membranes were given 5x 15 minute 
washes in TBST at room temperature on a shaker. Membranes were then visualised on the 
Licor Odyssey gel detection system using the Image Studio v2.1 software.  
2.4.4 In vitro protein translation 
The TnT® SP6 Quick Coupled Transcription/Translation kit (Promega L2080) was used to 
synthesise proteins directly from plasmid DNA in vitro. This technique was used to test the 
translation blocking activity of morpholinos. Reactions were set up as follows- 
10ul TNT Sp6 Quick Master Mix  
0.25ul Methionine 
200ng Plasmid DNA 
1ul Nuclease-free water/ morpholino. 
Reactions were incubated at 30°C for 30 minutes. The morpholinos were added at increasing 
concentrations, translation blocking morpholino 1 was added at a concentration of 40uM, 
20uM and 10uM. Translation blocking morpholino 2 was added at a concentration of 40uM, 
20uM, 10uM, 5uM, 2.5uM and 1.25uM. These increasingly lowered concentrations of 
morpholino allowed higher protein production of HA-tagged Mix1 or Mixer protein which 
was visualised by western blot.  
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2.5 Data Analysis 
 
2.5.1 Analysis of time-course RNA-seq data 
 
All RNA-seq data was analysed by Nick Owens. To evaluate gene expression abundances, 
time-series reads were aligned to the X. tropicalis v7.2 transcriptome and known off-genome 
sequences derived from EST assemblies using bowtie2 v2.1.0. Reads from X. laevis animal 
cap sequencing were aligned to the X. laevis v1.6 transcriptome using bowtie2 v2.1.0 
(Karpinka et al. 2015). Time-series data was normalised for each gene against the total reads 
in each library to a standard library size of 25 million reads. For cases in X. laevis where a 
homeolog pair were present they were counted together.  
 
To detect differential expression between different time-series conditions, for each gene, 
data-points were modelled with a Gaussian process which produced median lines of best fit 
and 95% confidence intervals (Owens 2015). Using the Gaussian process framework, 
differential expression was determined by hypothesis testing (Owens 2015). We compared 
the null hypothesis that knockdown and control conditions had equal temporal expression, 
against the alternative hypothesis that knockdown and control conditions had different 
temporal expression. Genes for which we prefer the alternative hypothesis were considered 
for morpholino-induced differential expression.  
Different models were tested for each gene in the knockdown and control conditions; a single 
model which places the knockdown and control data points together and two separate 
models for each condition. Genes which fit the two model condition were considered for 
differential expression. Only genes which diverge after the activation time of  mix1 were 
considered for differential expression for the splice MO and translation MO2 time-series. 
Genes were considered to be differentially expressed at the “divergence time” at which the 
Gaussian process models overlap by only 10%. The 30 minute time-point following this 
divergence was assigned the divergence time for a particular gene. A further condition was 
that the models must overlap by at least 15% before Mix1 was activated in the longer Mix1 
splice blocking MO time-series and translation blocking MO2 time-series. The translation 
MO1 time-series started after mix1-activation so genes were included in analysis if the 
models of control MO and MO1 overlap by at least 7.5% at the first time point. For each gene, 
time-series expression profiles were plotted using MATLAB. 
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Fold changes at 9.0hpf were calculated by taking number of reads from the median line and 
dividing control MO by Mix1 splice MO. The error bars were then derived from Gaussian 
process models. 
2.5.2 Analysing splicing of RNA-seq reads 
This analysis was done by Nick Owens. The sequencing reads from the six time-points from 
5.0-7.5 hpf were used in the analysis because mix1 transcripts are generated at these times 
and there are nascent un-spliced transcripts present. The reads were aligned against X. 
tropicalis transcript sequences from the v7.1 genome assembly using tophat2 v 2.0.10 
(Hellsten et al. 2010). Reads with a section in exon 1 and a section in intron 1 or exon 2 were 
counted to determine whether they had been spliced. Percentages of spliced transcripts 
were calculated for each condition and the average percentage of splicing over the 6 time-
points was reported. 
2.5.3 Detecting gene activations 
 
This analysis was done by Nick Owens. When normalised RNA-seq reads for a particular gene 
increase by a certain threshold over successive time-points, a gene is classified as “activated”. 
To indicate gene activation, the gene expression increase must be measured over at least 
three successive time-points and the fold change from the start of the increase to the end 
must exceed a threshold (e.g. 5x, 10x, 20x fold change, see text for details)  (Collart et al. 
2014). An activation point is assigned to the time-point at the start of the rapidly increasing 
run. 
 
2.5.4 NanoString data analysis 
 
Counts for each time point were normalised to odc1. Gene profiles plotted alongside RNA-
seq data using MATLAB, this analysis was done by Nick Owens. 
 
2.5.5 Statistics for detecting differential expression in animal cap sequencing data 
 
This analysis was done by Nick Owens. For animal cap data differential expression between 
WT and mix1-expressing animal caps for each gene was established using a likelihood ratio 
test on read counts to generate p values which were false discovery rate (FDR) corrected (De 
Domenico et al. 2015). All genes with FDR>0.1 were called as differentially expressed. 
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2.5.6 Mapping X. tropicalis and X. laevis genes 
 
This analysis was done by Nick Owens. The genes differentially expressed in X. laevis mix1-
expressing animal caps were compared to X. tropicalis genes by gene name matching and 
reciprocal blast of sequences. Each blast match with at least 85% identify over 25% of 
transcript was retained and given an alignment score. Up to four X. laevis genes could map 
to a single X. tropicalis gene, but all were required to have an alignment score within 75% of 
the top alignment. Genes were excluded where an X. laevis gene mapped to multiple X. 
tropicalis genes. 23% of relationships assign a single X. laevis transcript to a single X. tropicalis 
transcript and 70% of relationships assign two X. laevis transcripts to a single X. tropicalis 
transcript. 
 
2.5.7 Gene Ontology Analysis 
 
This analysis was done by Nick Owens. The genes detected in each time-series were assigned 
GO terms from an annotated gene list generated using blast2go. Fisher exact test was used 
to calculate p values. I calculated the enrichment of GO terms within the Group 1, 2 or 3 was 
calculated by dividing the observed proportion of genes annotated to a particular GO term 
within Group with the proportion of genes annotated to that GO term within the background 
of all genes detected in the time-series. 
 
2.5.8 Comparing differentially expressed genes from different experimental conditions 
 
Gene lists from different experimental conditions were compared using a web tool for list 
comparison (Whitehead-Institute 2015). To calculate p values using Fisher’s exact test and 
Chi-square test (both two-tailed) a web tool was used (Graphpad 2015). Chi-square test for 
comparison of three gene sets was calculated with a web tool (Lowry 2015).  
The expected overlap between three lists of genes A, B, C of respective size nA, nB, nC from a 
total list of genes size nT was calculated. To calculate the overlap (E) that would be expected 
if three sets of genes were chosen at random from the total set of genes nT, e.g. for list A 
probability pA = nA/nT   E= nT pA pB pC. 
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2.5.9 Transcription factor identification 
 
In order to identify which genes are transcription factors within the lists of differentially 
expressed genes, a set of transcription factors which had been compiled by Mike Gilchrist 
was used for list comparison. This set was generated using a program HMMER3 to look for 
Pfam DNA-binding motifs within X. tropicalis genes (Collart et al. 2014). 
 
2.6 Solutions and Reagents 
 
All solutions are dissolved in distilled water. 
 
10X Marc’s Modified Ringers (MMR) 
 
NaCL    1M 
KCL    20mM 
CaCl2    20mM 
MgSO4    10mM 
Hepes pH7.8   50mM 
EDTA    1mM 
 
Tris-Buffered Saline (TBS) 
Tris-HCl pH7.6   50mM 
NaCl    150mM 
 
TBST 
TBS + Tween 20 (0.2%). 
 
TAE  
Tris base   40mM 
Glacial acetic acid  20mM 
EDTA pH8   1mM 
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MEMFA 
MOPS    1M 
EGTA    20mM 
MgSO4    10mM 
Formaldehyde   3.7% 
pH7.5 
 
Phosphate Buffered Saline (PBS) 
NaCl    137mM 
KCl    2.7mM 
Na2HPO4   10mM 
KH2PO4   1.8mM 
pH7.4 
PBST 
PBS + Tween 20 (0.2%). 
 
Bead Blocking Buffer 
PBS +10% BSA 
 
1X Hybridisation buffer 
Formamide   50% 
SSC    5X 
Torula yeast RNA  1mg/ml 
Heparin   100ug/ml 
Denhart’s solution  1X 
Tween-20   0.1% 
CHAPS    0.1% 
EDTA     10mM 
Store -20°C 
 
20X Saline-Sodium Citrate buffer (SSC) 
NaCl    17.5% 
Sodium citrate   8.8% 
pH7 
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2X Maleic Acid Buffer (MAB) 
Maleic Acid   200mM 
NaCl     300mM 
 
1X Alkaline Phosphatase Buffer 
Tris    100uM 
NaCl    100uM 
Tween-20   0.1% 
MgCl2    40mM 
 
SDS-PAGE Running Buffer 
Tris base   25mM 
Glycine    192mM 
SDS    0.1% 
 
Transfer Buffer 
Tris Base   25mM 
Glycine    190mM 
Methanol   20% 
 
IP Buffer  
Tris, pH7.5   50mM 
NaCl    150mM 
EGTA    1mM 
Igepal CA-630   1% 
Sodium deoxycholate  0.25% 
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2.7 Tables 
 
Table 2.1 : Morpholino sequences 
Gene Morpholino Sequence 
Bix1.1  Splice blocking 5’-GATGACATATAAGCACCTACCTGAA-3’                                                                                                                                                                                                                                                                                                                             
Eomes  Splice blocking 5’-AGTTGGGCTAGTAACCTTACCTGCC-3’ 
Foxi4.2  Splice blocking 5’-GGGCATTACAGACGCTTACCTGGAT-3’ 
Grhl3  Splice blocking 5’-AATTGCATTATATGCATTACCCTGT-3’ 
Gsc  Splice blocking 5’-TGCGATTTGGTAGCGCTTACCTGTA-3’ 
Klf17 Splice blocking 5’-TGTAGAAAAGCTGTACTTACCGACA-3’ 
Translation blocking 5’-GGGTTGAGAAAGCCACACTCATCCT-3’ 
Lhx5 Splice blocking 5’-AGGCCATGCCAACTCCTTACCTGAA-3’ 
Mix1  Splice blocking 5’-TCCATGCCAATGTCCCTTACCTCTC-3-3’ 
Splice blocking 5 base 
mismatch control 
5’-TCgATcCgAATcTCCCTTAgCTCTC-3’-3’ 
Mixer  Splice blocking 5’-GAAATGACTGACTTACCCTTTAAGC-3’ 
Not  Splice blocking 5’-TACAATTAGGTGCCACTCACCTCTC-3’ 
Translation blocking 5’-CAGGAGAGTAGTCCAAGGTCTCACT-3’ 
Tfap2a Splice blocking 5’-GATTGAAGGGATTATGCTTACCGAT-3’ 
Ventx1.2 Splice blocking 5’-AAGAAAGACACATACCTGGTAAGGA-3’ 
Standard 
control 
N/A 5’-CCTCTTACCTCAGTTACAATTTATA-3’ 
Mix1 and 
Mixer 
Translation blocking MO1 5’-GACTGGCTGCTTCCTGGGTTCCCAA-3’ 
Mix1 and 
Mixer 
Translation blocking MO2 5’- GGTTCCCAAGGCTTGTGGCTCCCAA-3’ 
 
 
Table 2.2: X. tropicalis qPCR Primers 
 
Odc1 Forward  
 
GTTCGACCTGCCAGAGCTAC 
 
(Collart et al. 2014) 
 
Odc1 Reverse 
 
CAGGGAGAATGCCATGTTCT 
 
(Collart et al. 2014) 
 
Crx Forward  
 
TACCCAACAACCCCACGGAAA Designed myself 
Crx Reverse  
 
CACTCGGGACTCTGGTAGAT Designed myself 
Cer1 Forward 
 
CCCACGCAAACAAAAGTTCAA 
 
(Collart et al. 2014) 
 
Cer1 Reverse TGGCACCAGGCTTTTCAGTA (Collart et al. 2014) 
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Tnfrsf21 Forward  
 
GGACTAACTATGAACCGACAGATG Designed myself 
Tnfrsf21 Reverse  
 
GGGCGTCCTCTTGATGGT Designed myself 
Ppp1r10 Forward  
 
TTCTGTCCAAGTTTATTCGTGTTG Designed myself 
Ppp1r10 Reverse  
 
CCATCCAGTCATTGACCAAA 
 
Designed myself 
Ventx3.2 Forward  
 
CTCTCTGAGAATCAGATCAAAACCT Designed myself 
Ventx3.2 Reverse  
 
GACAGGAAACTCCGACTGGA Designed myself 
Szl Forward  
 
GCAATGACATCGGCTACTCG Designed myself 
Szl Reverse  
 
CAGGGCTGGATGAACGTATC Designed myself 
Zic3 Forward  
 
TCACATATGCTACTGGGAGGA Designed myself 
Zic3 Reverse 
 
GAATGGCTTCTCACCTGTATGA 
 
Designed myself 
Foxc1 Forward  CATCGTTGTGCCCATCTGAG 
 
Designed myself 
Foxc1 Reverse  CGCCCTGTAGTAACTCTGCT 
 
Designed myself 
 
 
Table 2.3: X. laevis qPCR Primers for animal caps 
Gsc-a Forward 
 
GCTGGCAAGGAGAGTTCATC George Gentsch 
Gsc-a Reverse 
 
TGGGCATTTTCTGATTCCTC George Gentsch 
VegT Forward TTTAGGAACATGCATTCTCTGC (Gentsch et al. 2013) 
 
VegT Reverse CAGTGTTGGGCAGGTAGAGG (Gentsch et al. 2013) 
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Table 2.4: Cloning primers for Mix1 targets for use making in situ hybridisation probes 
Gene Vector Forward primer Reverse primer Linearisation 
site 
Antisense 
promoter 
crx 
Zero blunt 
TOPO 
TGGCGTGGATCT
CAGACTTT 
 
TCCAGGAAGCAG
TTTGGTCT 
 
XhoI SP6 
cer1 Zero blunt 
TOPO 
ATGTTACTCTGT
GTACTTA 
 
AACTGTAATTTTA
GTCAA 
 
NotI SP6 
foxc1 pENTR D-
TOPO/ 
pCS2+ 
CACCAACGCCCC
TGAAAAGAAGA
T 
 
GCAGAGGTGGTG
GTGGTAGT 
 
ApaI T7 
 
Table 2.5: Cloning primers for expression of genes of interest 
Gene Vector Forward 
primer 
Reverse 
primer 
Linearisation 
site 
Sense 
promoter 
Mix1 ATG 
with stop 
codon 
pENTR D-
TOPO/ 
pCS2+ 
CACCATGGAC
TCATTCAGCCA
ACAACT 
TCAAAGGTGG
AGGAGCA 
ApaI SP6 
Mix1 
5’UTR no 
stop 
codon 
pENTR D-
TOPO/ 
pCS2+ 
CACCTTGGGA
ACCCAGGAAG
CAGC 
 
AAGGTGGAGG
AGCACACAGA  
 
ApaI SP6 
Mixer 
5’UTR no 
stop 
codon 
pENTR D-
TOPO/ 
pCS2+ 
CACCTCACTT
TGGGAGCCA
CAAGC 
 
GGCAGAATA
GATGGACTCT
GGACA 
 
ApaI SP6 
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Chapter 3: Mechanisms of gene activation 
3.1 Introduction 
3.1.1 Background and aims 
Two distinct early waves of gene activation are found in the early Xenopus tropicalis embryo, 
the first wave begins immediately after fertilisation and the second begins shortly before 
MBT. The MBT occurs after the first 12 rapid cell divisions. These waves of activation were 
identified using polyA+ RNA-seq to measure gene expression in clutches of embryos sampled 
over a time-series of the first 9.5 hours of development (Collart et al. 2014).  Here I set out 
to distinguish between polyadenylation of maternal mRNAs and de novo zygotic transcription. 
My work is based on polyA+ time-series data and genes activated in this dataset; I will refer 
to this polyA+ time-series as the original time-series (Collart et al. 2014). Using the original 
time series data alone, it is not possible to differentiate between transcript accumulation 
through de novo zygotic transcription and polyadenylation of existing maternally deposited 
transcripts. Both mechanisms of activation appear the same as increases in the polyA+ RNA-
seq data.  
The aim of this work was to measure mRNA without polyA+ selection to measure time-course 
gene expression in order to differentiate between these two classes of gene activation 
behaviour. Two techniques were applied; NanoString which uses hybridisation probes to 
quantify specific transcript numbers and Ribo-Zero RNA-seq which is used to measure 
relative global transcript abundance, independent of polyadenylation status. In this chapter 
I report two mechanisms of activation: polyadenylation of maternal transcripts dominant up 
to the 64-cell stage and transcription dominant from the 128-256 cell stage. 
3.1.2 Gene activation and gene expression profiles 
Here I use the term “gene activation” when expression levels of a particular transcript 
increase significantly over at least three consecutive time points at 30 minute intervals (see 
Materials and Methods for details)(Collart et al. 2014). Gene activations are either the rapid 
accumulation of new transcripts or rapid polyadenylation of existing maternal mRNA within 
embryos. In some cases, genes are activated by both of these mechanisms. The overall 
number of gene activation events for each time point was plotted to show the two distinct 
early waves of activation in the original time-series. In the first wave of activation 551 genes 
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were activated and in the second wave of activation 409 genes were activated (Collart et al. 
2014).  
3.1.3 Polyadenylation-independent transcript quantification 
Here I use two different techniques to differentiate between transcription and 
polyadenylation based gene activation. The NanoString nCounter system is a highly sensitive 
technique to quantify specific transcript numbers, independently of polyadenylation state, 
within cell lysate or extracted RNA samples. The technique uses two probes designed to bind 
to a specific mRNA; a capture probe comprised of a complementary binding sequence 
alongside a biotin affinity tag, and a reporter probe containing a complementary binding 
sequence alongside a series of sequences encoding fluorophores. The differently coloured 
fluorophores are arranged in a unique order in each mRNA reporter probe to allow 
identification of transcripts. RNA or cell lysates are mixed with the capture probes and 
reporter probes and pulled down using the biotin affinity tag onto an electrically charged 
streptavidin surface to elongate the mRNA strands. The unique fluorescent tags are then 
used to count transcripts in the sample (Geiss et al. 2008). The technique does not require 
any amplification steps and is therefore not subject to 3’ bias and can be carried out on low 
quantities of mRNA (Geiss et al. 2008).   
Alternatively, one can use Ribo-Zero RNA-seq to quantify overall transcript numbers 
independently of polyadenylation state. Ribosomal RNA (rRNA) makes up a large component 
of the RNA within a cell so must be removed to allow efficient sequencing of ribosomal-
depleted RNA. For Ribo-Zero library preparation, Ribo-Zero beads bind to rRNA and facilitate 
its removal. This allows RNA-seq of ribosomal-depleted RNA rather than selecting for polyA+ 
transcripts with oligo(dT)beads (Sooknanan, Pease, and Doyle 2010).  
3.2 Identifying mechanisms of gene activation using NanoString technology 
In order to investigate the mechanism of activation for a set of genes, I used the nCounter 
NanoString system to quantify transcript abundance of 43 genes. These 43 genes were 
selected with the aim to investigate the mechanisms of activation of genes which were some 
of the latest maternal transcripts to be polyadenylated and the earliest mRNAs to be 
transcribed. Therefore, genes were selected from within a few hours of when the earliest 
transcription has been detected previously (Skirkanich et al. 2011). These genes were 
distributed into two subsets based on their mechanism of activation; 22 genes were activated 
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before 3.0 hpf and are in the early onset category and 21 genes were activated at 3.0 hpf or 
later in the original time-series and are in the late onset category (Fig. 3.1). 
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Figure 3.1. Early and late onset gene expression profiles.  Time-series gene expression 
profiles from the original RNA-seq time-series.  Transcription factors have a blue tag and 
signalling molecules have a red tag. (A) Early onset genes with higher expression levels 
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targeted in the NanoString experiment. (B) Early onset genes with lower expression levels 
targeted in the NanoString experiment. (C) Late onset genes targeted in the NanoString 
experiment. (Collart et al. 2014). NF stages are marked below with blue arrows.  
 
Batches of five embryos were sampled every 15 minutes over the first 8 hours of 
development and extracted total RNA was assayed for expression of the 43 selected genes. 
Using NanoString, the normalised transcript counts for each gene were plotted and 
compared to the original RNA-seq time-series data to identify whether each gene is 
polyadenylated or transcribed. The timing of the cleavage cycles in the clutch of embryos 
used for collection was 20 minutes for the original time-series and 21 minutes for the 
NanoString time-series. The horizontal timescale on the original time-series data was 
therefore corrected by 20/21 to align the two data-sets. This procedure produced excellent 
agreement between the NanoString and RNA-seq data (Fig. 3.2). The relative abundance of 
transcripts is on an arbitrary vertical scale and was adjusted for the purposes of visualisation 
of the NanoString and RNA-seq data together (data was corrected and profiles plotted by 
Nick Owens, see Materials and Methods for detail). 
Transcripts which display an onset in the original polyA+ RNA-seq profile but have no onset 
in the NanoString data are maternal transcripts undergoing rapid polyadenylation (Fig. 3.2A). 
Transcripts which display an onset in both the original time-series and in the NanoString data 
are zygotically transcribed in the early embryo (Fig. 3.2B). RNA-seq read counts from the 
original time-series and NanoString expression counts are shown for four polyadenylated 
genes (Fig. 3.2A) and four transcribed genes (Fig. 3.2B).  
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Figure 3.2. NanoString time-series data. Time-series NanoString data (red points) is overlaid 
on RNA-seq expression profiles from the original time-series (blue points). NanoString 
horizonal axis is adjusted 20/21 to align time-series, NanoString vertical axis is manually 
adjusted to give the best fit for each gene. (A) Examples of genes activated by 
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polyadenylation of maternal mRNA indicated by indicated by a relatively high, constant 
level of transcripts detected in the early NanoString data points and an early increase in 
original time-series polyA+ transcripts. Cog8, hspa8, pak4 and lekr1 are shown as examples. 
(B) Examples of genes activated by zygotic transcription shortly before MBT, indicated by 
an increase in both Nanostring and original time-series polyA+ transcripts at or shortly 
before MBT. Irx1, nodal3.1, gdf3 and lhx5 are shown as examples. 
 
I found that the behaviour of the 22 early onset genes was consistent with polyadenylation 
and the behaviour of the 21 later onset genes was consistent with zygotic transcription. This 
demonstrates the existence of 2 classes of activation behaviour in early development. These 
two gene behaviours are temporally distinct, at least for the 41 genes tested, with maternal 
polyadenylation dominant in the post-fertilisation embryo up to and including 2.5 hpf and 
zygotic transcription dominant from 3.0 hpf which coincides with the 128-cell stage. This 
finding is supported by the gap found between the two separate waves of gene activation in 
the early embryo (Collart et al. 2014). 
 
3.3 Identifying global activation using Ribo-Zero RNA-seq 
3.3.1 Polyadenylation is the initial mechanism of gene activation and transcription is 
dominant shortly before MBT 
Ribo-Zero RNA-seq can be used to measure global expression in ribosomal-RNA depleted 
RNA samples. I used Ribo-Zero RNA-seq to build on the preliminary results obtained using 
NanoString, to investigate the mechanisms of activation for all genes detected in the early 
embryo. By measuring gene expression over a time-course I was able to differentiate 
between transcription and polyadenylation; the two mechanisms of gene activation found in 
the early embryo. 
Embryos were collected over a time-series to measure the dynamic gene expression changes 
during early development. Pools of five embryos were sampled at 30-minute intervals and 
total RNA was extracted. The samples were then split into two technical replicates to be used 
for polyA+ and Ribo-Zero RNA-seq. Ribo-Zero RNA-seq libraries were sequenced for every 1 
hour time point up to 8.0 hpf (stage 10), and polyA+ RNA-seq libraries were sequenced for 
every 30 minute time point up to 9.0 hpf (stage 11). PolyA+ and ribosomal-depleted RNA 
profiles were generated from normalised read counts and used to compare readouts 
between the two conditions (RNA-seq data analysed by Nick Owens, see Materials and 
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Methods for details). Full lists of activated genes from RiboZero and polyA+ RNA-seq can be 
found in the appendix on the attached CD (tab 1).  
 
Figure 3.3. All activated genes in the polyA+ and Ribo-Zero RNA-seq time-series. Total 
genes that display an onset (activation) at each one hour time point in the polyA+ time -
series (blue) and the RiboZero time-series (red). The mid-blastula transition (MBT) is 
marked as a vertical pink bar. (A) Total activations at a 5x fold change threshold. (B) Total 
activations at a 20x fold change threshold. Tables show total numbers of activated genes 
at each time point. 
 
I took the activated genes in the RNA-seq polyA+ time-series and compared their expression 
profiles to those in the ribosomal-depleted RNA time-series (Fig. 3.3). There is a clear early 
wave of activations immediately from fertilisation in which several hundred genes are 
activated by polyadenylation. After 4.0 hpf there is an increase in the numbers of activated 
genes in the ribosomal depleted RNA, indicative of transcriptional activation. Applying 
different fold change thresholds alters the number of gene activations measured. At a 5x fold 
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change threshold there are continual gene activations throughout the time series, but still I 
find two distinct activation waves (Fig. 3.3A). At a 20x fold change threshold, there is a clearer 
separation between the two peaks of activation (Fig. 3.3B), which suggests there is a distinct 
early wave of polyadenylation and a second wave where transcriptional activation is 
dominant.  
The comparison of the polyA+ and ribosomal-depleted RNA datasets revealed that genes 
were activated by polyadenylation after fertilisation, because the vast majority of activations 
are detected only in the polyA+ data at the earliest time points. Transcription of very few 
genes was detected from 3.0 hpf, approximately 2.0 hours before MBT (Fig. 3.3). From 4.0 
hpf I found that the number of activations in the RiboZero and polyA+ time-series matched 
more closely.  This indicates that from 4.0 hpf which is approximately one hour before MBT, 
genes were predominantly activated by zygotic transcription.  In the clutch of embryos used 
to generate the RiboZero and accompanying polyA+ sequencing data, the 256-cell stage was 
at 4.0hpf. Overall low levels of transcription were detected here from the 64-cell stage, and 
widespread transcription was found from the 256-cell stage. This demonstrates a 
mechanistic shift where before 4.0 hpf, polyadenylation is the predominant mechanism of 
activation and from the 256-cell stage at 4.0 hpf transcription is the predominant mechanism 
of gene activation. PolyA+ and Ribo-Zero normalised read counts are shown for four 
polyadenylated genes and four transcribed genes (Fig. 3.4). The data points for the RiboZero 
and polyA+ sequencing do not align well due to differences in relative normalisation and 
biases of the two different sequencing techniques used. 
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Figure 3.4. Ribo-Zero and polyA+ RNA-seq time-series data. (A) Genes activated by 
polyadenylation of maternal mRNA indicated by a relatively high, constant level of 
transcripts detected in the early RiboZero data points (squares) and an early increase in 
polyA+ transcripts (crosses), lekr1, gabpa, btbd17 and ets2 are shown as examples. (B) 
Genes activated by zygotic transcription indicated by an increase in both RiboZero 
(squares) and polyA+ transcripts (crosses) at or shortly before MBT, sox17a, mixer, lhx5 and 
nodal6 are shown as examples. Gene profiles generated by Nick Owens. 
 
3.3.2 Timing of gene activations are later than in the original time-series 
The temperature in the room used to collect embryos was lower than usual, causing a slower 
developmental rate in the clutch of embryos used for the Ribo-Zero time-series than in the 
original time-series and the NanoString time-series. I compared the activation times of 
several genes between my polyA+ time-series and the original polyA+ time-series. I found 
that nodal3.1 and sox2 were activated 1 hour later in my time-series (Fig. 3.5A, B), and nodal6 
and foxb1 were activated 1.5 hours later in my time-series (Fig. 3.5C, D). As a result of this, 
the timing of the switch between polyadenylation and transcriptional activation of genes is 
later in the Ribo-Zero time-series compared to the original time-series and the NanoString 
time-series.  
Chapter 3 – Mechanisms of gene activation 100 
 
Figure 3.5. Time shift of gene activations between the original and the Ribo-Zero time-
series data (Collart et al. 2014) (A) Gene expression profiles showing activation in the 
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original time-series, nodal3.1 and sox2 are shown as examples. (B) Gene expression profiles 
showing activation in the Ribo-Zero and polyA+ time-series with a 1 hour developmental 
delay compared to the original time-series, nodal3.1 and sox2 are shown as examples. (C) 
Gene expression profiles showing activation in the original time-series, nodal6 and foxb1 
are shown as examples. (D) Gene expression profiles showing activation in the Ribo-Zero 
and polyA+ time-series with a 1.5 hour developmental delay compared to the original time-
series, nodal6 and foxb1 are shown as examples. Gene profiles generated by Nick Owens.  
 
3.4. Discussion 
3.4.1 Transcription becomes the dominant mechanism of gene activation shortly before 
MBT 
I differentiate between 2 mechanisms of gene activation behaviour through comparison of 
polyA+ and ribosomal-depleted RNA-seq time-series data. The two mechanisms of gene 
activation in the early embryo; polyadenylation and transcription are easily delineated 
through comparison of the polyA+ and ribosomal-depleted RNA data. Ribosomal-depleted 
RNA data reflects changes in total transcript levels and polyA+ data reflects changes in 
numbers of polyadenylated transcripts.  
The degradation of transcripts is established at MBT, before these stable un-adenylated 
transcripts can persist in the embryo and polyadenylation is the mechanism which regulates 
translation (Paris and Philippe 1990; Voeltz and Steitz 1998). Therefore, it is unlikely that 
polyadenylation operates as a mechanism of activation after MBT as polyadenylation is then 
necessary to protect mRNAs from degradation.  
In the NanoString data which tested a small set of genes, I found that polyadenylation was 
the early mechanism of activation, and transcription became the predominant mechanism 
of activation shortly before MBT. The Ribo-Zero data gave the same conclusion for genome 
wide expression within the time-series. I observed a general mechanistic shift from 
polyadenylation to transcription as the predominant mechanism of gene activation over the 
first several hours of development. Appreciable numbers of genes were activated by 
transcription from the 256-cell stage in the Ribo-Zero time-series. Comparison of genes 
activated in the original time-series and in the RiboZero time-series described here, revealed 
that transcription was widespread in the second wave of activation found from the 128-256 
cell cycles (Collart et al. 2014).  
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It is difficult to determine whether the two mechanisms of activation are temporally distinct. 
A period of low activation activity was found at the 3.0 and 4.0 hpf time-points which could 
be caused by variation in the developmental rate of pooled embryos, or reflects that both 
mechanisms occur simultaneously in the pre-MBT embryo. It is difficult to tell how much 
overlap there is between the two mechanisms of activation once transcription has begun, 
but as mentioned it is unlikely that polyadenylation is a widespread activatory mechanism 
post-MBT. At all time-points, there were higher numbers of activated genes in the polyA+ 
time-series, this could reflect late polyadenylation for a number of transcripts or this could 
be due to differing detection rates in the two sequencing techniques. The fold change criteria 
are subjective, so there is no way to tell whether a gene is “activated” or not in an unbiased 
objective manner. For this reason, I cannot determine whether the mechanisms of activation 
are separate, but I find a general mechanistic switch from polyadenylation to transcription 
that occurs before the MBT. 
A limitation of the Ribo-Zero time-series approach to identify mechanisms of gene activation 
is that maternal-zygotic genes which are replaced by zygotic transcription as the maternal 
mRNAs are degraded, cannot be detected. This behaviour would not appear as gene 
activation in my data if the maternal transcripts are gradually replaced. Tackling this problem, 
zygotic expression was identified in zebrafish embryos by crossing two strains and 
differentiating between maternal and paternal SNPs to identify maternal and zygotic mRNAs 
in the sequencing reads. The first zygotic transcription was identified at the 128-cell stage 
(Harvey et al. 2013).  
  
3.4.2 Early polyadenylation is necessary for progression through MBT 
 
In zebrafish, by blocking polyadenylation using cordycepin, maternal polyadenylation was 
found to be essential for normal progression through MBT. The cordycepin-induced delay in 
MBT was measured by the delayed epiboly and death before 10 hpf in treated embryos. 
However to determine whether cordycepin treatment blocks zygotic transcription, 
measurement of the transcriptional output of MBT-transcribed genes is necessary (Aanes et 
al. 2011). This was addressed in cordycepin-treated X. tropicalis embryos using NanoString 
to demonstrate reduced transcription in the majority of genes tested. This indicates that 
polyadenylation of maternal transcripts is necessary for adequate transcription at MBT 
(Collart et al. 2014).  
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3.4.3 Detection of early transcription 
 
Work in X. laevis measured incorporation of a radioactive label to detect transcription from 
as early as the 128-cell stage (Kimelman, Kirschner, and Scherson 1987). This finding is 
consistent with our finding of genes which are transcriptionally activated from 128-256 cell 
cycles in the original time-series. Consistent with this, the earliest zygotic transcription in 
zebrafish was found at the 128-cell stage. Gene expression in zebrafish embryos was 
measured using RNA-seq and qPCR with random hexamer or oligo-dT primers at several 
developmental stages to differentiate between maternal and zygotic transcripts (Aanes et al. 
2011). This may reflect that radioactive labelling or qPCR are more sensitive than RNA-seq 
for identifying early transcription where relative transcript abundance may be very low. 
 
In X. laevis, nodal5 and nodal6 were found to be transcribed from the 256-cell stage using 
reverse transcription of RNA with either oligo-dT or random hexamer primers followed by 
RT-PCR (Yang et al. 2002). I find that these two genes were early transcribed genes in the 
NanoString and polyA+ time-series. In the original time-series, nodal5 has too weak an onset 
to be considered as activation by our criteria, but transcripts were present from 4.0 hpf, so 
3.5 hpf would be the activation time if the onset of nodal5 was more rapid. Nodal6 was 
activated at 3.5 hpf which coincides with the 256-stage (Collart et al. 2014). A later study 
detected expression of nodal5 and nodal6 in X. laevis from the 128-cell stage and pre-MBT 
expression of bix4, gdf3, sox17a and mixer emerging between the 4-cell and 256-cell stages. 
All six of these early-transcribed genes were regulated by VegT (Skirkanich et al. 2011). Bix4 
is not present in X. tropicalis but the related gene bix1.1 is found. Bix1.1, mixer, sox17a, gdf3, 
nodal5 and nodal6 were all found to be transcribed pre-MBT in the Ribo-Zero time-series.  
A study in X. tropicalis identified potential pre-MBT transcribed genes which displayed a two-
fold increase in sequencing reads from the 2-cell to the 32-cell stage (Tan, Au, Yablonovitch, 
et al. 2013). They report 36 pre-MBT rapidly transcribed genes, 13 of which were validated 
by qPCR with random hexamer primers for reverse transcription to detect total RNA. Less 
stringent criteria were then applied for gene expression levels and 303 genes were reported 
as likely to be early transcribed, and 6 of these were validated by qPCR (Tan, Au, Yablonovitch, 
et al. 2013). The Ribo-Zero data here clearly shows that all 19 validated genes described as 
pre-MBT transcribed genes were maternal transcripts activated by polyadenylation in the 
early embryo (cdc14b, dpp8, btbd17, cdk5r2, arih2, slc9a3r1, Xetrov72024821, mtx1, slain2, 
lrrcc1, gart, oct25, ets2, akt2, c20orf72, nkrf, rhou, spats2 and ier5). Two of these genes, ets2 
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and oct25 were activated first by polyadenylation and then were clearly transcriptionally 
activated after the MBT. It is unclear how Tan et al. find increases in total RNA levels where I 
find unchanging transcript levels. Generally, the pre-MBT fold changes in the qPCR data are 
low; between 2- and 3-fold, which is much lower than the fold changes found for the 
confirmed transcriptional targets Nodal5 and Brachyury, so there is some doubt that these 
low fold changes reflect genuine changes in transcript levels (Tan, Au, Yablonovitch, et al. 
2013). 
 
Time-course Ribo-Zero RNA-seq in X. tropicalis used RNA spikes for the absolute 
quantification of transcripts within the embryo. The earliest mRNAs detected were Nodal3.1, 
Nodal5, Nodal6, Sia1 and Sia2 from the 32-256 cell stages. The first of these to be detected 
was Nodal3.1 which appears at the 32-64 cell stage at 2.5 hpf. These genes were found to be 
transcribed later than this in our datasets, which could mean (i) variation in timing of 
transcription of specific genes exists between different clutches of embryos, or (ii) the Ribo-
Zero RNA-seq recovered more non-ribosomal reads than my RiboZero sequencing resulting 
in higher sensitivity (Owens 2015), or (iii) the intrinsic technical variation in each time-point 
sample means that a gene may be detectable at earlier or later time points.  
 
The original time-series, the Ribo-Zero time-series presented here and the Ribo-Zero time-
series sequenced by Owens et al. all have different genes emerging as the first transcribed. 
The order of early transcriptional events has some variation, which could have a technical or 
biological origin. Although the exact ordering of the activation time differs, genes are 
activated within a relatively close period of time in different experiments.  
 
The earliest transcripts in zebrafish, Drosophila and mouse are short and have few or no 
introns (Heyn et al. 2014). In X. tropicalis, transcripts of the early expressed genes nodal5 and 
nodal6 have relatively short transcripts of less than 2kb and two introns indicating that early 
transcribed genes in X. tropicalis may also be short. The first zygotic gene expression in fish, 
fly and mouse is not evolutionarily conserved indicating the existence of adaptive potential 
(Heyn et al. 2014). If the first transcription can vary so much between species, then perhaps 
early gene expression is not crucial in establishing gene pathways which direct patterning 
and embryogenesis. The maternally deposited proteins and transcripts may be sufficient to 
set up early networks. This poses the question of whether the specific genes which are the 
first to be transcribed are important. Xenopus may have evolved to have highly expanded 
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and diverged gene families responsible for patterning, giving rise to high levels of redundancy 
within the system. This ensures a highly robust organism which can develop even if 
something goes wrong and this may have driven the rapid evolution of Xenopus (Heyn et al. 
2014).  
 
3.4.4 Conclusion 
 
In summary, I report the same finding for the Ribo-Zero and NanoString time-series data, 
which is that there are two mechanisms of gene activation in the early embryo, genes are 
activated by polyadenylation in the post-fertilisation embryo and shortly before MBT, 
transcription becomes the dominant mechanism. There is a rapid increase in the amount of 
transcription detected as the control of the embryo shifts from maternal to zygotic.
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Chapter 4: Morpholino screen of early-activated genes 
 
4.1 Introduction 
As a starting point for the investigation of the gene regulatory networks directing early 
embryonic development, I needed to identify a small number of developmentally important 
transcription factors. These would be used later in the project to determine their 
downstream targets through perturbation analysis. In this chapter I describe the use of a 
preliminary morpholino oligonucleotide (MO) knockdown screen on a larger set of candidate 
target genes derived from data generated in the lab (Collart et al. 2014) to achieve this. I 
reasoned that genes whose depletion caused early and obvious developmental defects 
would likely be important regulators of early development.  After surveying twelve zygotically 
activated and ten rapidly polyadenylated maternal transcription factors, I selected mix1 for 
further investigation.  
4.2 Screening the candidate zygotic transcription factors  
4.2.1 Choice of genes 
To select the candidate gene list for the initial morpholino oligonucleotide (MO) knockdown 
screen of zygotically activated transcription factors, I decided on a set of attributes which 
would suggest genes likely to be important regulators of early developmental networks. 
These were; clear zygotic activation shortly before MBT, magnitude of activation and 
transient behaviour showing decline shortly after activation. I was particularly interested in 
genes showing transient behaviour, as these were suggestive of a network controlling genes 
with an on-off, switch-like behaviour, whose functional importance may be limited to an 
interestingly specific period of development. 
I used two sets of existing data to help make my selection: a set of high resolution time-series 
gene expression data covering the period from fertilisation through to mid-gastrulation 
(Collart et al. 2014), and a database of assembled expressed sequence tag (EST) data 
(Gilchrist et al. 2004). I used EST database to check the quality of each gene model by 
ensuring there was alignment of multiple clone sequences and orthology data along the 
entire open reading frame of each gene (Gilchrist et al. 2004). Splice junctions were identified 
by aligning  cDNA sequences to genomic sequence using the UCSC genome browser (UCSC 
2015). I used the activation times derived from the time-series data to find genes strongly, 
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and preferably transiently, activated at or around the MBT and then checked the gene 
models against the assembled EST data, before settling on a list of 12 candidate transcription 
factors: bix1.1, eomes, foxi4.2, grhl3, gsc, klf17, lhx5, mix1, mixer, not, tfap2a and ventx1.2 
for the MO screen (Fig. 4.1). The time-series data also showed which genes were present as 
maternal transcripts before zygotic gene activation, and which were not. 
 
 Figure 4.1 Zygotic genes for MO screen. Gene expression profiles from the original RNA-
seq time-series. Normalised read counts are shown for the twelve zygotic transcription 
factors included in the first MO screen for phenotypes. All twelve genes are rapidly and 
transiently expressed from shortly before the MBT which is marked with a pink bar (Collart 
et al. 2014).  
 
I used different MO depletion strategies, depending on whether genes had detectable 
maternal mRNAs prior to zygotic activation. For genes with a significant maternal mRNA 
component (klf17 and not) I used both a splice blocking MO and a translation blocking MO in 
separate experiments. For genes with little or no detectable maternal mRNA (<1% of post-
MBT levels of zygotic activation) I used only a splice blocking MO. See Table 4.1 for the full 
list of candidate genes and MO types used. The main reason for using splice blocking MOs 
was because they would not block injected mRNA used for rescue of the MO induced 
phenotype, with future validations for selected target genes in mind. In all cases I injected 
10ng of MO; and as a negative control I injected the standard control MO from Gene Tools 
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at 20ng. The control was injected at a higher dose as this was thought to be a robust strategy, 
however since the Gene tools standard control MO is known to cause no defects, the higher 
dose would not make a difference ad a 10ng would have been sufficient.  
4.2.2 Phenotypes arising from the screen 
MO knockdown of seven out of twelve genes induced a defective phenotype in injected 
embryos. The phenotypes ranged from minor defects such as a bent tail, to major defects 
such as blastopore closure failure (Fig. 4.2). Phenotypes are listed in Table 4.1. 
 
Figure 4.2. Phenotypes from the zygotic MO screen.  Embryos injected with 20ng standard 
control MO exhibit a normal phenotype. Embryos injected with 10ng of Foxi4.2 splice 
blocking MO have a bent tail (31/46), embryos injected with 10ng Ventx1.2 splice blocking 
MO are ventralised (36/47) and embryos injected with 10ng Not translation blocking MO 
have a truncated axis and head and tail defects (24/53). Embryos were imaged at stage 33, 
lateral view. 
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Gene Morpholino Knockdown phenotype Penetrance 
bix1.1  Splice blocking No defect 
 
N/A 
eomes  Splice blocking No defect 
 
N/A 
foxi4.2  Splice blocking Bent tail 
 
67% (31/46) 
grhl3  Splice blocking No defect 
 
N/A 
gsc  Splice blocking No defect 
 
N/A 
klf17 Splice blocking Truncated 
 
Cranial or ventral oedema 
40% (16/40) 
 
20% (8/40) 
Translation blocking Cranial oedema 
 
80% (40/50) 
lhx5 Splice blocking Lethal at early tailbud stage 
head and eye defect 
 
50% (23/46) 
mix1  Splice blocking Blastopore closure defect  
 
Ventralised 
 
Lethal at late tailbud stage 
58% (31/53) 
 
100% (53/53) 
 
100% (53/53) 
mixer  Splice blocking Blastopore closure defect 
 
Truncated with head and tail 
defects 
 
Lethal at late tailbud stage 
63% (30/48) 
 
96% (46/48) 
 
 
77% (37/48) 
not  Splice blocking No defect 
 
N/A 
Translation blocking Truncated axis and head and 
tail defects 
 
45% (24/53) 
tfap2a Splice blocking No defect 
 
N/A 
ventx1.2 Splice blocking Ventralised 
 
77% (36/47) 
 
Table 4.1. Zygotic MO screen phenotypes. The observed phenotypes and penetrance of 
each MO found in injected embryos. Each MO was tested in two clutches of embryos to 
ensure phenotypes were replicable. The results of the two separate experiments are 
pooled to give the penetrance of each MO.  
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4.2.3 Genes with strong and early defective phenotypes are interesting candidates for 
further study 
From the screen I selected mix1 as a candidate for further study. Mix1 knockdown embryos 
displayed an early, strong phenotype with high penetrance. Mix1 splice blocking MO-injected 
knockdown embryos appear ventralised at the tailbud stage and have head and tail defects. 
Around half of these embryos undergo incomplete blastopore closure during gastrulation. 
Mix1 MOs induce a phenotype which is lethal at the late tailbud stage (Fig. 4.3).  
Mixer was selected as a candidate gene for further study, however problems discussed in 
Chapter 6 and time limitations meant that this was not followed up. Mix1 and Mixer are 
related Mix family homeobox transcription factors and their proteins share 40% identity. 
Mixer splice blocking MO-injected knockdown embryos display incomplete blastopore 
closure and defective head and tail development and are truncated (Fig. 4.3). Similar 
phenotypes were found in the Mix1 and Mixer MO knockdowns. Mixer MO-injected embryos 
were not ventralised, but did have a blastopore closure defect and were truncated with head 
and tail defects (Fig. 4.3). 
 
Figure 4.3. Mix1 and Mixer MO phenotypes.  Embryos injected with 20ng standard control 
MO exhibit a normal phenotype. Embryos injected with 10ng Mixer splice blocking MO 
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displayed a blastopore closure defect (30/48), a truncated axis with head and tail defects 
(46/48) and were lethal at the late tailbud stage (37/48). Embryos injected with 10ng Mix1 
splice blocking MO displayed a blastopore closure defect (31/53), were ventralised (53/53) 
and were lethal at the late tailbud stage (53/53).  Lateral view of Mix1 knockdown embryos, 
Mixer knockdown embryos and control embryos at stage 29.  
Further investigation of Mix1 knockdown embryos was carried out to identify the targets of 
this transcription factor, see Chapters 5 and 6. I note that Mixer, Foxi4.2, Ventx1.2 and Not 
knockdown embryos also generated strong phenotypes, including bent tail and head and tail 
defects and would make good candidates for further investigation (Fig. 4.2). 
4.3 Screening the candidate maternal transcription factors 
4.3.1 Choice of genes  
In addition to testing a set of zygotically transcribed genes, I screened genes which exist as 
maternal transcripts in the early embryo and are rapidly polyadenylated shortly after 
fertilisation (presumably to make them translationally available). Knockdown embryos were 
screened for phenotypes as a means of identifying genes which potentially have an important 
role in development.  I selected ten genes based on their expression, which had to be strongly 
activated shortly after fertilisation and closely followed by some level of deactivation (Fig. 
4.4). As mentioned earlier, transiently activated genes may function to briefly regulate 
downstream events. 
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Figure 4.4. Maternal genes for MO screen. Gene expression profiles from the original RNA-
seq time-series. Normalised read counts are shown for the ten maternal transcription 
factors included in the second MO screen for phenotypes. All ten genes are rapidly and 
transiently expressed from shortly after fertilisation. The MBT is marked with a pink bar 
(Collart et al. 2014).  
 
As before, I used the EST database to check the quality of each gene model. 10ng of a 
translation blocking MO was injected in each knockdown experiment and 20ng of the 
standard control MO from Gene Tools was used for control injections. 
 
4.3.2 Phenotypes from the MO screen 
Genes tested and phenotypes are listed in Table 4.2. Two out of ten maternal gene 
knockdowns generated a defective phenotype, these were Znf821 and Clock. Both gene 
knockdowns generate a phenotypic defect at gastrulation; the incomplete closure of the 
blastopore (Fig. 4.5). The severity of the phenotype implies that these two genes may have 
important roles in early development. Given more time, Znf821 and Clock would make 
interesting targets for downstream analysis. 
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Figure 4.5. Phenotypes from the maternal MO screen.  Embryos injected with 20ng standard 
control MO exhibit a normal phenotype. Embryos injected with 10ng of Znf821 MO or Clock 
MO display defective blastopore closure phenotypes (31/47) for Znf821 MO and (41/41) 
for Clock MO. Embryos were imaged at stage 26, lateral view. 
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Gene Morpholino Knockdown phenotype Penetrance 
gabpa Translation blocking No defect N/A 
zhx3 Translation blocking 
 
No defect N/A 
adnp Translation blocking 
 
No defect N/A 
zfp64 Translation blocking 
 
No defect N/A 
sp2 Translation blocking 
 
No defect N/A 
znf526 Translation blocking 
 
No defect N/A 
znf821 Translation blocking 
 
Blastopore closure defect 84% (31/37)  
znf639 Translation blocking 
 
No defect N/A 
clock Translation blocking 
 
Blastopore closure defect 100% (41/41) 
znf827 Translation blocking 
 
No defect N/A 
 
Table 4.2. Maternal MO screen phenotypes. The penetrance of observed phenotypes of 
MO-injected embryos.  Each MO was tested in two clutches of embryos to ensure 
phenotypes were replicable. The results of the two separate experiments are pooled to 
give the penetrance of each MO.  
4.4 Discussion 
4.4.1 MOs as a knockdown tool 
The MO screen for phenotypes was an efficient way to identify genes which are likely to have 
an important early developmental function. A problem with MO knockdown is the potential 
for off-target effects where the MO erroneously targets incorrect mRNAs (Eisen and Smith 
2008) Ideally, rescue or antibodies would be used to validate the knockdowns but time 
restrictions and a general lack of antibodies for Xenopus proteins meant this was not possible.   
4.4.2 Mix1 and Mixer are interesting candidates for further investigation 
The strong phenotypes displayed by Mix1 and Mixer knockdown embryos suggest a 
developmentally important role for these two transcription factors. From these two genes 
Mix1 was selected for further study to determine its downstream targets. The induction of 
similar phenotypes by different MOs targeting the same gene adds to the reliability of the 
results. The Mix1 MO was subject to further validations and downstream analysis in Chapters 
5 and 6. 
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4.4.3 Several MOs do not generate a phenotype 
Five of the zygotic and eight of the maternal gene knockdowns did not display a defective 
phenotype. It is possible that depletion of these five transcription factors does not affect the 
patterning of the embryo, and may have some impact on development which is unobservable 
in the phenotype. In situ hybridisation, qPCR or RNA-Seq could be used to find effects on 
downstream gene expression caused by knockdown of these transcription factors.  
Another possibility is that the MOs are ineffective in knocking down the targeted genes. This 
could be the result of a robust system in which other genes compensate for the loss of a gene, 
or the MOs may simply not effectively block translation or splicing of the targeted transcripts. 
It is possible for the maternal genes that protein is also maternally contributed at fertilisation 
which might be the case if the maternal factors are important for development, meaning the 
knockdown would be harder to achieve. 
 
4.4.4 The translation blocking MOs induced greater phenotypic effects than splice blocking 
MOs for genes which have maternal and zygotic transcripts 
The Klf17 translation blocking MO induced a cranial oedema phenotype at higher penetrance 
than the splice blocking MO. This difference in penetrance is most likely  an effect of the 
maternal transcripts which are not targeted by the splice blocking MO. Only splice blocking 
MO-injected embryos display a truncated phenotype. Based on the idea that the translation 
blocking MO has a greater impact on Klf17 depletion, it is likely that the truncated phenotype 
is due to off-target effects of the splice blocking MO. This could be tested using a second MO 
or a dominant negative Klf17 construct.  
Not translation blocking MO-injected embryos displayed a phenotype whereas Not splice 
blocking MO-injected embryos did not. There are abundant maternal not transcripts present 
from fertilisation which are not targeted by the splice blocking MO. The maternal transcripts 
most likely generate sufficient levels of Not protein to maintain normal gene function, thus 
cancelling the effect of the splice blocking MO. The level of maternal not mRNA is much 
higher than the maternal klf17 mRNA in the embryo, which may explain why the Klf17 splice 
blocking MO has an effect on the phenotype and the Not splice blocking MO does not. 
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4.4.5 Comparison of phenotypes from my screen to previous knockdown studies 
Comparison to previous knockdown experiments gives some indication of the specificity of 
the MOs used in my screen. Comparisons to other MO knockdown experiments are discussed 
below (Table 4.3). 
Gene Species Phenotype In situ staining Reference 
bix1.1 No MO 
studies 
N/A N/A N/A 
eomes X. tropicalis No morphological 
phenotype 
Reduced vegt (Fukuda et al. 
2010) 
zebrafish No morphological 
phenotype 
Reduced gsc and 
flh (not) 
(Bruce et al. 
2003) 
foxi4.2 X. laevis No morphological 
phenotype 
Head ectoderm 
impaired 
(Matsuo-
Takasaki, 
Matsumura, 
and Sasai 2005) 
grhl3 No MO 
studies 
N/A N/A N/A 
gsc X. laevis Anterior 
truncations and 
ventralised 
Expanded ventral 
expression and 
reduced myod 
(Sander, 
Reversade, and 
De Robertis 
2007) 
zebrafish Cyclopia and loss 
of head 
development 
Presumptive 
forebrain and 
midbrain markers 
reduced and wnt8 
up-regulated 
dorsally. 
(Seiliez, Thisse, 
and Thisse 
2006) 
klf17 X. laevis Loss of hatching 
gland and otic 
vesicle formation. 
Reduced neural 
crest formation. 
(Kurauchi, 
Izutsu, and 
Maeno 2010) 
lhx5 X. laevis Neural tube 
closure delay 
N/A (Houston and 
Wylie 2003) 
zebrafish Defective 
forebrain 
development 
Reduced the Wnt 
antagonist sfrp1 in 
presumptive 
forebrain 
(Peng and 
Westerfield 
2006). 
mix1 X. laevis Head defects Increased levels of 
fgf, myod, 
brachyury, pax8 
and lhx1. 
(Colas et al. 
2008) 
mixer X. laevis Anterior and gut 
abnormalities 
Reduced 
endodermal 
marker expression 
and increased 
mesodermal 
marker and nodal 
expression. 
(Kofron, Wylie, 
and Heasman 
2004) 
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Table 4.3. Knockdown phenotypes in previous studies. A summary of phenotypes identified 
in previous studies for all genes tested in the zygotic and maternal gene MO screens 
outlined in this chapter. All visible phenotypes and phenotypes identified using in situ 
hybridisation staining are outline in the table. 
4.4.6 Comparing the zygotic gene screen to previous studies 
Eomes: No observable phenotypic defects were found in Eomes knockdown embryos both in 
my screen and in previous studies. Although no phenotype was found in previous studies, in 
situ hybridisation revealed differential expression of vegt, gsc and not (Table 4.3) (Fukuda et 
al. 2010; Bruce et al. 2003). 
not No MO 
studies 
N/A N/A N/A 
tfap2a X. laevis No morphological 
phenotype 
Loss of neural crest 
marker expression 
(Luo et al. 
2003) 
ventx1.2 X. laevis No morphological 
phenotype 
Expanded neural 
plate 
(Sander, 
Reversade, and 
De Robertis 
2007) 
adnp 
 
No MO 
studies 
N/A N/A N/A 
clock zebrafish No morphological 
phenotype 
N/A (Li et al. 2008) 
gabpa No MO 
studies 
N/A N/A N/A 
sp2 
 
zebrafish Arrest at 
gastrulation and 
lethal within 24 
hours. Lower 
doses induced a 
shortened axis 
defective head, 
tail and somite 
development.  
N/A (Xie et al. 2010) 
zfp64 No MO 
studies 
N/A N/A N/A 
zhx3 No MO 
studies 
N/A N/A N/A 
znf526 No MO 
studies 
N/A N/A N/A 
znf639 No MO 
studies 
N/A N/A N/A 
znf821 No MO 
studies 
N/A N/A N/A 
znf827 No MO 
studies 
N/A N/A N/A 
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Gsc: No phenotypic defects were observed in Gsc knockdown embryos in my screen, but 
previous MO knockdown studies in zebrafish and X. laevis report anterior defects in 
knockdown embryos (Seiliez, Thisse, and Thisse 2006; Sander, Reversade, and De Robertis 
2007). Gsc has been linked to head specification and the gsc mis-expression in X. laevis 
induced a secondary dorsal axis (Cho et al. 1991). X. laevis embryos injected with gsc 
antisense RNA also displayed anterior head defects (Steinbeisser et al. 1995).  
Lhx5: The head and eye defects found in Lhx5 morphants in my screen contrasts with the 
neural tube closure delay found in X. laevis morphants (Houston and Wylie 2003). The 
phenotypes are somewhat similar to the zebrafish Lhx5 knockdown phenotype in which 
forebrain development is defective and the dominant negative Lhx5 phenotype in which 
head and eye development are impaired (Peng and Westerfield 2006). 
Mix1: MO knockdown of Mix1 in X. laevis generated embryos with head defects which is 
consistent with the head defect phenotype found in my screen. There was no report of an 
early gastrulation defect or ventralised phenotype in the Mix1 morphant X. laevis embryos 
(Colas et al. 2008).  
Mixer: Mixer MO was injected into X. laevis embryos resulting in anterior and gut 
abnormalities, the Mixer MO-injected embryos in my screen also displayed anterior 
abnormalities (Kofron, Wylie, and Heasman 2004). No gut abnormalities were visible in the 
Mixer morphant tailbud stage embryos in my screen, which are clearly different to the 
ventral abnormalities presented by Kofron et al. The phenotypes are similar; both have a 
shortened antero-posterior axis and reduced head and eye development. Differences may 
be due to different penetrance of the two MOs (Kofron, Wylie, and Heasman 2004). 
Tfap2a: No observable phenotypic defects were found in Tfap2a knockdown embryos both 
in my screen and in another knockdown study. No visible knockdown phenotype was 
observed, but neural crest marker gene expression was perturbed (Luo et al. 2003).  
Foxi4.2, Klf17 and Ventx1.2: The zygotic gene knockdowns of Foxi4.2, Klf17 and Ventx1.2 
displayed defective phenotypes in my screen but previous knockdown studies did not report 
any defects. In situ staining revealed perturbed gene expression in the Foxi4.2, Klf17 and 
Ventx1.2 knockdowns in X. laevis (Table 4.3) (Kurauchi, Izutsu, and Maeno 2010; Matsuo-
Takasaki, Matsumura, and Sasai 2005) (Sander, Reversade, and De Robertis 2007). 
No previous MO studies have been carried out for Bix1.1, Not and Grhl3. 
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4.4.7 Comparing the maternal gene screen to previous studies 
Clock: Clock was knocked down in Zebrafish using a MO, and no morphological defects were 
reported, which is inconsistent with my finding (Li et al. 2008). 
Sp2: No phenotypic defects were observed in Sp2 knockdown embryos in my screen, 
however previous studies report defective phenotypes. Sp2 MO knockdown in zebrafish 
caused embryos to stall during gastrulation (Xie et al. 2010). Sp2 null mouse embryos were 
lethal at E9.5 of gestation, indicating an essential role for Sp2 in early development (Baur et 
al. 2010).   
There are no published MO knockdown studies for Adnp, Gabpa, Zfp64, Zhx3, Znf526, Znf639, 
Znf821 and Znf827. 
The differences in knockdown phenotypes found between my zygotic and maternal screen 
and other studies could be due to ineffective MOs, off-target effects, or could be due to 
species differences; most previous studies are carried out in X. laevis and zebrafish. An 
intriguing possibility is that X. laevis and X. tropicalis regulatory pathways differ as there are 
several more mix family genes in X. laevis then in X. tropicalis which may have overlapping 
functions (Pereira et al. 2012).  
4.4.8 Conclusion 
This work reveals a higher propensity for phenotypes when knocking down zygotic genes 
compared to maternal genes. This may reflect a more important developmental role for the 
zygotic transcription factors, or may simply be an effect of the technical issues of gene 
knockdown. The aim of using the screen to select genes with interesting phenotypes for 
further work has been fulfilled, and Mix1 is characterised for its downstream targets in 
subsequent chapters.  
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Chapter 5: Investigating downstream targets of Mix1 
5.1. Introduction 
In this chapter I investigate the downstream targets of Mix1, a transcription factor which was 
included in the knockdown screen described in the previous chapter. Mix1 was selected for 
the screen because it is one of the first transcription factors to be transcribed in early  X. 
tropicalis development, and is expressed transiently. This time-limited effect may mean that 
Mix1 is only present for a short period and therefore its direct targets can be elucidated 
within a relatively short time-window. Mix1 was selected from the screen for further study 
because of the strong and early phenotype exhibited by Mix1 morpholino oligomer (MO)-
injected embryos, indicating potential developmental significance for Mix1. Only two direct 
targets have been reported: cer1 and gsc, and identifying more targets may reveal novel 
functions for Mix1 (Sudou et al. 2012).  
This chapter’s aims were to investigate how Mix1 regulates early development by 
determining its downstream targets and to evaluate the effectiveness of the time-series 
approach for identifying transcription factor targets. RNA was sequenced from splice 
blocking MO-injected Mix1 knockdown and control embryos sampled over a time-series and 
then analysed to find which genes showed divergent expression, suggesting up- or down-
regulation by Mix1.  
5.2 Results 
5.2.1 Phenotypes and validation of the Mix1 splice blocking MO  
5.2.1.1 Mix1 splice blocking MO-induced phenotypes 
The injection of the Mix1 splice blocking MO was shown to induce phenotypic defects in the 
screen described in Chapter 4. With the knowledge that 10ng gives a penetrant phenotype, 
the MO was also injected at 10ng and at lower doses and the morphology of control and 
knockdown embryos was compared in order to observe the penetrance of phenotypic 
defects caused by depletion of Mix1. The Mix1 splice blocking MO generated defective 
phenotypes in injected embryos at the 5ng and 10ng doses (Fig. 5.1B, C). Of the three doses 
tested, 10ng of splice blocking MO was found to give the highest penetrance of phenotype 
(Fig. 5.1A). 95% of embryos injected with Mix1 splice blocking MO were ventralised with head 
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and tail defects (Fig. 5.1C), 51% failed to undergo complete blastopore closure (Fig. 5.1B) and 
for 100% of embryos splice blocking MO injection was lethal at the late tailbud stage.  
 
Figure 5.1. Mix1 splice blocking MO phenotype. (A) Increasing doses of Mix1 splice blocking 
MO were injected and phenotypic penetrance was recorded. Penetrance of ventralised 
phenotype for splice blocking MO is shown. Mix1 MO was injected at the three doses into 
three separate clutches of embryos in independent experiments, and the results were 
pooled to give the penetrance for each dose.  (B) Vegetal view of stage 13 embryos injected 
with 20ng control 5-base mismatch MO (top) or 10ng Mix1 splice blocking MO (lower). (C) 
Lateral view of stage 26 embryos injected with 20ng 5-base mismatch control MO display 
no visible phenotype. Embryos injected with 10ng Mix1 splice blocking MO were 
ventralised in 76/80 embryos with defective blastopore closure in 41/80 embryos. The MO 
caused lethality at the late tailbud stage in 100% of injected embryos at 10ng and 5ng dose. 
4/77 (5%) embryos injected with 2ng MO were dead at the late tailbud stage. 
 
5.2.1.2 Mix1 splice blocking MO validation 
I carried out validation experiments to test the splice blocking activity of the Mix1 splice 
blocking MO. I used RT-PCR to confirm the disrupted splicing of Mix1 mRNA in splice blocking 
MO-injected embryos. The splice blocking MO was targeted to the 1 st exon-intron boundary 
to prevent splicing of the 1st intron. The inclusion of the first intron placed an in-frame stop 
codon within the mis-spliced mRNA. This stop codon was upstream of the homeodomain, 
which is encoded in the 2nd and 3rd exons (Fig. 5.2C).  
To test the effect on splicing for the splice blocking MO, embryos were injected with either 
10ng of Mix1 splice blocking MO or 20ng of 5-base mismatch negative control MO and 
harvested at 7.0 hpf. The 5-base mismatch control MO should not impair development, so a 
higher dose was injected to ensure the control had no phenotypic effect. RT-PCR using 
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primers annealing to the 1st and 3rd exons revealed a larger splice variant in Mix1 MO samples 
compared to controls. The fragment size confirmed the inclusion of the first intron. As a 
control, primers were targeted to the 2nd and 3rd exon which generated two bands of equal 
size (Fig. 5.2A, C).  
 
Figure 5.2. Mix1 splice blocking MO activity (A) Mix1 MO splice blocking assay by RT-PCR 
from embryos injected with control 5-base mismatch control MO or Mix1 splice blocking 
MO. Inclusion of the first intron in Mix1 splice blocking MO cDNA generated a longer 
fragment from exon 1- exon 3 (1332bp instead of 827bp). The fragment from exon 2- exon 
3 was amplified as a control to reveal unaffected splicing beyond intron 1 (947bp). (B) RNA-
seq reads were aligned to the Mix1 locus, the mean percentage of spliced reads over six 30 
minute time points from 5-7.5 hpf when Mix1 is transcribed. RNA-seq samples at the first 
exon overhang are shown, error bars give standard deviation. (C) The Mix1 genomic locus 
has three exons. The MO binding sites, early stop codon induced by the splice blocking MO 
and homeodomain region are labelled.  
As a second confirmation of Mix1 splice blocking MO activity, RNA-seq reads from Mix1 MO-
injected, Mix1 5-base mismatch MO-injected and WT un-injected embryos were aligned to 
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the Mix1 locus (see below for details of time-series collection and sequencing). The 
percentage of transcripts partially overlapping the 3’ end of exon 1 which were spliced out 
of the total reads (spliced and un-spliced) was calculated for the three different experimental 
conditions. This analysis was done by Nick Owens. This was used to compare the splicing 
efficiency between conditions (see Materials and Methods for details) (Fig. 5.2 B, C). The 
percentage of spliced transcripts in the WT condition was 91%. Less than 1% of transcripts 
were spliced at this junction in Mix1 splice blocking MO-injected embryos indicative of 
effective splice blocking. Interestingly, in the control 5-base mismatch MO condition 64% of 
transcripts were spliced which indicates that that the 5-base mismatch control MO has some 
splice blocking activity (Fig. 5.2B). Importantly, no phenotypic defects were observed in 
embryos injected with the 5-base mismatch MO suggesting that the partial splice blocking 
does not knock down Mix1 function (see below). These two assays demonstrate the ability 
of the Mix1 splice blocking MO to effectively inhibit splicing of mix1 mRNA.  
5.2.2 Expression of mix1 in the early embryo 
5.2.2.1 Expression of mix1 
In order to understand where Mix1 targets might be expressed, I first explored the 
localisation of mix1 mRNA within the embryo during the blastula and gastrula stages. Mix1 
and its activatory targets should be expressed in overlapping regions and its repressive 
targets may be expressed in unshared regions. This information was used to guide later 
validation experiments. In situ hybridisation analyses showed that mix1 expression is first 
detected in the dorsal marginal region in the early NF stage 9 embryo (Nieuwkoop and Faber 
1994) . This dorsal expression domain includes the region fated to become the blastopore lip 
at the start of gastrulation. By late stage 9 the mix1 expression domain expands to occupy 
the entire marginal zone, but is more highly expressed in the dorsal region. At stage 10 mix1 
has prominent expression throughout the marginal zone with lower expression throughout 
the vegetal pole. This has been demonstrated previously using RT-PCR, in which explants 
from the dorsal-marginal zone and vegetal pole were assayed for mix1 expression, and a 
longer gel exposure was required for the vegetal explant condition due to a lower amount of 
mRNA present in the vegetal cells (Lemaire et al. 1998). At stage 10.5 mix1 is expressed 
around the marginal zone but is diminished in the dorsal-most region. Overall there is a shift 
in the mix1 expression domain from dorsal to ventral (Fig. 5.3). The developmental stages 
used for in situ hybridisation are marked on a time scale of hours post fertilisation (Fig. 5.3).  
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Figure 5.3. Localisation of mix1. The stages at which embryos were harvested and fixed for 
in situ hybridisation are marked with arrows on the time scale. Stages are marked 
according to the developmental rate used in this particular RNA-seq experiment. Mix1 
expression is stained by whole mount in situ hybridisation at stage 9 (early), stage 9 (late), 
stage 10 and stage 10.5. Embryos are viewed from the vegetal pole, with the dorsal side 
oriented at the top. Mix1 is expressed first at the dorsal blastopore lip, the expression 
domain gradually expands to the entire marginal zone and dorsal expression depletes by 
stage 10.5. Embryos are viewed dorso-vegetally with the dorsal pole towards the top. Early 
stage 9 and stage 10.5 are tilted, so slightly more dorsal pole is viewed. Arrows mark the 
time of in situ (hours post fertilisation). 
 
5.2.3 Time-series analysis of Mix1 splice blocking MO-injected knockdown embryos reveals 
candidate Mix1 targets 
5.2.3.1 Generating knockdown and control time-series 
A high resolution RNA-seq time-series was generated over several hours of early 
development. The aim was to use a time-series approach to identify candidate Mix1 targets 
by investigating differential downstream expression in knockdown embryos and to 
determine which genes are affected by the depletion of Mix1. 
To generate the time-series data, embryos from a single clutch were either injected with 
Mix1 splice blocking MO, injected with 5-base mismatch control MO or were not injected 
(WT). By removal of asynchronously dividing embryos during the first five cleavages, 
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synchronous embryos were collected every 30 minutes from 2.5 hpf until 9.0 hpf (Fig. 5.4). 
Sampling from 2.5 hpf ensured the activation of mix1 was captured as published wild type X. 
tropicalis time-series data reports mix1 activation at 4.0 hpf when embryos were incubated 
at 23°C (Collart et al. 2014). PolyA+ mRNA from the embryos collected in this time-series was 
sequenced to find differences in gene expression between the knockdown and control 
embryos, in order to investigate the effects of Mix1 depletion. 
 
Fig. 5.4. Mix1 knockdown time-series collection. The time points collected for the Mix1 
splice blocking MO time-series are marked on the time-scale (hpf).  
 
5.2.3.2 Data normalisation and differential expression calling 
RNA-seq reads were aligned to the X. tropicalis transcriptome and read counts for each gene 
were normalised against the total read counts. Normalised read counts were plotted to 
generate high resolution expression profiles for all detected genes (analysis by Nick Owens, 
see Materials and Methods for details).  
Gene expression profiles from the splice blocking MO and control MO conditions were 
compared for each gene to determine which were differentially expressed (analysis by Nick 
Owens, see Materials and Methods for details). The 5-base mismatch control MO condition 
is the correct control for the Mix1 splice blocking MO. Some splice blocking activity was 
demonstrated for the 5-base mismatch control MO and the wild type condition was used to 
confirm that this partial splice blocking did not unduly affect gene expression. The wild type 
and control MO conditions showed congruent expression patterns, so the control condition 
was used in the differential expression analysis. The genes which are differentially expressed 
between knockdown and control conditions are candidate targets of Mix1. Experiments to 
validate these candidate targets can be found in Chapter 6. 
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5.2.3.3 Activation of mix1 
Mix1 targets will be perturbed after mix1 is activated. To limit off-target effects of the Mix1 
MO, I examined the activation time of mix1 in this time-series. The activation was calculated 
according to published methods (Collart et al. 2014) by measuring gene expression increases 
in time-series RNA-seq data, to define activation where successive time-points rise past a 10 
fold threshold (analysis by Nick Owens, see Materials and Methods for details). The time-
series expression profile of wild type mix1 shows it is activated at 5.0 hours post fertilisation 
(hpf), just under an hour before MBT (Fig. 5.5). This is slower than in previous time-series 
(Collart et al. 2014) and is likely caused by low incubation temperatures, which were 21-22°C 
rather than 23°C.  
 
Fig. 5.5. The mix1 expression profile. Profile derived from normalised RNA-seq reads from 
WT embryos shows activation at 5.0 hpf (inset) and peaks at 7.5 hpf. MBT is marked with 
a vertical pink bar. The line represents the median and the shaded region shows the 95% 
confidence intervals. Figure generated by Nick Owens. 
5.2.3.4 Assigning divergence times 
In order to understand when Mix1 regulates its targets, I investigated the timing of 
differential expression events. A gene is considered to be a candidate target if its control MO 
and Mix1 splice blocking MO expression is equal prior to Mix1 activation and the control MO 
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and Mix1 splice blocking MO expression diverges after Mix1 activation. Any gene that 
diverges prior to Mix1 activation is likely to be an off-target effect. The divergence time is 
assigned as the time point after the Gaussian process models overlap by only 10% (analysis 
by Nick Owens, see Materials and Methods for details). This allows clear comparison of 
divergences. The divergence time of each differentially expressed gene is marked on the gene 
profile as a red vertical line. The expression profile of the Mix1 candidate activatory targets; 
cer1, crx, foxc1 and irx1 and the candidate Mix1 repressive targets; bix1.1, ppp1r10, ventx3.2 
and szl are shown as examples (Fig. 5.6). The majority of detected genes did not display a 
divergent profile (15148 genes had no differential expression) indicating that differential 
expression is not a result of developmental delay.  
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Figure 5.6. Candidate Mix1 target expression profiles. The expression profiles of (A) The 
candidate Mix1 activatory targets; cer1, crx, foxc1 and irx1, and (B) The candidate Mix1 
repressive targets; bix1.1, ppp1r10, ventx3.2 and szl. These genes are differentially 
expressed in the Mix1 splice blocking MO time-series.  Normalised read counts for Mix1 
MO (red), 5-base mismatch control MO (blue) and wild type (green) conditions were 
plotted for all time points. Best fit lines with 95% confidence intervals were calculated. The 
red vertical line marks the calculated divergence time. Gene expression profiles generated 
by Nick Owens. This experiment was carried out in a single clutch of embryos.  
 
5.2.3.5 Many candidate Mix1 targets were identified 
ixIn total 497 genes were differentially expressed in the Mix1 splice blocking MO knockdown 
time-series compared to controls. 189 genes were down-regulated after divergence in 
knockdown embryos and are candidate Mix1 activatory targets. 308 genes were up-
regulated after divergence and are candidate Mix1 repressive targets (Fig. 5.7). The full list 
of differentially expressed genes can be found in the appendix on the attached CD (tab 2). 
Interestingly, the BMP signalling molecules, which are ventralisation markers, were not 
significantly upregulated, which might be expected since Mix1 knockdown embryos display 
a ventralised phenotype. BMP7.1 is slightly upregulated, but is not significantly differentially 
expressed.  
 
Figure 5.7. Total candidate Mix1 targets. Total activatory and repressive candidate Mix1 
target genes differentially expressed in the splice blocking MO time-series. 308 genes were 
found to have reduced expression in knockdown embryos compared to controls and are 
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known as candidate Mix1 activatory targets. 497 genes were found to have increased 
expression in knockdown embryos compared to controls and are known as candidate Mix1 
repressive targets. This experiment was carried out in a single clutch of embryos.  
5.2.4 The divergence timings in the splice blocking MO time-series 
To explore the timing of differential expression events in Mix1-depleted embryos, I examined 
the number of divergences at each time point in the splice blocking MO time-series (Fig. 5.8). 
The majority of divergences occur from 6.0 to 8.0 hpf.  The number of divergences diminishes 
from 8.5 hpf. With the proximity to the end of the time-series, the capacity to detect late 
divergences diminishes. A number of time points are required to clearly call a divergence and 
the number of time-points required depends on the magnitude of the divergence. Later in 
the time-series, only genes that diverge rapidly can be detected. 
 
 
Figure 5.8. Divergence times of candidate Mix1 targets. (A) The number of divergences at 
each time point for candidate Mix1 targets which are differentially expressed in the splice 
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blocking MO time-series. (B) The number of divergences at each time point for candidate 
Mix1 activatory targets (green) and candidate Mix1 repressive targets (red) which are 
differentially expressed in the splice blocking MO time-series.  
 
5.2.5 Gene expression perturbations are reproducible in Mix1 knockdown embryos 
5.2.5.1 Gene expression perturbations found in the splice blocking MO knockdown time-
series were replicated and measured by qPCR 
To confirm the reproducibility of gene expression perturbations observed in the knockdown 
time-series, I compared expression of candidate Mix1 targets between Mix1 splice blocking 
MO-injected and control MO-injected embryos. I performed qPCR on cDNA from three new, 
separate clutches of embryos harvested at 9.0 hpf. This is when the maximum expression 
difference is observed in the gene expression profiles of most Mix1 candidate targets. The 
fold changes in expression levels between Mix1 splice blocking MO and control MO cDNA 
samples were calculated. All three activatory target genes tested crx, foxc1 and cer1 
displayed significantly reduced expression in the Mix1 splice blocking MO-injected embryos 
compared to controls (Fig. 5.9). The fold changes found in the qPCR replicates were 
consistent with those found in the RNA-seq data (see Materials and Methods for calculation 
of RNA-seq fold changes and error). This demonstrates the reproducibility of Mix1 
downstream target expression perturbations in knockdown embryos. 
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Figure 5.9. Candidate Mix1 target expression is reproducible. Quantitative PCR of three 
biological replicates of Mix1 splice blocking MO-injected and control MO-injected embryos 
at stage 10.5 (9.0 hpf) shows reproducible differential expression of the Mix1 activatory 
targets crx, foxc1 and cer1. Averaged replicate values give a fold change of at least 1.5 for 
all genes tested.  The Student’s t-test was applied to control and MO concentrations 
normalised to odc1 to show a significant difference p-values: crx: 0.0440, foxc1: 0.0287, 
cer1: 0.0159. See Materials and Methods for the calculation of the RNA-seq error bars. 
RNA-seq fold changes at 9.0 hpf are also shown and are comparable to qPCR fold changes.   
 
5.2.5.2 Confirmation of differentially expressed genes in Mix1 depleted embryos  
I used in situ hybridisation to validate the localised mis-expression of some Mix1 activatory 
targets within the mix1 expression domain in response to MO injection. Mix1 splice blocking 
MO was injected unilaterally to compare gene expression between knockdown and wild-type 
halves of the embryo. The MO was co-injected with NLS-β-galactosidase mRNA to confirm 
the injected region. Embryos were then fixed at stage 10 (Fig. 5.10A).  
I stained for expression of three candidate Mix1 targets cer1, crx and foxc1 to test for altered 
expression in the region where mix1 would normally have been expressed. Mix1 activatory 
targets would be expected to have reduced expression within the mix1 expression domain in 
the Mix1-depleted half of the embryo. At stage 10 mix1 is expressed throughout the vegetal 
hemisphere and is highest in the marginal zone (Fig. 5.10A).  
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Consistent with the reduced expression of these genes in the knockdown time-series, the 
Mix1 activatory targets cer1, crx and foxc1 underwent a reduction in the intensity of 
expression in the Mix1 depleted half of the embryo (Fig. 5.10B, C, D). The expression domains 
of foxc1 and cer1 were reduced in intensity within the mix1 expression domain (Fig. 5.10C, 
D). The domain of crx was almost entirely depleted in the vegetal region of its expression 
domain within the mix1 expression domain and appears to be more weakly depleted towards 
the animal pole, which is outside of the mix1 expression domain (Fig. 5.10B). These three 
candidate Mix1 targets all showed depleted expression in the mix1 expression domain and 
strengthen the evidence that these are Mix1 targets. 
Chapter 5 – Investigating downstream targets of Mix1 134 
Figure 5.10. Altered expression of candidate Mix1 activatory targets in response to Mix1 
depletion. (A) Embryos were injected with Mix1 MO into one blastomere at the 2-cell stage 
to give unilateral knockdown (on the right side of embryos). NLS-β-galactosidase mRNA 
was co-injected as a lineage tracer to give nuclear red stain seen in the injected region of 
embryos. The expression domain of Mix1 at stage 10 spans the marginal zone. Mix1 target 
mRNA was stained in stage 10 embryos by whole mount in situ hybridisation. (B, C, D) 
Expression of the candidate Mix1 activatory targets crx, foxc1 and cer1. In situ 
hybridisations were carried out on embryos from three separate clutches in independent 
experiments. Stage 10 embryos are viewed from the vegetal pole, with the dorsal side 
oriented at the top. The blastopore lip is marked with an arrowhead. Phenotypic 
penetrance is shown in the bottom right corner for each gene tested. Xenopus stage images 
reproduced from Nieuwkoop and Faber (Nieuwkoop and Faber 1994) with permission 
Garland Science/Taylor & Francis, LLC.  
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5.2.6 Overexpression of mix1 disrupts embryonic development 
Mix1 mRNA was injected into embryos in order to test the effects of mix1 overexpression. 
The response to different doses of mix1 mRNA was used to guide the levels injected for 
rescue experiments (see below).   
Control embryos were injected with GFP mRNA at 50pg, as this mRNA should not induce any 
phenotypic changes. As expected, control embryos displayed a normal phenotype and GFP 
expression was confirmed (not shown) (Fig. 5.11A). Embryos injected with 25pg of mix1 
mRNA were truncated along the antero-posterior axis and had shortened tails (37/40) (Fig. 
5.10B). Embryos injected with 50pg of mix1 mRNA failed to undergo elongation of the antero-
posterior axis (43/43) and in many cases embryos completely lacked a head (27/43) (Fig. 
5.11C). All injections were carried out on embryos from two separate clutches in independent 
experiments, total numbers were pooled to give total numbers. The overexpression 
phenotype demonstrates that increased expression of mix1 has the potential to induce 
morphological changes in the embryo in a dose-dependent manner. Injection of a higher 
dose of 100pg was lethal to embryos at gastrulation (not shown).  
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Figure 5.11. Overexpression of mix1 disrupts development. Lateral view of stage 26 
embryos. (A) Embryos injected with 50pg GFP mRNA appear normal. (B) Embryos injected 
with 25pg mix1 mRNA were truncated along the antero-posterior axis and had shortened 
tails (37/40). (C) Embryos injected with 50pg of mix1 mRNA failed to undergo elongation 
of the antero-posterior axis (43/43) and in many cases embryos did not form a head (27/43). 
Embryos from two separate clutches were injected with each dose in independent 
experiments.  
 
5.2.7 The Mix1 splice blocking MO knockdown phenotype and downstream gene 
expression perturbations were not rescued 
5.2.7.1 The Mix1 splice blocking MO knockdown phenotype was not rescued 
To validate that the effects of Mix splice blocking MO-injection were caused by the depletion 
of Mix1, I attempted to rescue the phenotype and gene expression changes found in 
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knockdown embryos by co-injecting mix1 mRNA with the MO. A range of doses of mix1 mRNA 
were injected alongside 10ng splice blocking MO, from 2.5pg-100pg. The mRNA was resistant 
to the MO as it contained no introns. When the Mix1 splice blocking MO and mRNA were 
injected into embryos, no doses rescued the morphant phenotype. For the lower doses of 
mix1 mRNA 2.5pg, 5pg and 10pg embryos appeared similar to MO-injected embryos (not 
shown). At the higher doses of mix1 mRNA 15pg, 25pg, 50pg and 100pg, embryos were more 
defective than morphant embryos and the rate of lethality was higher. (Observed 
phenotypes at 24 hpf- 10ng MO 40/45 truncated, 5/45 dead, 10ng MO + 2.5pg mRNA 26/26 
truncated, 10ng MO + 5pg mRNA 31/32 truncated, 1/32 dead, 10ng MO + 10pg mRNA 28/31 
truncated, 3/31 dead, 10ng MO + 15pg 25/36 truncated, 11/36 dead, 10ng MO + 25pg 30/49 
truncated, 19/49 dead, 10ng MO + 50pg 32/32 dead, 10ng MO +100pg 34/34 dead.)  
5.2.7.2 The downstream gene expression perturbations in Mix1 knockdown embryos were 
not rescued 
Following the failure of phenotypic rescue, I tried the rescue experiment again and measured 
the transcriptional output of several candidate Mix1 targets identified in the splice blocking 
MO time-series to see if their expression levels could be restored towards control expression 
levels. Even a partial rescue of these downstream effects would indicate the specificity of the 
MO. Embryos were injected with Mix1 splice blocking MO, Mix1 splice blocking MO +25pg 
mRNA, Mix1 splice blocking MO +50pg mRNA or Mix1 splice blocking MO +100pg mRNA and 
harvested at 9.0 hpf. This timing coincides with the end of the time-series when the 
difference in expression between the knockdown and control conditions is at the maximum 
for these two genes. I used qPCR to measure the fold change difference in the expression 
level of candidate Mix1 targets between rescue and knockdown embryos (Fig 5.12). The fold 
changes of cer1, zic3, crx, tnfrsf21, ppp1r10, szl and ventx3.2 expression were below 1.6 and 
a Student’s t-test fails to find a significant difference between the splice blocking MO-injected 
and attempted rescue embryos. Three biological replicates of this experiment were 
performed. This experiment confirms that Mix1 target expression is not rescued in these 
experiments. There is no validation that depletion of Mix1 in MO-injected embryos is the 
cause of phenotypic or downstream expression changes. 
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Figure 5.12. Candidate Mix1 target expression was not rescued.  Mix1 rescue was 
attempted, qPCR shows no significant fold change difference in the expression levels of the 
candidate Mix1 activatory targets cer1, zic3, crx and tnfrsf21, and the candidate Mix1 
repressive targets ppp1r10, szl and ventx3.2 between MO-injected and MO + Mix1 mRNA-
injected embryos at three doses (n= 3 biological replicates). The Student’s t -test was 
applied to MO and MO=mRNA concentrations normalised to odc1 to show no significant 
difference. p-values: all >0.05.  
 
5.2.8 The expression of mix1 is perturbed in the Mix1 knockdown time-series 
The expression of mix1 is up-regulated in the splice blocking MO time-series, indicating the 
possible loss of a negative feedback loop (Fig. 5.13). This could be regulated by direct 
feedback where Mix1 normally represses its own transcription or could be regulated by 
indirect feedback, where a Mix1 activatory target represses the transcription of Mix1. Mix1 
falls into the list of candidate repressive targets because it is up-regulated in the knockdown 
time-series. 
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Figure 5.13. Mix1 is up-regulated in knockdown embryos. Time-series expression profile of 
mix1 in splice blocking MO time-series reveals up-regulation of mix1 expression in 
knockdown embryos compared to controls.  
 
5.3 Discussion 
5.3.1 Time-series analysis reveals candidate Mix1 targets 
This work demonstrates the effectiveness of knockdown time-series data for identifying gene 
expression changes. Time-series sequencing reveals the timing and magnitude of these 
expression changes. The methodology for collecting synchronous embryos and determining 
gene divergences is established here. Despite the failure of the rescue experiment, I 
identified 497 candidate Mix1 targets. This work forms the basis for further experiments 
described in Chapter 6. In order to control for possible off-target effects, I generated two 
new Mix1 MO time-series using different MOs. To validate candidate Mix1 targets, mix1-
expressing animal caps were sequenced (see Chapter 6). It should be noted that some of the 
candidate Mix1 targets mentioned in this chapter are not validated in subsequent 
experiments. 
5.3.2 Mix1 knockdown phenotype 
5.3.2.1 The Mix1 splice blocking MO phenotype 
Mix1 splice blocking MO-injected embryos appear similar to UV irradiated embryos, which 
are ventralised as shown on the dorso-anterior deficiency index at 3 and 4 and are 
Chapter 5 – Investigating downstream targets of Mix1 140 
characterised by axis deficiency and reduced eyes and forehead or cyclopia (Kao and Elinson 
1988). The ventralised phenotype is also reminiscent of the ventralised phenotype found in 
chordin knockdown embryos (Oelgeschlager et al. 2003). Interestingly, chordin is not 
differentially expressed in either Mix1 knockdown time-series. The ventralised phenotype of 
Mix1 knockdown embryos may be caused by the reduced expression of other genes which 
are expressed by the Spemann organiser in the dorsal mesoderm and have dorsalising 
potential e.g. gsc and cer1 (Cho et al. 1991; Kuroda, Wessely, and De Robertis 2004). 
5.3.2.2 Differences to the Mix1 knockdown phenotype found in X. laevis 
The phenotypes generated here with a Mix1 splice blocking MO appear to be different from 
the Mix1 knockdown phenotype found in X. laevis embryos injected in the dorsal marginal 
zone with a translation blocking MO. These embryos developed abnormal heads at the 
tailbud stage but no ventralisation or blastopore defects were reported (Colas et al. 2008). 
An MO targeting the X. laevis homeologs, Mix1 and Mix2, was injected and no phenotypic 
defects were reported, however it seems as though this MO was not injected into the dorsal 
marginal zone to test for head defects. It is therefore possible that Mix1 and Mix2 knockdown 
would have the same effect on head development as Mix1 knockdown. The absence of 
ventralised phenotypes and blastopore defects in the X. laevis study suggests that these 
defects are specific to my Mix1 knockdown (Colas et al. 2008). The differences between the 
phenotype for my splice blocking MO and the Mix1 knockdown phenotype found in X. laevis 
may be due to species differences. 
5.3.3 Divergences give insight into the dynamic regulation by Mix1 
The divergence timings reflect the timing of interactions between Mix1 and its targets. The 
peak of divergences is found from 6.0 hpf to 8.0 hpf which indicates that Mix1 may have the 
greatest effect on downstream gene expression after 1.5 hours of its own activation. The 
timing of these gene divergences is in agreement with previous work showing that Brachyury 
and Mixer activate targets within 1.5-3.5 hours of their own activation (Collart et al. 2014). A 
major advantage of the time-series approach is that we gain a unique insight into the timing 
of transcription factor interactions. Some of these targets have to be direct targets and the 
earlier targets are more likely to be direct. However, this cannot be determined from this 
data. Further experiments would be needed to determine whether Mix1 targets are direct , 
e.g. reporter assays or ChIP experiments.  
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5.3.4 Reproducibility of Mix1 target expression perturbations in splice blocking MO -
injected embryos 
The fold changes found in the qPCR data comparing knockdown and control expression of 
candidate Mix1 targets were consistent with fold changes found in the RNA-seq data. The 
gene expression perturbations observed in the time-series can be closely replicated which 
suggests that the changes in gene expression are not the effects of variat ion between 
clutches of embryos - but effects caused by MO injection. 
The in situ hybridisation images of Mix1 half-depleted embryos show that Mix1 activatory 
targets underwent expression changes within the normal mix1 expression domain, with a 
reduction in expression which is consistent with perturbations seen in the RNA-seq time-
series (Fig. 5.10). This is consistent with the idea that these are true Mix1 targets, although it 
does not validate the specific gene interactions because the same MO is used in the qPCR 
and RNA-seq experiments. I observed the apparent weak depletion of crx expression in the 
ectoderm on the periphery of the mix1 expression domain. Crx may be a direct target of Mix1, 
and mix1 may be weakly expressed outside of the visible expression domain. Crx could be 
depleted indirectly in the ectoderm by signalling molecules and transcription factors 
downstream of Mix1. The differential expression of crx could be an off-target effect. In 
subsequent experiments (see Chapter 6), crx is upregulated in mix1-expressing animal caps, 
but is not differentially expressed in all MO knockdown experiments, so it unclear whether 
crx is a genuine Mix1 target.  
5.3.5 Mix1 overexpression 
The overexpression phenotype is similar to one previously found, in which embryos undergo 
a reduction in the dorsal axial structures notochord and muscle (Lemaire et al. 1998). In 
contrast to Lemaire et al. who found that tail formation was completely inhibited in mix1-
overexpressing embryos, I found that tail formation was only disrupted. This difference in 
phenotype may be because Lemaire et al. injected dorsally at the 4-cell stage to give localised, 
ectopic expression, whereas I injected mix1 mRNA vegetally at the 1-cell stage (Lemaire et al. 
1998). More localised injection of mix1 mRNA at later stages may have been a better way to 
test the effects of mix1 overexpression.  
5.3.6 Failure of Mix1 rescue 
There is no commercially available antibody for Xenopus Mix1. Without a Mix1 antibody, it 
was not possible to test for the depletion of Mix1 protein in MO-injected embryos. The 
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validation of Mix1 splice blocking MO through rescue would have confirmed both the 
specificity of the phenotype and the correct dosing of the MO. Without these control 
experiments, there is a possibility that Mix1 splice blocking MO may incorrectly target 
transcripts, leading to off-target effects. 
There are several possible reasons for the failure to rescue Mix1 knockdown embryos. When 
injecting mRNA into an embryo it does not disperse efficiently, so it is difficult to recapitulate 
the wild type localisation of transcripts. MOs disperse more effectively than mRNA within the 
embryo, so knockdown is easier than rescue. As mix1 is expressed throughout the marginal 
zone in the vegetal hemisphere, the mRNA was injected into the vegetal region -but may 
have been insufficiently distributed in the marginal zone to rescue the effects of Mix1 
depletion. The timing and dose of endogenous gene expression are difficult to replicate 
through microinjection of mRNA. Mix1 is rapidly activated at 4.5 hpf, so injecting mix1 mRNA 
into the stage 1 embryo allows aberrant expression of mix1 for over four hours. This could 
disrupt early gene expression and developmental processes. Injection of the mix1 mRNA 
causes embryonic defects at certain doses and therefore mix1 mRNA may not be suitable for 
rescue. The phenotype is more severe in “rescue” embryos than knockdown embryos leading 
to earlier lethality in 100% of embryos.  
I assayed the expression of several Mix1 candidate target genes in “rescue” embryos, and 
found that gene expression perturbations were not rescued. However, the qPCR was only 
carried out on embryos injected with 25pg and 50pg of Mix1 mRNA which caused severe 
phenotypes. The dose for rescue was most likely disruptive to development and given more 
time, I would attempt qPCR for embryos injected with lower doses of mRNA with Mix1 MO. 
5.3.7 The limitations of sequencing whole embryos 
As I sequenced whole embryos, I could not detect whether expression changes were localised 
in a particular region of the embryo. In the case of irx1 the gene expression profile that shows 
two “waves” of activation in the knockdown and control time-series (Fig. 5.6A), I cannot 
determine whether these are two separate activation events in different regions of the 
embryo or spatially identical events. It is also possible that small localised changes in 
expression occur, but are too small to be detected when the whole embryo is sequenced. 
This is a limitation of this approach which has been addressed in zebrafish by taking fine 
sections of the embryo across three body axes and sequencing the sections to generate a 3D 
digital image of gene expression (Junker et al. 2014). This provides rich spatial information 
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for each gene at three developmental stages. If used in knockdown embryos, the specific 
localised changes in expression could be accurately measured - however this would be a very 
expensive and time-consuming method to characterise knockdowns. 
5.3.8 Conclusions 
In this chapter I used a time-series sequencing approach to identify a number of candidate 
Mix1 targets. In order to determine whether the expression changes found in knockdown 
embryos are caused by the depletion of Mix1 rather than off-target effects, the candidate 
Mix1 targets identified here must be compared to other datasets (see Chapter 6). 
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Chapter 6 – Controlling for MO off-target effects to determine Mix1 
targets 
6.1 Introduction 
In this chapter I build on data described in Chapter 5 where I used a Mix1 splice blocking 
morpholino (MO) to identify several hundred candidate activatory and repressive Mix1 
targets. This set of targets may include off-target effects caused by the MO. The strategy in 
this chapter was to generate additional lists of Mix1 targets using different MOs to create 
knockdown and control time-series. The assumption is that only genuine Mix1 targets will 
appear in all lists of targets. 
I used two different MOs which target Mix1 and the related transcription factor Mixer; 
translation blocking MO1 and translation blocking MO2. These two MOs were originally 
intended for identifying the targets of these two transcription factors separately, however, 
it came to light that the 5’UTR and initial part of the coding sequence is 100% identical for 
Mix1 and Mixer (Fig. 6.1). This region covers all possible binding sites for translation blocking 
MOs in both genes. Each MO was only tested for the capacity to block translation of both of 
these transcription factors but given the sequence similarity the assumption is that the two 
MOs target both Mix1 and Mixer. 
 
Fig. 6.1. Mixer and Mix1 share 5’UTR sequences.  The alignment of the mix1 (upper) and 
mixer (lower) cDNA sequences which have 100% identity over the 5’UTR and initial coding 
sequence. Binding sites of the translation blocking MO1 and MO2 are illustrated. The start 
codon is highlighted in green. 
 
This sequence similarity of the Mix1 and Mixer 5’UTRs poses challenges, but I use these MOs 
to identify candidate Mix1 targets which are then used in comparative analysis with the Mix1 
splice blocking MO data. The expectation for these two translation blocking MOs is that they 
will each block the translation of both Mix1 and Mixer. It is also possible that each translation 
blocking MO will cause off-target effects and it is likely that these off-target effects will be 
MO-specific. Genes that are consistently differentially expressed in both translation blocking 
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MO1 and MO2 time-series are candidate Mix1 and/or Mixer targets. Genes that are 
differentially expressed in just one MO time-series may be off-target effects.  
The candidate Mix1 and/or Mixer targets identified in the comparison of the two translation 
blocking MO time-series were then compared to the candidate targets identified in the Mix1 
splice blocking MO time-series. The assumption is that the Mix1 targets identified using the 
splice blocking MO will contain Mix1 targets and off-target genes. Genes that are consistently 
differentially expressed in all three MO time-series are therefore strong candidate Mix1 
targets. These genes are assigned to Group 1 (See table 6.1). This strategy should eliminate 
off-target effects because the three MOs have different sequences and therefore should not 
target the same off-target sequences. I found statistically significant numbers of genes 
consistently differentially expressed in all three MO time-series 
In order to validate the candidate Mix1 targets identified in the three MO time-series, mix1-
expressing animal caps were sequenced. If the differential expression of a gene was in 
agreement in all experimental conditions tested, which includes loss-of-function and gain-of-
function analysis, I think that this is strong evidence that this gene is a true target of Mix1 
and I refer to these genes as validated Mix1 targets.  By injecting X. laevis animal caps with 
mix1 mRNA, Mix1 protein is produced and can induce or up-regulate expression of Mix1 
activatory targets. Likewise, the expression of Mix1 repressive targets which are 
endogenously expressed in the animal cap cells may be down-regulated. Limitations of this 
assay are that the timing of the expression of mix1 and the environment e.g. co-factors and 
chromatin state are not recapitulated in the animal cap, so some Mix1 targets might not be 
mis-expressed in animal caps.  
A list of candidate Mix1 targets was generated based on differential expression detected in 
the animal cap sequencing data. These candidate Mix1 targets were compared to the strong 
candidate targets identified by comparing the three MO knockdown time-series. Nine genes 
were consistently differentially regulated in all four experimental conditions are v alidated 
Mix1 targets which is significantly more than would be expected by overlap between 
conditions by chance. These validated Mix1 targets were assigned to Group 2 (see table. 6.1). 
This is because their differential expression has been demonstrated in response to Mix1 
depletion and mix1 expression using different experimental approaches.  
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Table 6.1. Group 1 strong candidate and Group 2 validated Mix1 targets.  Groups of strong 
candidate and validated Mix1 targets identified through overlap of genes differentially 
expressed in different experimental conditions.  The full list of Group 1 and Group 2 genes 
can be found in the appendix on the attached CD (tab 6). 
6.2 Results 
6.2.1 Translation blocking MO1 validation 
In order to test the activity of the translation blocking MO1, an in vitro assay was performed 
using the TNT transcription/translation system. A mix1 HA-tagged vector was used to 
generate Mix1 protein. A series of reactions was set up, with increasing concentrations of 
Mix1 translation blocking MO and western blot was used to detect the HA-epitope. With the 
addition of MO, the intensity of the band for HA-tagged Mix1 was reduced compared to the 
MO free condition in a dose dependent manner. At the highest concentration of 40mM, the 
Mix1-HA band disappears almost entirely. This assay demonstrates the ability of MO1 to 
block translation of Mix1 (Fig. 6.2).  
 
 
 
 
 
 
 
 
Group No. Genes Target strength Overlap criteria 
Group 1 
targets 
33 Strong candidate 
Mix1 targets 
Consistently differentially expressed in 
all three MO time-series. 
Group 2 
targets 
9 Validated Mix1 
targets  
Consistently differentially regulated in 
all three MO time-series and mix1-
expressing animal caps. 
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Figure 6.2. Translation blocking MO1 activity.  Tagged mix1-HA western blot of translation 
blocking MO1 activity demonstrated by in vitro SP6 coupled transcription/translation (TNT) 
assay. Translation of HA-tagged mix1 vector produces a band of Mix1 protein at 49kDa. 
Intensity of the band decreases with increasing concentrations of MO.  
 
6.2.2 Translation blocking MO2 validation 
The translation blocking activity of the translation blocking MO2 was tested in vivo by 
injecting HA-tagged mixer mRNA into embryos and with increasing doses of the MO. Mixer 
depletion was tested rather than Mix1, because the MO was originally intended to target 
mixer. Embryos were harvested at 7.0 hpf and an immunoprecipitation was performed with 
an HA antibody followed by western blot to assay the level of translation blocking activity by 
the MO at different doses. I found that at the 15ng dose, no band for tagged Mixer protein 
was visible, indicating efficient translation blocking. At lower doses (5ng and 10ng) the 
amount of tagged Mixer protein was lower than in the MO-free condition, indicating some 
translation blocking activity (Fig. 6.3A). This demonstrates the ability of the MO to block the 
translation of Mixer in vivo. The dose of 15ng was sufficient to deplete the injected HA-tagged 
mixer mRNA in the presence of endogenous mixer mRNA. It is therefore likely that a 15ng 
dose is sufficient to block translation of endogenous Mixer and Mix1 protein in the absence 
of injected mRNA. 
In addition, an in vitro assay was performed using the TNT transcription/translation system 
to test the MO translation blocking activity. As described for the translation blocking MO1, 
increasing concentrations of translation blocking MO2 were used to set up several reactions 
to produce HA-tagged Mixer protein and western blot was used to detect the HA-epitope. I 
found that higher concentrations (20nM and 40nM) were sufficient to entirely block 
translation of Mixer (Fig. 6.3B).  
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Figure 6.3. Translation blocking MO2 activity. (A) Tagged mixer-HA immunoprecipitation 
and western blot of translation blocking MO2 activity in vivo by injection of mixer mRNA 
and increasing doses of translation blocking MO2.  A non-immunoprecipitated input sample 
in the far right lane gives no band.  (B) Tagged mixer-HA western blot of translation blocking 
MO2 activity demonstrated by in vitro SP6 coupled transcription/translation (TNT) assay. 
Translation of HA-tagged mixer vector produces a band of Mixer protein at 42kDa. Intensity 
of the band decreases with increasing concentrations of MO. 
 
6.2.3 Phenotypes generated by the two MOs 
I injected different doses of each translation blocking MO into embryos to determine the 
appropriate dose to use in later time-series experiments. Of the three doses tested for each 
MO, 15ng was found to give the highest penetrance of phenotype. The 15ng dose was used 
in later validation and time-series experiments as this likely indicates efficient knockdown of 
Mix1.  
Embryos were injected with translation blocking MO1; at a 15ng dose 45/50 (90%) were 
truncated with a blastopore closure defect, at a 10ng dose 12/56 (21%) were truncated and 
none had blastopore closure defects, at a 5ng dose 16/57 (28%) were truncated and 2/57 
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(4%) also had blastopore defects (Fig. 6.4A, C). Morpholino injection was lethal to defective 
embryos during the late tailbud stage. Embryos were injected with translation blocking MO2, 
this generated a truncated phenotype and embryos displayed head and tail defects; at a 15ng 
dose 35/43 (81%) were truncated and 27/43 (63%) had a blastopore closure defect, at a 10ng 
dose 27/48 (56%) were truncated and 10/48 (21%) had blastopore closure defects, at a 5ng 
17/33 (51%) were truncated and none had a blastopore closure defect. Morpholino injection 
was lethal to defective embryos during the late tailbud stage (Fig. 6.4B, C). All injections were 
carried out on embryos from two separate clutches in independent experiments, total 
numbers were pooled to give penetrance for each MO.  
The phenotypes generated by translation blocking MO1 and MO2 were similar and highly 
penetrant at the 15ng dose so this dose was used in further experiments. This dose of MO2 
was sufficient to block in vivo translation of injected mixer mRNA, so it is likely that 15ng is 
sufficient to block translation of endogenous Mix1 and Mixer.  
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Figure 6.4. Phenotypes induced by translation blocking MO1 and MO2. (A) Increasing doses 
of translation blocking MO1 and MO2 were injected and the penetrance of the truncated 
phenotype was recorded. (B) Embryos injected with 20ng control MO have a normal 
phenotype. Embryos injected with 15ng translation blocking MO1 and MO2 have a 
truncated phenotype and head and tail defects. MO1 and MO2 were injected at the three 
doses into two separate clutches of embryos in independent experiments, and the results 
were pooled to give the penetrance for each dose. 
 
6.2.4 Time-series analysis of gene expression in translation blocking MO1 and MO2 -
injected embryos 
The Mix1 splice blocking MO knockdown time-series data was used to identify candidate 
Mix1 targets (see Chapter 5). To control for off-target effects caused by the splice blocking 
MO, the two Mix1/Mixer translation blocking MOs were used to generate two additional 
RNA-seq time-series. As before, embryos were synchronised and sampled at 30-minute 
intervals from a single clutch for knockdown, control and wild type conditions in each time-
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series. In the translation blocking MO1 time-series, embryos were collected from 5.5 hpf to 
9.0 hpf. In the translation blocking MO2 time-series, embryos were collected from 4.0 hpf to 
10.0 hpf (Fig. 6.5). The MO1 time-series covered fewer time-points because of lower 
numbers of embryos in the clutch used for collection. The MO2 time series is longer as there 
were more embryos in that particular clutch and this allowed me to extend the time-series 
so I might identify later diverging genes. 
 
 
Figure 6.5. Time-series and animal cap collection times.  The time points collected for the 
three MO knockdown time-series are marked on the time-scale (hpf). The X. laevis mix1-
expressing animal caps were harvested at stage 9 which is equivalent to 6.5 hpf in X. 
tropicalis (see below for details of animal cap experiment).  
 
Instead of using a 5-base mismatch MO as used for the for the Mix1 splice blocking time-
series in Chapter 5, a standard control MO from Gene Tools was used for both time-series. 
This is because the 5-base mismatch MO for the Mix1 splice blocking MO was found to have 
some splice blocking activity in the RNA-seq read alignments (see Chapter 5). Because of this 
I was concerned that any 5-base mismatch MOs designed for the translation blocking MOs 
would have some translation blocking activity. Wild type un-injected embryos were collected 
as an additional control in each time-series. As described for the splice blocking MO time-
series, RNA was sequenced, reads aligned, normalised and analysed for differential 
expression (see Materials and Methods for detail). The wild-type and control MO expression 
profiles were similar in both translation blocking MO time-series. The control profiles were 
used in the differential expression analysis.  
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Figure 6.6. Total differentially expressed genes in the translation blocking MO1 and MO2 
time-series. Numbers of differentially expressed genes in the translation blocking MO1 and 
MO2 time-series. 628 candidate activatory and 103 candidate repressive targets were 
identified in the translation blocking MO1 time-series. 346 candidate activatory and 212 
repressive targets were identified in the translation blocking MO2 time -series. These 
experiments were each carried out in a single clutch of embryos.  
In the translation blocking MO1 time-series 731 genes were detected with differential 
expression in knockdown embryos compared to controls. Of these genes, 628 were down-
regulated after divergence and 103 were up-regulated after divergence (Fig. 6.6). In the 
translation blocking MO2 time-series 558 genes were differentially expressed, of these 346 
were down-regulated after divergence and 212 were up-regulated after divergence (Fig.6.6). 
The full lists of differentially expressed genes can be found in the appendix on the attached 
CD (tab 3 and 4). 
There are clear differences in the number of targets differentially expressed in two different 
translation blocking MO time-series and differences in the proportions of activatory and 
repressive targets. In total 81% of all differentially expressed genes in the MO1 time-series 
and 57% of all differentially expressed genes in the MO2 time-series were not differentially 
expressed in the other translation blocking MO time-series.  
Because the MO1 time-series was sampled from after mix1 was activated, it was not possible 
to test whether control MO and MO1 expression profiles were equal prior to mix1 activation. 
Chapter 6 – Controlling for MO off-target effects to determine Mix1 targets 153 
For this reason, different parameters had to be applied, which required the confidence 
intervals of the control MO and MO1 data points to be within close proximity at the start of 
the time-series (see Materials and Methods for details). This contributes to there being more 
differentially expressed genes in the MO1 compared to the MO2 time-series. I found more 
genes differentially expressed at later time points compared to the MO1 time-series because 
the MO2 time-series extends by an extra two time-points. This has an effect on the overall 
numbers of differentially expressed genes in each time-series. However, these non-
overlapping differentially expressed genes may reflect that off-target effects are prevalent in 
each MO knockdown time-series. 
6.2.5 Comparison of the two translation blocking MO time-series 
As a control for off-target effects, the differentially expressed genes from the two translation 
blocking MO time-series were compared, as it is unlikely that two different MOs targeting 
different sequences would influence the same off-target gene expression. 126 overlapping 
activatory targets and 15 overlapping repressive targets were found (Fig. 6.7). There are 
significantly more genes overlapping than would be expected to overlap by chance i.e. if all 
effects were off-target: only 14.4 activatory targets and 1.4 repressive targets would be 
expected to overlap by chance in the two conditions (8.8x and 10.7x enrichment of activatory 
and repressive targets respectively, chi square test p < 0.0001). The consistent regulation by 
the two MOs indicates that these genes are likely to be targets of Mix1, Mixer or both 
transcription factors, rather than off-target effects.  
Genes up-regulated in both time-series are candidate activatory targets of Mix1 and/or Mixer, 
and genes down-regulated in both time-series are candidate repressive targets of Mix1 
and/or Mixer. Only the genes which were differentially expressed in both translation blocking 
MO time-series were included in further analysis to investigate which genes might be Mix1 
targets. This was achieved first by comparison to the Mix1 specific splice blocking MO data 
and then to mix1-expressing animal cap sequencing data. 
6.2.6 Comparison to the splice blocking MO time-series 
To investigate which genes identified in the Mix1 splice blocking MO time-series (see Chapter 
5) are Mix1 targets, I compared these genes to the candidate Mix1 targets identified in the 
two Mix1 translation blocking MO time-series. I found 32 activatory targets and 3 repressive 
targets which are consistently differentially expressed in the three MO time-series (Fig. 6.7). 
These overlaps are significantly higher than would be expected by chance in the three time-
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series; for activatory targets 0.16 genes would be expected to overlap at random and for 
repressive targets 0.03 genes would be expected to overlap at random (200x enrichment of 
activatory targets and 115x enrichment of repressive targets). Interestingly, 6 genes are 
found in all three MO time-series with conflicting directionality in one time-series. As only 
0.79 genes would be expected to overlap by chance, these genes are 7.6x enriched which is 
significantly more than would be expected to overlap by chance, but is considerably less 
enrichment than is found for the activatory and repressive overlapping targets.  
The overlapping genes from the three knockdown time-series experiments are strong 
candidate Mix1 targets, as they exhibit consistent differential expression in three different 
experimental conditions. These strong candidate Mix1 targets are assigned to Group 1 (See 
table 6.1). Most of the Group 1 strong candidate Mix1 targets are activatory targets and this 
suggests that Mix1 primarily functions as a transcriptional activator.  
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Figure 6.7. Comparison of candidate targets from the three MO time-series. Total 
activatory and repressive candidate Mix1 target genes differentially expressed in the splice 
blocking MO time-series and translation blocking MO1 and MO2 time-series and overlap 
between the conditions (Chi square test p < 0.0001 for activatory and repressive overlaps 
in all three conditions).  
6.2.7 Mix1-expressing animal caps were sequenced to validate Mix1 target genes 
Next I used a gain-of-function approach to determine Mix1 targets using an animal cap assay. 
For practicality, X. laevis embryos were used instead of X. tropicalis because slower cell 
divisions allow more time for animal cap dissection and the larger embryos are easier to 
dissect. X. tropicalis mix1 mRNA was injected into X. laevis embryos, the animal caps were 
dissected at stage 8 and then cultured for two hours and harvested during stage 9. For each 
sample, 30 animal caps were collected from each of four separate clutches to give four 
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replicates of mix1-expressing animal caps but only three replicates of WT caps due to failed 
RNA extraction of one sample (Fig. 6.5). Mix1 activatory targets are likely to be induced in 
animal caps in response to ectopic Mix1 protein. Mix1 repressive targets might be down-
regulated in animal caps in response to ectopic Mix1 protein, provided they were expressed 
in animal cap cells in the first place. 
A preliminary experiment was performed to check that the dose of mix1 mRNA injected was 
sufficient to induce the expression of Mix1 targets in animal caps. The expression of gsc, a 
known Mix1 target from previous work (Latinkic and Smith 1999), was measured by qPCR to 
confirm a significant up-regulation in mix1-expressing animal caps (Fig. 6.8). Vegt expression 
was used as a negative control gene, as this gene was not differentially expressed in the Mix1 
splice blocking MO time-series and is expressed vegetally and is not expressed in animal caps 
(Sudou et al. 2012). As expected, vegt was not induced in mix1-expressing animal caps (Fig. 
6.8). In the wild type embryo, gsc is expressed in dorsal-vegetal tissue and vegt is expressed 
throughout the marginal zone at stage 10 (Sudou et al. 2012). CDNA from dorsal-vegetal 
tissue dissected from stage 10 X. laevis embryos was used as a positive control for gsc and 
vegt expression. The expression level of gsc in mix1-expressing animal caps was 
approximately half as much as in the positive control and vegt expression was much lower in 
mix1-expressing animal caps (Fig. 6.8). This indicates that biologically relevant levels of gsc 
were induced by Mix1 in stage 9 animal caps. Expression of the “housekeeping” gene odc1 
was measured and used to normalise expression levels of gsc and vegt. 
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Figure 6.8. Mix1 induces gsc expression in animal cap explants. Gene expression in dorsal 
tissue and animal cap explants (A) gsc expression in stage 10 dorsal tissue (positive control) 
and stage 9 animal caps, either expressing mix1 (n=4) or wild type (n=3). Expression is 
induced beyond background level in mix1-expressing animal caps. The Student’s t-test was 
applied to Mix1 and WT concentrations to show a significant difference, p-value: 0.0009 
(B) Vegt expression in cDNA from dorsal tissue from stage 10 embryos and animal caps at 
stage 9, either expressing mix1 (n=4) or wild type (n=3). Expression is not induced in animal 
caps. The Student’s t-test was applied to Mix1 and WT concentrations to show no 
significant difference, p-value: 0.0692. 
Following the preliminary experiment which confirmed the induction of the Mix1 target gsc, 
the same animal cap RNA samples used for qPCR were also sequenced. Genes differentially 
expressed between WT and mix1-expressing animal caps are candidate Mix1 targets. The 
fold changes in expression between the replicate WT and mix1-expressing animal caps were 
calculated. Genes with an FDR<0.1 meet the criteria for differential expression. The FDR<0.1 
was used as a threshold to correct for the large number of genes in the data set and allows 
genes with an expected false discovery rate of 10% to meet criteria, which is acceptable since 
the genes are to be used for comparative analysis with other data sets. The X. laevis 
differentially expressed genes were then mapped to the X. tropicalis genes for comparison 
with time-series data (analysis by Nick Owens, see Materials and Methods for detail). 236 
genes were up-regulated in mix1-expressing animal caps and were identified as candidate 
Mix1 activatory targets. 118 genes were down-regulated in mix1-expressing animal caps and 
were identified as candidate Mix1 repressive targets (Fig. 6.9). The full list of differentially 
expressed genes can be found in the appendix on the attached CD (tab 5). 
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Figure 6.9. Total differentially expressed genes in mix1-expressing animal caps. Numbers 
of differentially expressed genes detected in RNA-seq of mix1-expressing animal caps. 236 
candidate activatory and 118 candidate repressive targets were identified. This experiment 
was carried out in four clutches of embryos (mix1 mRNA injected) and three clutches of 
embryos (control un-injected).  
 
6.2.8 Comparison of differentially expressed genes in the three knockdown time-series and 
mix1-expressing animal caps 
To validate candidate Mix1 targets, the Group 1 strong candidate Mix1 targets and candidate 
targets from the animal cap sequencing were compared. Candidate targets which overlap in 
these two sets are considered to be validated because the perturbed expression of these 
genes has been demonstrated in response to both depletion of Mix1 protein in whole 
embryos and to mix1 expression in animal caps. 
Activatory targets are likely to be up-regulated in animal caps, due to activation by Mix1, and 
down-regulated in MO knockdowns in response to depletion of Mix1. The opposite is true 
for repressive targets. However, repressive targets must be expressed in the animal cap to 
be down-regulated by Mix1 in animal cap explants, therefore some repressive targets will 
not be observed in this data.  
Nine genes were consistently differentially regulated in all conditions and therefore I 
designate these genes as validated Mix1 targets and assign them to Group 2 (See table 6.1). 
The nine validated genes are all Mix1 activatory targets and demonstrate a significant overlap 
between the different datasets. Less than one gene would be expected to overlap by chance 
(Fig. 6.10). There were no repressive targets consistently differentially regulated in all 
experimental conditions. There are two Group 1 Mix1 targets for which no orthologue in X. 
laevis could be found. Therefore, there could be more Group 2 validated Mix1 targets which 
cannot be identified in the X. laevis animal caps. 
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Figure 6.10. Comparison of Group 1 strong candidate Mix1 targets and mix1-expressing 
animal cap targets. Total activatory and repressive Group 1 Mix1 strong candidate targets 
and genes differentially expressed in mix1-expressing animal caps and overlap between 
the conditions (Activatory target overlap: Chi square test p <0.0001).  
As the nine Group 2 targets are the only validated Mix1 targets, these are the focus of later 
analysis to understand likely functions of Mix1 through GO analysis and literature searching. 
The validated targets are all activatory targets, six of these are transcription factors; arx, 
foxc1, irx1, irx3, phox2b and msx2, two are signalling molecules; admp and cer1 and finally 
gjb2 is a gap junction protein (Fig. 6.11). 
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Figure 6.11. Group 2 validated Mix1 target expression profiles. Profiles of validated Mix1 
targets which were differentially expressed with consistent differential regulation in the 
splice blocking MO time-series, the translation blocking MO1 time-series, the translation 
blocking MO2 time-series and the animal cap sequencing. The nine validated activatory 
targets admp, arx, cer1, foxc1, gjb2, irx1, irx3, msx2 and phox2b are shown. Normalised 
read counts for Mix1 splice blocking MO (red circles), 5-base mismatch control MO (blue 
circles), Mix1 translation blocking MO1 (red squares), the standard control MO (blue 
squares), Mix1 translation blocking MO2 (red triangles) and the standard control MO (blue 
triangles) were plotted for all time points in the two time-series. Gaussian Process median 
lines and 95% confidence intervals are shown. Red vertical lines mark divergence times and 
grey vertical lines mark the activation time of Mix1 at 4.5 hpf. Four replicates of mix1-
expressing animal caps and three replicates of WT animal caps were sequenced to give 
average normalised reads. Animal cap error bars mark standard deviation, * and ** mark 
p < 0.05 and p < 0.01 respectively. Gene expression profiles and histograms generated by 
Nick Owens.  
Then I examined genes which were not consistently differentially regulated in all four 
conditions. There are 24 genes in Group 1 that are differentially expressed in all three MO 
time-series but not in animal caps. These 24 candidate Mix1 targets found in Group 1 are not 
validated (see discussion). 
Mix1 expression is up-regulated in all three MO time-series and is therefore identified as a 
repressive target. In animal caps mix1 expression is higher in mix1-expressing animal caps 
than in wild types because the mRNA is injected, so mix1 is therefore untestable in the animal 
caps.  
6.2.9 Conflicting differential expression of gsc in the MO time-series 
The Group 1 genes are strong candidate Mix1 targets in the sense that off-target effects are 
well controlled for. However, an issue with the two translation blocking MOs is that they 
target Mix1 and Mixer so the depletion of Mixer may alter the expression of Mix1 targets. 
The expression of the established Mix1 target gsc (Latinkic and Smith 1999) is down-
regulated in the splice blocking MO time-series and up-regulated in both of the translation 
blocking MO time-series. Although gsc expression does not diverge sufficiently to be 
considered differentially expressed in the translation blocking MO1 time-series, it seems 
likely that a longer time-series would reveal differential expression of gsc (Fig. 6.12). The 
opposing regulation of this gene indicates that gsc may be a repressive target of Mixer and 
an activatory target of Mix1. 
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Figure. 6.12. Differential expression of gsc reveals different regulation in the splice and 
translation blocking MO time-series. Gsc expression is down-regulated in the splice 
blocking MO time-series indicating activation by Mix1. Gsc expression is up-regulated in 
the MO1 and MO2 time-series, in which both Mixer and Mix1 are knocked out. These 
opposing effects indicate that Mixer may be responsible for repressing gsc expression in 
wild type embryos. Gene expression profiles generated by Nick Owens.  
6.2.10 Mix1 targets are enriched for transcription factors 
In order to understand more about the role of Mix1, I investigated the number of 
transcription factors in the Group 1 and Group 2 Mix1 targets which contain consistently 
differentially regulated genes (see Materials and Methods for detail). I found significant 
enrichment of transcription factors in both sets, compared to inconsistently differentially 
regulated genes (non-overlapping genes) that did not fall in to Group 1 or Group 2. The 
highest proportion of transcription factors is found in the Group 2 validated Mix1 targets (Fig. 
6.13).  
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Figure 6.13. Many consistently differentially regulated genes in Group 1 and Group 2 are 
transcription factors. Percentage of transcription factors within the Group 1 strong 
candidate Mix1 targets and the Group 2 validated Mix1 targets. Group 1: 10/33 (30%) are 
TFs, Group 2: 6/9 (67%) are TFs. The number of TFs in the consistently differentially 
regulated and inconsistently differentially regulated genes was compared, the Fisher’s 
exact two tailed test p values are: Group 1; 0.0045, Group 2; 0.0006. 4.5% represents the 
percentage of transcription factors present in the X. tropicalis transcriptome.  
6.2.11 Gene ontology analysis of Mix1 targets reveals potential functions of Mix1  
The Mix1 targets were examined using gene ontology (GO) analysis by searching for 
functional annotations of Mix1 target genes (GO analysis by Nick Owens, see Materials and 
Methods for detail). The full list of enriched GO terms can be found in the appendix on the 
attached CD (tabs 7 and 8). Using this information, I can infer the specific functions of Mix1 
as a transcriptional regulator. The Group 1 genes were included in the GO analysis even 
though not all of these genes are validated, this is because they might be absent from the 
animal cap data for various reasons (see discussion). The comparison between the candidate 
and validated targets might reveal similarities between the two sets of genes. Group 2 is a 
subset of Group 1, but some genes which are exclusive to Group 1 are annotated with some 
of the same gene ontology enrichments. A large number of highly enriched GO terms were 
found to be enriched in the Group 1 and Group 2 Mix1 targets.  
The biological process GO terms enriched in the Group 1 and Group 2 Mix1 targets include; 
dorsal/ventral pattern formation, regulation of BMP signalling pathway, mesoderm 
development, cell fate commitment, anterior/posterior pattern specification, regionalization, 
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ossification, brain development, central nervous system development, sensory organ 
development, organ morphogenesis, cell proliferation and locomotion (Fig. 6.14). 
Several GO terms were enriched in Group 1 strong candidate Mix1 targets but not in the 
Group 2 validated Mix1 targets; Somitogenesis, gastrulation and regulation of Wnt receptor 
signaling pathway (Fig. 6.14).  
 
Figure 6.14. Annotated GO terms for biological processes enriched in the Group 1 and 
Group 2 Mix1 targets. Enriched GO terms in Group 1 Mix1 targets (purple) which includes 
validated Mix1 targets with consistent differential expression in all three MO time-series 
and in mix1-expressing animal caps. Enriched terms in Group 2 Mix1 targets (blue) which 
includes strong candidate Mix1 targets with consistent differential expression in all three 
MO time-series. Fold changes represent the observed/expected count for each term. 
 
6.3 Discussion 
6.3.1 Genes are validated through perturbation in various experimental conditions 
My experimental design of combining data from four separate datasets facilitates robust 
identification of Mix1 targets.  I sequenced three different MO time-series as a strategy to 
control for off-target effects and then sequenced mix1-expressing animal caps as an 
additional control to validate the strong candidate Mix1 targets in Group 1. Nine genes were 
identified as activatory targets in the Group 2 Mix1 targets. These are validated Mix1 targets 
since their perturbed expression has been induced by both loss-of-function and gain-of-
function of Mix1. Many of these validated targets are novel Mix1 targets.  
Chapter 6 – Controlling for MO off-target effects to determine Mix1 targets 165 
In support of the validation of these Mix1 targets, I found that a significantly greater number 
of genes are differentially expressed with consistent differential regulation under different 
experimental conditions than would be expected by chance.  The prevalence of transcription 
factors within the validated Mix1 targets, all of which are activatory targets, indicates that 
Mix1 functions to positively regulate early developmental gene regulatory networks.  
The time-series approach facilitates the detection of small changes in expression by using 
sequential time points to calculate the error across the data points, and then to call 
differential expression taking this into account. This means the approach is much more 
powerful than sequencing a single time-point, as small divergences in gene expression might 
be attributed to random variation. Furthermore, as genes have different optimal time-points, 
a single time point approach would not detect the maximum differential expression of many 
genes.  
6.3.2 Limitations of using sequencing data from mix1-expressing animal caps to identify 
Mix1 targets in this analysis 
There are 24 genes from the Group 1 candidate Mix1 targets which are differentially 
expressed in the three MO knockdown time-series but not in mix1-expressing animal caps. 
There are several reasons which may explain why these genes are not differentially expressed 
in animal caps: 
1. Mix1 repressive targets would not be down-regulated in animal caps unless already 
expressed there. There are two repressive targets in Group 1.  
2. No X. laevis orthologue could be found for two of the Group 1 genes, so they could 
not be validated this way. 
3. The animal cap does not recapitulate the conditions of the embryo, so chromatin 
may not be accessible at gene regulatory regions, and co-factors involved in gene 
regulation may not be present in animal cap cells. Targets which are cooperatively 
activated by Mix1 and other transcription factors therefore may not be identified 
using this approach.  
For these reasons, despite not being confirmed by the animal cap overexpression experiment, 
any of these 24 candidate Mix1 targets may be real targets of Mix1. 
Furthermore, in the comparison between time-series and animal cap data, numerous genes 
are differentially expressed in animal caps but are not differentially expressed in any of the 
MO knockdown time-series: 
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1. These could reflect random variation in animal cap gene expression. 
2. These may be targets that are robustly regulated by a gene regulatory network that 
can compensate for the depletion of Mix1 in knockdown embryos.  
3. These may be genes that are not endogenous Mix1 targets, but are regulated by Mix1 
when it is ectopically expressed in animal caps, potentially due to the different 
availability of co-factors.  
6.3.3 Combining data from three conditions controls for MO off-target effects 
In each of the three MO time-series, the majority of differentially expressed genes do not 
overlap with targets identified in the other MO time-series. These are weak candidate targets 
and it is possible that differential expression of some of these genes is caused by off-target 
effects, due to the unintended blocking of gene expression in a MO-specific manner. Another 
possibility is that clutch variation exists, resulting in different genes being differentially 
expressed in separate experiments. This could be caused by varying quantities of maternal 
proteins and transcripts which affects the downstream changes in gene expression. Ideally, 
at least two replicate time-series from different clutches of embryos should have been 
collected for each MO in order to control for this variation. The lack of biological repeats in 
this work may contribute to the lack of overlap between the different conditions. This means 
that the MOs may not each induce numerous off-target effects, and the problem may be 
caused by the experimental design.  
A technical factor which contributes to the numbers of non-overlapping targets found in the 
three MO time-series is the different lengths of the time-series. The different lengths meant 
that a different detection threshold was used for the MO1 time-series because the time-
series was collected after mix1 was activated (see Materials and Methods for detail). The 
different analysis meant more targets could be detected, which could be real targets or off-
target effects. Furthermore, the longer time-series for MO2 means that more late-diverging 
genes were detected than in the other two time-series. This means that, for technical reasons, 
the three time-series are not directly comparable and therefore I cannot determine which 
differentially expressed genes are off-target effects in each time-series. 
Recent work in zebrafish comparing MO knockdown phenotypes to mutant phenotypes 
generated using ZFNs, TALENs and CRISPR has found that approximately 80% of MO 
phenotypes were not recapitulated in mutant embryos (Kok et al. 2015). This study suggests 
that genome targeting knockout approaches are more reliable for phenotypic analysis. This 
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study emphasises the need to exercise caution when using MOs, and I do so by generating 
three independent MO knockdown time-series, and examining only genes which are 
perturbed in all three MO knockdown conditions to control for off-target effects. Also by 
sequencing mix1-expressing animal caps, Mix1 targets are validated, which adds further 
robustness to my approach.  
However, it has been recognised that compensatory pathways can be activated in mutant 
lines which are not activated in MO knockdowns. MO knockdown of the endothelial 
extracellular matrix protein Egfl7 caused severe vascular defects in morphants, whereas 
mutants generated using TALENs displayed no defects apart from brain haemorrhage in 5% 
of cases. These differences were attributed to the up-regulation of the related emilin genes 
which were able to rescue the morphant phenotype (Rossi et al. 2015). Knockout lines may 
have epigenetic alterations which are heritable and alter gene expression to obscure the 
effects of gene deletion. This indicates that MO studies may be more reliable than has been 
suggested in recent knockout studies, since compensatory pathways are not activated in 
morphants.  
In zebrafish embryos, the apoptotic pathway can be activated by MOs, prompting the use of 
p53 knockout zebrafish lines in MO studies. Surprisingly, apoptotic genes were found to 
induce neurogenic gene expression in zebrafish hindbrain boundaries (Gerety and Wilkinson 
2011). This indicates that apoptotic genes have the potential to activate different regulatory 
pathways in MO knockdowns. In both Mix1 knockdown time-series, I found tp53, mdm2 and 
cdkn1a (p21) were not differentially expressed. Bcl3 was up-regulated in the splice blocking 
MO knockdowns and just slightly up-regulated in the translation blocking MO knockdowns 
(although not classified as differentially expressed). Bcl3 is an apoptotic gene, so could be the 
cause of off-target effects in any of the knockdown time-series, which might account for the 
genes differentially expressed in just one MO time-series (Brocke-Heidrich et al. 2006). 
In light of these numerous possible causes of off-target effects, and significant overlap 
between experimental conditions, it is possible that the three MOs target Mix1, but also have 
individual off-target effects. My experimental design addresses this problem by selecting 
only genes that are differentially expressed in all three time-series to control for off-target 
effects to ensure robust identification of Mix1 targets. However, this may eliminate some 
real Mix1 targets that do not appear in one time-series for various reasons (see below). 
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6.3.4 Targets not differentially expressed in all three MO time-series 
The experiments carried out in this thesis may give variable results due to several possible 
factors. Here I explore reasons that might explain why targets might not be identified as 
differentially expressed in all three time-series. 
1. On a technical basis, the differing lengths of time-series mean analysis thresholds 
and detection of targets is different in each time-series experiment. 
2. In the case of the two translation blocking MO time-series, Mixer targets will be 
present which are not found in the splice blocking MO time-series. 
3. False negative and false positive results can be produced as artefacts of the 
experimental method. Each MO injected may have differing efficacy to regulate Mix1 
depletion, and the effect of Mix1 depletion on gene expression may be non-linear 
with respect to the Mix1 concentration where specific thresholds of transcription 
factor binding produce a transcriptional output.  
4. Off-target effects caused by specific MOs blocking expression of unintended genes 
can generate false negative or false positive results, and off-target genes can have 
secondary effects which can lead to further false negative or positive results. 
5. Variation in gene expression between clutches of embryos could mean some genes 
are regulated differently and pathways may be more or less susceptible to Mix1 
depletion.  
 
6.3.5 Mix1 targets not found in this work 
Previous studies have showed that the mesoderm-expressed genes brachyury, fgf4 and fgf8 
were repressed in mix1-overexpressing gastrula stage X. laevis embryos (Colas et al. 2008) 
and a2m (endodermin) and hba1 (α-globin) were marginally induced in mix1-expressing 
animal caps (Henry and Melton 1998). Hba1 is activated much later than could be detected 
by the three MO time-series, and a2m is activated close to the end of the time-series (Owens 
2015), so differential expression of these genes is difficult to determine. Fgf4 is expressed at 
a very low level in wild type embryos (Owens 2015), so may have fallen below the RNA-seq 
detection threshold in either time-series.  
The MO time-series data does not support the finding that fgf8 and brachyury are repressive 
Mix1 targets. Fgf8 is not differentially expressed in any of the MO time-series or in mix1-
expressing animal caps and brachyury was differentially expressed in the translation blocking 
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MO2 time-series where it was up-regulated, but was not differentially expressed in the other 
two MO time-series or in the mix1-expressing animal caps.  
The previous MO study in X. laevis measured the expression of Mix1 target genes after 3 
hours incubation of stage 10 embryos, meaning they were likely stage 11 when the targets 
brachyury, fgf4 and fgf8 were identified (Colas et al. 2008). The longer nature of the MO2 
time-series seems to explain why brachyury was detected here, but not in the other MO time-
series. It is likely that the time-series are not sufficiently long enough to detect all Mix1 
targets. Interestingly, brachyury has been found to be up-regulated in response to Mixer 
knockdown (Kofron, Wylie, and Heasman 2004), so the differential expression seen in the 
MO2 time-series may be an effect of Mixer depletion.   
Brachyury is thought to be indirectly repressed by Mix1 which fits with the idea that Mix1 
represses mesoderm through its activatory function (Lemaire et al. 1998; Latinkic and Smith 
1999; Fletcher, Baker, and Harland 2006). Two suggested mechanisms of the indirect 
repression of brachyury by Mix1 are (i) through repression of fgf8 which is an activator of 
brachyury (Fletcher, Baker, and Harland 2006) or (ii) through activation of gsc, a repressor of 
brachyury (Latinkic and Smith 1999). I find support for neither mechanism, as brachyury and 
fgf8 are not differentially expressed in the Mix1 splice blocking MO knockdown time-series. 
It is possible that Gsc activates brachyury, but since gsc was only partially repressed in the 
splice MO time-series the levels of Gsc might be too high to allow the de-repression of 
brachyury expression. Alternatively, the absence of brachyury and fgf8 in the Mix1 repressive 
target set could potentially arise from gene interaction differences between X. laevis and X. 
tropicalis (Colas et al. 2008).  
6.3.6 Gene ontology analysis of Mix1 targets 
6.3.6.1 Analysis of Mix1 targets reveals a likely function for Mix1 in neural development 
GO analysis of the Mix1 candidate and validated targets revealed enrichment for functional 
annotations in neural development, the terms brain development and central nervous system 
development were enriched in Group 1 and Group 2 Mix1 targets. Previous studies have 
identified functional roles for the nine validated Mix1 targets in neural development. Here I 
outline some of the functions of the validated Mix1 targets in regulation of neural 
development. 
In X. laevis, cer1 is expressed in the anterior endomesoderm at gastrula and neurula stages 
(Bouwmeester et al. 1996). Cer1 is a secreted antagonist of BMP, Wnt and Nodals and is 
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necessary for induction of neuroectoderm (Silva et al. 2003). Irx1 is expressed in the 
presumptive midbrain in the X. laevis embryo and regulates the midbrain-hindbrain 
boundary (Glavic, Gomez-Skarmeta, and Mayor 2001). Irx1 represses transcription of BMP 
and is necessary for neural development (Gomez-Skarmeta, de La Calle-Mustienes, and 
Modolell 2001). The related gene irx3 is expressed in the presumptive midbrain, hindbrain 
and spinal cord in zebrafish (Tan, Korzh, and Gong 1999). Irx3 regulates the patterning of the 
antero-posterior neural axis downstream of Wnt signals in X. laevis (Janssens et al. 2010). Arx 
is expressed in the diencephalon and telencephalon in X. laevis and is necessary for normal 
forebrain development (Seufert, Prescott, and El-Hodiri 2005). Interestingly, Arx antagonises 
irx1 and irx3 in the regionalisation of neural plate. Arx represses the expression of  irx genes 
in the anterior forebrain, and Irx factors repress posterior expression of arx (Rodriguez-
Seguel, Alarcon, and Gomez-Skarmeta 2009). In X. laevis, foxc1 is expressed in the marginal 
zone at the gastrula stage and in the lateral neural plate at the neurula stage and is required 
for normal neural tube development (Koster, Dillinger, and Knochel 1998; Cha et al. 2007). 
In X. laevis, phox2b is expressed in the hindbrain and neural tube as well as the ventral heart 
field (Talikka et al. 2004). Phox2b regulates differentiation of neuronal progenitor cells in 
chick (Dubreuil et al. 2000) and regulates differentiation of motor neurons in mouse 
hindbrain (Pattyn et al. 2000). In X. laevis msx2 is expressed in the epidermal-neural border 
where neural crest is induced. Both msx2 and msx1 are essential for neural crest induction in 
X. laevis (Khadka, Luo, and Sargent 2006). Admp antagonises head formation which contrasts 
with the pro-anterior function of other Mix1 targets (Dosch and Niehrs 2000). In X. laevis 
Admp is expressed in the Spemann organiser and later in the prechordal plate (Moos, Wang, 
and Krinks 1995). The gap junction protein Gjb2 is not well characterised for neural functions, 
but mutation in gjb2 has been linked to neural deafness indicating a likely role in sensory 
organ development (Lee, Derosa, and White 2009).  
Two studies have revealed a potential neural-inductive function of Mix1. In support of a pro-
neural role for Mix1, neural expression of pax2 and pax8 was down-regulated in Mix1 and 
Mix1/Mix2 depleted embryos at the neurula and tailbud stages respectively (Colas et al. 
2008). I did not detect differential expression of pax2 and pax8 because their late expression 
was not within the time-series. The expression of these two genes may be regulated by some 
of the validated Mix1 targets outlined above. 
The zebrafish gene mixl1 is an orthologue of Xenopus mix1 (Ensembl 2015). Mixl1 knockout 
disrupted forebrain development and reduced the expression of the neural plate marker otx2 
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and the dorso-anterior gene gsc (Trinh, Meyer, and Stainier 2003). Mixl1 is not expressed in 
the forebrain, but could regulate forebrain development indirectly through otx2 which has 
an overlapping expression domain with mixl1 in the mesoderm, but is also expressed in the 
ectoderm. This is in accordance with the splice blocking MO time-series where otx2 and gsc 
are down-regulated, and the animal cap data where they are up-regulated. Gsc and otx2 are 
both up-regulated in both translation blocking MO time-series, although only gsc in the 
translation blocking MO2 time-series diverges sufficiently to be considered differentially 
expressed. This suggests that Mixer depletion may be responsible for this up-regulation (see 
below for Mixer discussion). 
Given that most of the validated Mix1 targets are expressed in neural tissues and have 
established roles in regulating neural development it seems likely that, through regulation of 
these targets, Mix1 promotes neural development. Admp is an exception, as this is an anti-
neural BMP signalling molecule, but is important in regulating the BMP gradient which fine 
tunes dorsal and neural patterning (Reversade and De Robertis 2005). 
6.3.6.2 Mix1 as a regulator of dorso-anterior development 
The GO terms dorsal/ventral pattern formation and anterior/posterior pattern specification 
are enriched in the Group 1 and Group 2 Mix1 targets. Many of the Group 2 Mix1 targets are 
expressed in the Spemann organiser at the gastrula stage; admp (Reversade and De Robertis 
2005), gjb2 (Bowes et al. 2010), irx1 (Rodriguez-Seguel, Alarcon, and Gomez-Skarmeta 2009), 
irx3 (Rodriguez-Seguel, Alarcon, and Gomez-Skarmeta 2009) and cer1 (Wills et al. 2008). The 
Spemann organiser has the potential to induce the dorsal axis, which forms anterior 
structures (Cooke 1972), so the expression of the validated Mix1 targets in this region 
supports the idea that these genes contribute to the establishment of the dorsal and anterior 
poles.. 
Support for Mix1 as a regulator of anterior development comes from Mix1 loss-of-function 
studies in which anterior structures were disrupted in X. laevis embryos. Injection of mRNA 
encoding dominant negative Mix1 or antisense mix1 caused embryos to develop dorso-
anterior defects, ranging from reduced anterior structures to complete loss of head 
development (Latinkic and Smith 1999; Lemaire et al. 1998). The two known direct Mix1 
targets, gsc and cer1 (Sudou et al. 2012), are expressed in the dorsal organizer region (De 
Roberts et al. 1992; Bouwmeester et al. 1996) and they both have the ability to induce a 
secondary dorsal axis with ectopic head structures when expressed in the ventral 
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blastomeres (Cho et al. 1991; Bouwmeester et al. 1996). Cer1 is a BMP, Wnt and nodal 
antagonist, and blocking these two signals is sufficient for head induction in ventral marginal 
zone explants (Piccolo et al. 1999). These experiments identify a strong dorso-anterior 
inducing potential for Gsc and Cer1. Cer1 is in the validated Mix1 target set, but gsc is only 
identified as a Mix1 activatory target in the splice blocking MO time-series and animal cap 
data. As discussed earlier, Mixer may affect the expression of gsc, and antagonise the effect 
of Mix1 depletion in the two translation blocking MO time-series.  
In further support for the role of Mix1 in dorso-anterior development, Mix1 can form 
heterodimers with Gsc (Wilson et al. 1993) and Sia (Mead et al. 1996). Ventral injection of 
gsc or sia mRNA was sufficient to induce a secondary dorsal axis including axial and head 
structures (Cho et al. 1991; Lemaire, Garrett, and Gurdon 1995).  
6.3.6.3 Mix1 as a regulator of endoderm and mesoderm development 
The GO term mesoderm development is enriched in the Group 1 and Group 2 Mix1 targets. 
As most Mix1 targets are activatory, this suggests a pro-mesodermal function for Mix1. 
Published studies are somewhat conflicted over the role of Mix1 in mesoderm development. 
Studies have shown that Mix1 can repress mesoderm marker genes in whole embryo 
overexpression experiments (Lemaire et al. 1998; Colas et al. 2008). Some studies propose a 
role for Mix1 in promoting mesoderm development, as Mix1 overexpression can increase 
blood formation, and loss-of-function can block heart development (Mead et al. 1996; 
Latinkic and Smith 1999). It is possible that Mix1 has a dose-dependent effect on mesoderm 
formation, exerting a repressive or activatory effect on genes which specify mesoderm, 
depending on expression level in particular regions.  
6.3.7 The translation blocking MOs target Mix1 and Mixer 
The two translation blocking MOs target Mix1 and Mixer, these two transcription factors may 
have some common and different targets. The homeodomains in Mix1 and Mixer share 84% 
identity in the protein sequences in X. laevis and 77% in X. tropicalis. Mix1 alone does not 
have endoderm inducing potential whereas Mixer does (Doherty et al. 2006). The different 
amino acids in the Mix1 and Mixer homeodomain do not affect endoderm induction, rather 
the conserved c-terminal acidic domain found in Mixer was found to be necessary for 
endoderm induction, but the Mix1 acidic domain with the Mixer homeodomain was 
insufficient for endoderm induction (Doherty et al. 2006). The similarity of the homeodomain 
within the Mix1 and Mixer proteins may account for their similar roles in mesoderm 
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repression (Lemaire et al. 1998; Kofron, Wylie, and Heasman 2004). Given the differing 
endoderm-inducing potential of these two proteins, I would expect them to have some 
different targets. 
The two translation blocking MOs target Mixer and Mix1, so more targets would be expected 
to be shared between the two translation blocking MO time-series than either with the Mix1 
splice blocking MO time-series. I found a slightly larger enrichment in the number of genes 
overlapping between the two translation blocking MOs compared to genes overlapping 
between the splice blocking MO and either one of the translation blocking MOs (5.4x 
enrichment in splice-MO1 overlap, 5.7x enrichment in splice-MO2 overlap, 6.5x enrichment 
in MO1-MO2 overlap). This fits with the idea that the translation blocking MOs would share 
more targets with each other than with the splice blocking MO, because both Mixer and Mix1 
targets are shared.  
The 7.6x enrichment found in the overlap of targets with conflicting directionality of 
differential expression between the three MO time-series (section 6.2.6) may be caused by 
interference by Mixer depletion in the two translation blocking MO time-series. Importantly, 
this enrichment is much lower than is found for the consistently differentially regulated 
targets which supports the idea that these genes are genuinely differentially expressed in 
response to Mix1 depletion. 
Gsc may be an example of a gene that is a target of both Mix1 and Mixer; it is identified as a 
candidate activatory target in the splice blocking MO time-series data and is up-regulated in 
mix1-expressing animal caps. In contrast, gsc is identified as a repressive target in the 
translation blocking MO2 time-series and begins to be up-regulated at the end of the MO1 
time-series. The up-regulation in the translation blocking MO time-series suggests that gsc 
may be a repressive target of Mixer and an activatory target of Mix1. Gsc is an established 
activatory target of Mix1, demonstrated by its expression in mix1-expressing animal caps and 
through cooperative binding of Mix1 to the gsc promoter region (Latinkic and Smith 1999; 
Sudou et al. 2012). It is known that gsc is not an activatory target of Mixer: in an animal cap 
assay in X. laevis, gsc was induced in sox17b-expressing animal caps, but not in mixer-
expressing animal caps (Dickinson, Leonard, and Baker 2006). It is possible that gsc is a 
repressive target of Mixer and that Mixer has a stronger effect than Mix1 on gsc expression, 
which would explain the different regulation between time-series.  
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6.3.8 Some known Mixer targets were consistently differentially expressed in the two 
translation blocking MO time-series but not in the Mix1 splice blocking MO time-series 
To test for Mixer depletion in the two translation blocking MO time-series, I examined 
differential expression of known Mixer targets within the two translation blocking MO time-
series. Using a set of Mixer targets identified previously in a MO knockdown study in X. laevis, 
I searched for differential expression of the activatory targets gata5, cer1, a2m, sox17, 
brachyury, vegt and fgf4 and the repressive targets eomes, bix1, not, gata2, fgf3, fgf8, nodal1 
and nodal5 in the two translation blocking MO time-series (Kofron, Wylie, and Heasman 
2004).  
The activatory targets gata5, sox17a and cer1 were down-regulated in both of the translation 
blocking MO time-series. Cer1 is an established Mix1 target both in previous work and is 
differentially expressed in the splice blocking MO time-series so is most likely a target of both 
Mix1 and Mixer (Sudou et al. 2012). The differential expression of the known Mixer activatory 
targets gata5 and sox17a in the two translation blocking MO time-series but not in the Mix1 
splice blocking MO time-series suggests that these genes are differentially expressed in 
response to Mixer depletion in MO1 and MO2-injected embryos. 
The activatory targets brachyury and vegt were up-regulated only in the MO2 time-series and 
the repressive target eomes was up-regulated only in the MO1 time-series. The activatory 
target sox17b and the repressive targets fgf8, not, gata2, nodal1, nodal5 were not 
differentially expressed in either time-series. The activatory targets a2m and fgf4 and the 
repressive targets bix1.1, bix1.2 and fgf3 expression were not detected in either time-series. 
The reason for the absence of the bix genes is unclear, but the late activation of fgf3 and a2m, 
and the low expression level of fgf4 (Owens 2015), may explain why they were not detected 
in either time-series. 
It is likely that timing is important in identifying transcription factor targets, and the 
regulation of other known targets by Mixer may occur later than the time points covered in 
the two time-series. The depletion of Mixer appears to have a more marked effect on target 
gene expression in the previous MO study at stage 11 than at stage 10 (Kofron, Wylie, and 
Heasman 2004). The 10 hpf time-point roughly coincides with stage 11 in the time-series 
used here, due to slow developing clutches of embryos, so it is likely that more Mixer targets 
would be detected in a longer time-series.  
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6.3.9 The Mix1 translation blocking MO phenotypes 
The two translation blocking MOs targeting Mix1 and Mixer both generated similar 
phenotypic defects when injected. The phenotype is different to the ventralised phenotype 
found in embryos injected with the Mix1 splice blocking MO. There were some similarities, 
as all three MOs generate a truncated phenotype and head and tail defects. The difference 
in phenotype is therefore likely to be caused by the additional Mixer depletion in the two 
translation blocking MO time-series. As mentioned in Chapter 5, the ventralised phenotype 
induced by the splice blocking MO was not found in X. laevis when a Mix1 MO was injected 
(Colas et al. 2008). The ventralised phenotype may then be caused by off-target effects of 
the Mix1 splice blocking MO. 
When comparing the phenotype of the Mix1/Mixer translation blocking MOs to the 
individual Mixer splice blocking MO-induced phenotype (see Chapter 4), there are clear 
similarities. All embryos are truncated with defective head and tail development. 
Interestingly, the loss of head development seems to be more severe in the individual splice 
blocking MOs, whereas one might expect the double knockdown phenotype to be more 
severe. Head development was affected in the three MO knockdowns, which may be caused 
by some loss of neural induction in Mix1 depleted embryos.  
6.3.10 Conclusions 
My experimental design uses multiple knockdown time-series and animal cap expression 
analysis to robustly identify targets of Mix1, an early-activated transcription factor. I 
identified and validated nine Mix1 targets and analysed their known functions in order to 
better understand the role of Mix1 in early development. I found that many Mix1 of these 
promote neural development, suggesting a novel function for Mix1. I identified many weaker 
candidate Mix1 targets, which have similar functional annotation to the validated targets. 
These candidate targets must be validated e.g. using ChIP-seq or mutant embryos to 
demonstrate the transcription factor-target interaction without using MOs. Time-series 
analysis is particularly useful for observing precise timings of gene interactions within a short 
window of development in great detail. This approach could be applied to other early 
transcription factors and used to delineate the GRNs which regulate embryonic development.  
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Chapter 7: Final summary and discussion 
7.1 Chapter 3: mechanisms of gene activation 
In the first results chapter I differentiated between the two mechanisms of gene activation 
in the early embryo; polyadenylation and transcription. I used non-polyA selective gene 
expression analysis to characterise the switch from early polyadenylation of maternally 
deposited transcripts, to de novo transcription shortly before MBT. This builds on previous 
work which suggests there are two early, distinct waves of gene activation and reveals that 
polyadenylation is the predominant mechanism of activation in the first wave and zygotic 
transcription is the predominant mechanism of activation in the second wave. 
7.2 Chapter 4: Morpholino screen of early-activated genes 
In this chapter I set out to select early activated transcription factors for later knockdown 
sequencing analysis to determine transcription factor targets. I screened a selection of 
maternal polyadenylated and zygotically transcribed transcription factors. From this screen I 
selected the zygotically transcribed transcription factor Mix1 due to its transient, early 
activation and the early, and highly penetrant, phenotype produced in response to 
morpholino knockdown.  
7.3 Chapter 5: Investigating downstream targets of Mix1 
The aim of this chapter was to investigate the targets of Mix1 using morpholino knockdown 
and time-series RNA-seq. By comparing divergent expression between the control MO and 
Mix1 splice blocking MO conditions I was able to identify almost 500 candidate Mix1 targets. 
I demonstrated the mis-expression of some of these candidate targets within the mix1 
expression domain. The Mix1 knockdown phenotype was not rescued and without this 
validation, I decided that additional experimental conditions must be tested to control for 
off-target effects of the MO, and to validate the candidate targets using an alternative 
approach. 
I demonstrated the effectiveness of using morpholino knockdown time-series RNA-seq to 
identify transcription factor targets. By sequencing embryos collected at regular time-points 
gene expression changes can be identified and the timing at which regulation events occur 
can be understood. Gaussian process models are used to evaluate and handle experimental 
noise, and call differential expression based on the confidence intervals calculated from the 
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noise. This enables the detection of small changes in gene expression in a way that is not 
reliant on arbitrary thresholds. This approach is more powerful than sequencing a single 
time-point as it possible to ensure that differential expression is caused by a divergence in 
gene expression over time. Different targets would have different optimal time-points for 
measuring differential expression, therefore using a time-series captures a larger range of 
differential expression than a single time-point could. 
7.4 Chapter 6 – Controlling for MO off-target effects to determine Mix1 targets 
In the final results chapter, I introduced two additional morpholinos that target Mix1 and 
Mixer, and also sequence mix1-expressing animal caps. I used the two morpholinos to 
generate two further knockdown time-series, which were sequenced to identify additional 
sets of candidate Mix1 targets: 731 and 558 candidate targets were identified in these two 
experiments. I then compared the candidate targets from the three MO time-series and 
found significant numbers of genes consistently differentially expressed in all three 
conditions; 32 activatory targets and 3 repressive targets. I then tested the effect of Mix1 
gain-of-function by sequencing mix1-expressing animal caps. From this data I identified an 
additional set of 354 candidate Mix1 targets, which I used to validate the targets identified 
in the three MO time-series. Targets were designated as validated if consistently 
differentially regulated in the four experimental conditions which included gain-of-function 
and loss-of-function approaches.  Nine genes had consistent differential regulation in all four 
experimental conditions, and are therefore considered validated Mix1 targets. However, to 
truly validate these targets, the genomic interaction of Mix1 with the regulatory regions of 
these genes should be demonstrated using ChIP analysis. The validated Mix1 targets 
represent a statistically significant overlap between experimental conditions, and are 
enriched for transcription factors indicating that Mix1 has a role in establishing early gene 
regulatory networks. The strong candidate and validated Mix1 targets were enriched for 
gene ontology terms linked to neural development, indicating a novel function for Mix1. 
Gene ontology terms also support the findings from previous studies that suggest Mix1 
regulates dorsal-ventral and antero-posterior patterning.  
Overall this work contributes to the understanding of Mix1 function and for the first time, 
has produced a list of validated Mix1 targets. I detected a large number of differentially 
expressed genes which were unique to each morpholino tested, which suggests that off-
target effects are prevalent in each knockdown. These off-target effects are most likely 
sequence specific for each morpholino, through binding to off-target mRNAs and 
Chapter 7 – Final summary and discussion 178 
unintentionally blocking gene expression. I propose that multiple morpholino time-series 
should be used to control for off-target effects. 
7.5 Limitations of the approaches used in this thesis 
Although the approaches outlined in this thesis have been used to identify targets of Mix1, 
and to suggest likely roles for this transcription factor, some approaches could have been 
carried out more effectively. These are described in the following sections. 
7.5.1 The morpholino screen 
Firstly, in the early morpholino screen to select for phenotypes, screening for phenotypes 
using just one MO allows morpholinos with off target effects to be selected. It was not 
possible to validate all MOs in the screen because of the time-consuming nature of this task. 
Similarly, it was not possible to screen each knockdown for gene expression changes by  in 
situ hybridisation. It may have been more practical to rely on published studies to indicate 
which transcription factors might have a significant developmental role accompanied by 
validations such as rescue. This may have introduced a selection bias, however, for the 
purposes of testing the knockdown time-series RNA-seq approach for the ability to identify 
transcription factor targets, this is not necessarily important. It is likely that interesting data 
could have been generated for any early transcription factor tested, as long as an early 
knockdown phenotype was observed.  
7.5.2 Additional experiments to complement the Mix1 splice blocking morpholino time -
series 
Given the scale of genes with inconsistent differential expression in the three MO time-series 
outlined in this thesis, it is likely that each MO has a large repertoire of off-target effects. 
Based on the small sample of three MOs, I find similar numbers of possible off-target effects 
for each. This supports the idea that these effects are quite general and therefore a good 
strategy for knockdown studies would be to use more than one MO. Here I suggest a series 
of experiments which could be used to further understand the scale of off-target effects, and 
strategies for controlling for these effects.  
Following the Mix1 splice blocking morpholino time-series, in order to fully understand the 
implications of using a morpholino for such a study, a biological replicate time-series using 
the same Mix1 splice blocking MO would have been a good approach for testing the 
variability of gene expression within the system. This biological replicate would allow me to 
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distinguish between clutch-specific effects and MO-specific off-target effects. Then to control 
for MO-specific off-target effects, instead of using two alternative MOs which block 
translation of Mix1 and Mixer, alternative non-overlapping Mix1 splice blocking MO could be 
designed. A morpholino targeting the intron 1-exon 2 boundary would cause the deletion of 
exon 2 which contains a large portion of the homeodomain sequence. This second splice 
blocking MO would be equivalent to the original splice blocking MO so would be a good 
control for off-target effects. As the two translation blocking MOs used in this work target 
both Mix1 and Mixer, due to an identical region in the 5’UTR of both mRNAs, the splice MO 
is preferred as it is specific to Mix1.  
Furthermore, in order to differentiate between off-target effects and technical differences 
between time-series, the collection of the time-series should be as similar as possible. Ideally, 
the two Mix1 splice blocking MOs and control MOs would be injected into embryos from the 
same clutch to control for gene expression variation between clutches and the differences in 
developmental rates. At the very least, clutches of embryos should be collected at the same 
time-points to allow equivalent analysis to allow comparison of targets from different time-
series. Biological replicates should be generated for each time-series. Any genes differentially 
expressed in only one of the Mix1 splice blocking MO time-series would likely be off-target 
effects.  
A ChIP-seq experiment would complement the findings of the Mix1 time-series data. A Mix1 
antibody must first be obtained, and then ChIP-seq could be used to identify genomic binding 
locations of Mix1. An antibody was generated for Mix1; however, it was not immunoreactive 
against Mix1 protein (data not shown). The genes found closest to these binding regions 
would make up a list of candidate Mix1 targets. Comparison to the Mix1 candidate targets 
identified in the knockdown time-series could validate the direct targets of Mix1.  
Mix1 mutant embryos could be generated using the CRISPR-Cas9 technology to induce 
targeted genomic alterations. If the homozygous mutant embryos exhibit the same early 
lethal phenotype as the MO-injected embryos this would indicate that the Mix1 MO is 
responsible for the depletion of Mix1 and that the phenotype is an effect of this. If  the 
homozygous mutant embryos survived through part of development they could be 
sequenced to identify Mix1 targets using the time-series approach. It would be particularly 
interesting to examine whether the targets identified using Mix1 knockdown were the same. 
If compensatory networks were activated in the knockouts, then this would not be useful for 
time-series analysis to identify Mix1 targets (Rossi et al. 2015).  
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If the homozygous mutant embryos did not exhibit any phenotype, this would either indicate 
that the deletion of Mix1 has no major effect on development or that compensatory 
mechanisms are present in the knockout embryos which replace the function of Mix1 
allowing normal development (Rossi et al. 2015).  
7.5.3 Additional experiments to investigate Mix1 function 
The biggest question specific to Mix1 which arises from this work is whether it is essential for 
neural development, or whether it simply contributes to the gene regulatory networks which 
regulate neural development. In order to understand the physiological effects of Mix1 
depletion on neural development, in situ hybridisation for neural markers e.g. the pan-neural 
marker N-CAM, the hindbrain marker Krox-20 and the anterior neural markers En-2, Otx2  
and Foxg1 (Bolce et al. 1992) should be performed. This would reveal whether Mix1 is 
necessary for formation of specific neural tissues. 
The work presented here does not measure combinatorial effects with other transcription 
factors. Mix1 has been shown to bind cooperatively to genomic regulatory regions with other 
transcription factors (Sudou et al. 2012), so future ChIP-seq studies examining the 
cooperative binding of multiple transcription factors will contribute to a richer understanding 
of Mix1 function.  
Mix1 has been shown to dimerise with Gsc (Wilson et al. 1993) and Sia1 (Mead et al. 1996), 
both of which have the ability to induce a secondary dorsal axis with head structures (Cho et 
al. 1991; Lemaire, Garrett, and Gurdon 1995). Furthermore, these three transcription factors 
have been shown to cooperatively regulate the migration of the head mesoderm (Luu et al. 
2008). For these reasons, a ChIP-seq experiment for these three transcription factors could 
be used to determine shared genomic binding regions which might be used to identify targets 
involved in the regulation of dorsal and anterior development.   
Double morpholino knockdown studies of Mix1 with Gsc or Sia1 would be interesting, 
particularly if this data could be compared to ChIP-seq data. Double knockdown time-series 
RNA-seq studies would most likely be problematic because of the potential for both MOs to 
induce off-target effects. Multiple MOs should be used to identify real and off-target effects 
caused by MOs targeting a single gene, then double knockdown time-series sequencing could 
be used, and the known off-target genes could be removed during analysis. The double 
knockdown data could then be compared to the single knockdown data to identify common 
targets which might be compensated for by the other gene in single knockdown experiments.  
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Finally, an interesting experiment would be to dissect Mix1 knockdown embryos and 
sequence different regions of the embryo, e.g. animal and vegetal halves, dorsal and ventral 
halves, and the marginal zone. This might eliminate the problem of small gene expression 
changes not being detectable when whole embryos are sequenced. Since many of the 
validated Mix1 targets are dorsally expressed, sequencing the dorsal half of the embryo 
might reveal more Mix1 targets that exhibit weaker differential expression in response to 
Mix1 depletion.  
7.5.4 Limitations of control morpholinos 
The standard control MO has limited practicality because the off-target effects of 
morpholinos seem to be sequence specific. This means that the same problem may apply to 
5-base mismatch morpholinos. As these are closer in sequence to the morpholino than the 
standard control morpholino, 5 bases may be sufficiently similar to exert an effect on the 
gene of interest. I identified some splice blocking activity for my 5-base mismatch Mix1 
morpholino. Evidence suggests that 4-base mismatch morpholinos have the ability to induce 
phenotypic defects in injected embryos (Wickstrom et al. 2004). Mismatching more bases 
may generate a morpholino so dissimilar to the original that it is not an effective control.  
7.6 Conclusion 
To conclude, I present a strategy for identifying transcription factor targets over a time-series. 
The use of multiple morpholinos controls for off-target effects, which may be prevalent in 
each morpholino knockdown. I used this approach to identify a list of candidate Mix1 targets, 
and validate nine of these targets using animal cap explants. Most of the validated Mix1 
targets have established functions in neural development. This reveals likely novel role for 
Mix1 in the regulation of neural development. This approach could be applied to other early 
transcription factors in order to delineate the early gene regulatory networks which control 
embryonic development.  
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